EU-1-04-273,"{'status': 'ACTIVE', 'name': 'Lysodren', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/273', 'active_substance': 'Mitotane', 'market_auth_holder': 'HRA Pharma Rare Diseases', 'atc_code': 'L01XX23'}"
EU-1-04-274,"{'status': 'ACTIVE', 'name': 'VELCADE', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/274', 'active_substance': 'bortezomib', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'L01XG01'}"
EU-1-04-275,"{'status': 'ACTIVE', 'name': 'Litak', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/275', 'active_substance': 'Cladribine', 'market_auth_holder': 'Lipomed GmbH', 'atc_code': 'L01BB04'}"
EU-1-98-091,"{'status': 'ACTIVE', 'name': 'Kinzalmono', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/091', 'active_substance': 'telmisartan', 'market_auth_holder': 'Bayer AG', 'atc_code': 'C09CA07'}"
EU-1-04-278,"{'status': 'ACTIVE', 'name': 'Levemir', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/278', 'active_substance': 'insulin detemir', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AE05'}"
EU-1-04-276,"{'status': 'ACTIVE', 'name': 'Abilify', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/276', 'active_substance': 'aripiprazole', 'market_auth_holder': 'Otsuka Pharmaceutical Netherlands B.V.', 'atc_code': 'N05AX12'}"
EU-1-04-277,"{'status': 'ACTIVE', 'name': 'TachoSil', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/277', 'active_substance': 'Human Fibrinogen / Human Thrombin', 'market_auth_holder': 'Corza Medical GmbH', 'atc_code': 'B02BC30'}"
EU-1-04-281,"{'status': 'ACTIVE', 'name': 'Erbitux', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/281', 'active_substance': 'cetuximab', 'market_auth_holder': 'Merck Europe B.V.'}"
EU-1-04-282,"{'status': 'ACTIVE', 'name': 'Telzir', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/282', 'active_substance': 'Fosamprenavir', 'market_auth_holder': 'ViiV Healthcare BV', 'atc_code': 'J05AE07'}"
EU-1-04-279,"{'status': 'ACTIVE', 'name': 'Lyrica', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/279', 'active_substance': 'pregabalin', 'market_auth_holder': 'Upjohn EESV', 'atc_code': 'N03AX16'}"
EU-1-04-280,"{'status': 'ACTIVE', 'name': 'Yentreve', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/280', 'active_substance': 'duloxetine hydrochloride', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'N06AX21'}"
EU-1-04-284,"{'status': 'ACTIVE', 'name': 'Pedea', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/284', 'active_substance': 'Ibuprofen', 'market_auth_holder': 'Recordati Rare Diseases', 'atc_code': 'C01EB16'}"
EU-1-04-285,"{'status': 'ACTIVE', 'name': 'Apidra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/285', 'active_substance': 'Insulin glulisine', 'market_auth_holder': 'Sanofi-Aventis Deutschland GmbH', 'atc_code': 'A10AB06'}"
EU-1-04-286,"{'status': 'ACTIVE', 'name': 'Wilzin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/286', 'active_substance': 'Zinc acetate dihydrate', 'market_auth_holder': 'Recordati Rare Diseases', 'atc_code': 'A16AX05'}"
EU-1-04-290,"{'status': 'ACTIVE', 'name': 'Alimta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/290', 'active_substance': 'pemetrexed', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'L01BA04'}"
EU-1-04-292,"{'status': 'ACTIVE', 'name': 'Mimpara', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/292', 'active_substance': 'Cinacalcet', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'H05BX01'}"
EU-1-04-294,"{'status': 'ACTIVE', 'name': 'Emselex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/294', 'active_substance': 'darifenacin hydrobromide', 'market_auth_holder': 'zr pharma&amp; GmbH', 'atc_code': 'G04BD10'}"
EU-1-04-295,"{'status': 'ACTIVE', 'name': 'Xagrid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/295', 'active_substance': 'anagrelide', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'L01XX35'}"
EU-1-04-296,"{'status': 'ACTIVE', 'name': 'Cymbalta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/296', 'active_substance': 'duloxetine hydrochloride', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'N06AX21'}"
EU-1-04-298,"{'status': 'ACTIVE', 'name': 'Kivexa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/298', 'active_substance': 'abacavir / Lamivudine', 'market_auth_holder': 'ViiV Healthcare BV', 'atc_code': 'J05AR02'}"
EU-1-04-299,"{'status': 'ACTIVE', 'name': 'Fendrix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/299', 'active_substance': 'Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)', 'market_auth_holder': 'GlaxoSmithKline Biologicals S.A.', 'atc_code': 'J07BC01'}"
EU-1-04-300,"{'status': 'ACTIVE', 'name': 'Avastin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/300', 'active_substance': 'bevacizumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01XC07'}"
EU-1-04-302,"{'status': 'ACTIVE', 'name': 'Prialt', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/302', 'active_substance': 'ziconotide', 'market_auth_holder': 'Esteve Pharmaceuticals GmbH', 'atc_code': 'N02BG08'}"
EU-1-04-303,"{'status': 'ACTIVE', 'name': 'Orfadin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/303', 'active_substance': 'Nitisinone', 'market_auth_holder': 'Swedish Orphan Biovitrum International AB', 'atc_code': 'A16AX04'}"
EU-1-04-305,"{'status': 'ACTIVE', 'name': 'Truvada', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/305', 'active_substance': 'emtricitabine / tenofovir disoproxil fumarate', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AR03'}"
EU-1-04-304,"{'status': 'ACTIVE', 'name': 'Azilect', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/304', 'active_substance': 'rasagiline', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'N04BD02'}"
EU-1-04-306,"{'status': 'ACTIVE', 'name': 'Aloxi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/306', 'active_substance': 'Palonosetron', 'market_auth_holder': 'Helsinn Birex Pharmaceuticals Ltd', 'atc_code': 'A04AA05'}"
EU-1-04-307,"{'status': 'ACTIVE', 'name': 'Zonegran', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/04/307', 'active_substance': 'zonisamide', 'market_auth_holder': 'Amdipharm Limited', 'atc_code': 'N03AX15'}"
EU-1-05-308,"{'status': 'ACTIVE', 'name': 'Aclasta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/308', 'active_substance': 'zoledronic acid', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'M05BA08'}"
EU-1-05-310,"{'status': 'ACTIVE', 'name': 'Fosavance', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/310', 'active_substance': 'Alendronate Sodium / Colecalciferol', 'market_auth_holder': 'N.V. Organon', 'atc_code': 'M05BB03'}"
EU-1-05-311,"{'status': 'ACTIVE', 'name': 'Tarceva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/311', 'active_substance': 'Erlotinib', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01EB02'}"
EU-1-05-312,"{'status': 'ACTIVE', 'name': 'Xyrem', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/312', 'active_substance': 'Sodium oxybate', 'market_auth_holder': 'UCB Pharma S.A.', 'atc_code': 'N07XX04'}"
EU-1-05-315,"{'status': 'ACTIVE', 'name': 'APTIVUS', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/315', 'active_substance': 'Tipranavir', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'J05AE09'}"
EU-1-05-316,"{'status': 'ACTIVE', 'name': 'Procoralan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/316', 'active_substance': 'Ivabradine', 'market_auth_holder': 'Les Laboratoires Servier', 'atc_code': 'C01EB17'}"
EU-1-05-317,"{'status': 'ACTIVE', 'name': 'Corlentor', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/317', 'active_substance': 'Ivabradine', 'market_auth_holder': 'Les Laboratoires Servier', 'atc_code': 'C01EB17'}"
EU-1-05-320,"{'status': 'ACTIVE', 'name': 'Noxafil', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/320', 'active_substance': 'Posaconazole', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J02AC04'}"
EU-1-05-319,"{'status': 'ACTIVE', 'name': 'Xolair', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/319', 'active_substance': 'omalizumab', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03DX05'}"
EU-1-05-318,"{'status': 'ACTIVE', 'name': 'Revatio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/318', 'active_substance': 'sildenafil', 'market_auth_holder': 'Upjohn EESV', 'atc_code': 'G04BE03'}"
EU-1-05-322,"{'status': 'ACTIVE', 'name': 'Yttriga', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/322', 'active_substance': 'Yttrium (<sup>90</sup>Y) Chloride', 'market_auth_holder': 'Eckert &amp; Ziegler Radiopharma GmbH', 'atc_code': 'V10X'}"
EU-1-05-323,"{'status': 'ACTIVE', 'name': 'ProQuad', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/323', 'active_substance': 'Measles, Mumps, Rubella and Varicella Vaccine (Live)', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J07BD54'}"
EU-1-05-324,"{'status': 'ACTIVE', 'name': 'Naglazyme', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/324', 'active_substance': 'galsulfase', 'market_auth_holder': 'BioMarin International Limited', 'atc_code': 'A16AB08'}"
EU-1-05-328,"{'status': 'ACTIVE', 'name': 'Cubicin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/328', 'active_substance': 'Daptomycin', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J01XX09'}"
EU-1-05-329,"{'status': 'ACTIVE', 'name': 'Kiovig', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/329', 'active_substance': 'Human normal immunoglobulin (IVIg)', 'market_auth_holder': 'Baxter AG', 'atc_code': 'J06BA02'}"
EU-1-05-330,"{'status': 'ACTIVE', 'name': 'Rotarix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/330', 'active_substance': 'Rotavirus vaccine, live', 'market_auth_holder': 'GlaxoSmithKline Biologicals S.A.', 'atc_code': 'J07BH01'}"
EU-1-05-331,"{'status': 'ACTIVE', 'name': 'Neupro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/05/331', 'active_substance': 'Rotigotine', 'market_auth_holder': 'UCB Pharma S.A.', 'atc_code': 'N04BC09'}"
EU-1-06-332,"{'status': 'ACTIVE', 'name': 'Omnitrope', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/332', 'active_substance': 'Somatropin', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'H01AC01'}"
EU-1-06-333,"{'status': 'ACTIVE', 'name': 'Myozyme', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/333', 'active_substance': 'alglucosidase alfa', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'A16AB07'}"
EU-1-06-336,"{'status': 'ACTIVE', 'name': 'Tygacil', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/336', 'active_substance': 'Tigecycline', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'J01AA12'}"
EU-1-06-337,"{'status': 'ACTIVE', 'name': 'M-M-RVAXPRO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/337', 'active_substance': 'Measles, Mumps and Rubella Vaccine (Live)', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J07BD52'}"
EU-1-06-334,"{'status': 'ACTIVE', 'name': 'Evoltra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/334', 'active_substance': 'clofarabine', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'L01BB06'}"
EU-1-06-338,"{'status': 'ACTIVE', 'name': 'DuoTrav', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/338', 'active_substance': 'Travoprost / Timolol', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01ED51'}"
EU-1-06-340,"{'status': 'ACTIVE', 'name': 'Ganfort', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/340', 'active_substance': 'bimatoprost / timolol', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'S01ED51'}"
EU-1-06-341,"{'status': 'ACTIVE', 'name': 'Zostavax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/341', 'active_substance': 'shingles (herpes zoster) vaccine (live)', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J07BK02'}"
EU-1-06-342,"{'status': 'ACTIVE', 'name': 'Nexavar', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/342', 'active_substance': 'Sorafenib', 'market_auth_holder': 'Bayer AG', 'atc_code': 'L01EX02'}"
EU-1-06-346,"{'status': 'ACTIVE', 'name': 'Tysabri', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/346', 'active_substance': 'Natalizumab', 'market_auth_holder': 'Biogen Netherlands B.V.', 'atc_code': 'L04AA23'}"
EU-1-06-347,"{'status': 'ACTIVE', 'name': 'Sutent', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/347', 'active_substance': 'sunitinib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01EX01'}"
EU-1-06-343,"{'status': 'ACTIVE', 'name': 'Baraclude', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/343', 'active_substance': 'entecavir', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'J05AF10'}"
EU-1-06-348,"{'status': 'ACTIVE', 'name': 'RotaTeq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/348', 'active_substance': 'Rotavirus vaccine (live, oral)', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J07BH02'}"
EU-1-06-350,"{'status': 'ACTIVE', 'name': 'Savene', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/350', 'active_substance': 'Dexrazoxane', 'market_auth_holder': 'Clinigen Healthcare B.V.', 'atc_code': 'V03AF02'}"
EU-1-06-354,"{'status': 'ACTIVE', 'name': 'Competact', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/354', 'active_substance': 'Pioglitazone / metformin', 'market_auth_holder': 'CHEPLAPHARM Arzneimittel GmbH', 'atc_code': 'A10BD05'}"
EU-1-06-356,"{'status': 'ACTIVE', 'name': 'Exjade', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/356', 'active_substance': 'deferasirox', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'V03AC03'}"
EU-1-06-357,"{'status': 'ACTIVE', 'name': 'Gardasil', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/357', 'active_substance': 'Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J07BM01'}"
EU-1-06-359,"{'status': 'ACTIVE', 'name': 'Suboxone', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/359', 'active_substance': 'buprenorphine / naloxone', 'market_auth_holder': 'Indivior Europe Limited', 'atc_code': 'N07BC51'}"
EU-1-06-360,"{'status': 'ACTIVE', 'name': 'Champix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/360', 'active_substance': 'varenicline tartrate', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'N07BA03'}"
EU-1-06-361,"{'status': 'ACTIVE', 'name': 'Luminity', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/361', 'active_substance': 'perflutren', 'market_auth_holder': 'Lantheus EU Limited', 'atc_code': 'V08DA04'}"
EU-1-06-362,"{'status': 'ACTIVE', 'name': 'Byetta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/362', 'active_substance': 'exenatide', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'A10BJ01'}"
EU-1-06-363,"{'status': 'ACTIVE', 'name': 'Sprycel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/363', 'active_substance': 'Dasatinib', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'L01XE06'}"
EU-1-06-367,"{'status': 'ACTIVE', 'name': 'Diacomit', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/367', 'active_substance': 'Stiripentol', 'market_auth_holder': 'Biocodex', 'atc_code': 'N03AX17'}"
EU-1-06-364,"{'status': 'ACTIVE', 'name': 'Adrovance', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/364', 'active_substance': 'Alendronate sodium / Colecalciferol', 'market_auth_holder': 'N.V. Organon', 'atc_code': 'M05BB03'}"
EU-1-06-365,"{'status': 'ACTIVE', 'name': 'Elaprase', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/365', 'active_substance': 'Idursulfase', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'A16AB09'}"
EU-1-06-366,"{'status': 'ACTIVE', 'name': 'Tandemact', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/366', 'active_substance': 'Pioglitazone / Glimepiride', 'market_auth_holder': 'CHEPLAPHARM Arzneimittel GmbH', 'atc_code': 'A10BD06'}"
EU-1-06-378,"{'status': 'ACTIVE', 'name': 'Inovelon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/378', 'active_substance': 'Rufinamide', 'market_auth_holder': 'Eisai GmbH', 'atc_code': 'N03AF03'}"
EU-1-06-376,"{'status': 'ACTIVE', 'name': 'Irbesartan Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/376', 'active_substance': 'Irbesartan', 'market_auth_holder': 'Zentiva k.s.', 'atc_code': 'C09DA04'}"
EU-1-06-370,"{'status': 'ACTIVE', 'name': 'Exforge', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/370', 'active_substance': 'amlodipine / valsartan', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'C09DB01'}"
EU-1-06-372,"{'status': 'ACTIVE', 'name': 'Copalia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/372', 'active_substance': 'amlodipine / valsartan', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'C09DB01'}"
EU-1-06-371,"{'status': 'ACTIVE', 'name': 'Dafiro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/371', 'active_substance': 'amlodipine / valsartan', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'C09DB01'}"
EU-1-06-374,"{'status': 'ACTIVE', 'name': 'Lucentis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/374', 'active_substance': 'ranibizumab', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01LA04'}"
EU-1-06-377,"{'status': 'ACTIVE', 'name': 'Irbesartan HCT Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/377', 'active_substance': 'irbesartan / hydrochlorothiazide', 'market_auth_holder': 'Zentiva k.s.', 'atc_code': 'C09DA04'}"
EU-1-06-380,"{'status': 'ACTIVE', 'name': 'PREZISTA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/380', 'active_substance': 'darunavir', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'J05AE10'}"
EU-1-06-379,"{'status': 'ACTIVE', 'name': 'Cystadane', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/06/379', 'active_substance': 'Betaine anhydrous', 'market_auth_holder': 'Recordati Rare Diseases', 'atc_code': 'A16AA06'}"
EU-1-07-382,"{'status': 'ACTIVE', 'name': 'Xelevia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/382', 'active_substance': 'sitagliptin', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BH01'}"
EU-1-07-383,"{'status': 'ACTIVE', 'name': 'Januvia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/383', 'active_substance': 'sitagliptin', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BH01'}"
EU-1-07-387,"{'status': 'ACTIVE', 'name': 'Advagraf', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/387', 'active_substance': 'Tacrolimus', 'market_auth_holder': 'Astellas Pharma Europe B.V.', 'atc_code': 'L04AD02'}"
EU-1-07-386,"{'status': 'ACTIVE', 'name': 'Toviaz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/386', 'active_substance': 'fesoterodine', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'G04BD11'}"
EU-1-07-389,"{'status': 'ACTIVE', 'name': 'Orencia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/389', 'active_substance': 'abatacept', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'L04AA24'}"
EU-1-07-391,"{'status': 'ACTIVE', 'name': 'Revlimid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/391', 'active_substance': 'Lenalidomide', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'L04AX04'}"
EU-1-07-392,"{'status': 'ACTIVE', 'name': 'Circadin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/392', 'active_substance': 'Melatonin', 'market_auth_holder': 'RAD Neurim Pharmaceuticals EEC SARL', 'atc_code': 'N05CH01'}"
EU-1-07-393,"{'status': 'ACTIVE', 'name': 'Soliris', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/393', 'active_substance': 'Eculizumab', 'market_auth_holder': 'Alexion Europe SAS', 'atc_code': 'L04AA25'}"
EU-1-07-396,"{'status': 'ACTIVE', 'name': 'Pergoveris', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/396', 'active_substance': 'follitropin alfa / lutropin alfa', 'market_auth_holder': 'Merck Europe B.V.', 'atc_code': 'G03GA30'}"
EU-1-07-395,"{'status': 'ACTIVE', 'name': 'Invega', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/395', 'active_substance': 'paliperidone', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'N05AX13'}"
EU-1-07-397,"{'status': 'ACTIVE', 'name': 'Siklos', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/397', 'active_substance': 'hydroxycarbamide', 'market_auth_holder': 'Addmedica', 'atc_code': 'L01XX05'}"
EU-1-07-400,"{'status': 'ACTIVE', 'name': 'Mircera', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/400', 'active_substance': 'methoxy polyethylene glycol-epoetin beta', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'B03XA03'}"
EU-1-07-399,"{'status': 'ACTIVE', 'name': 'Aerinaze', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/399', 'active_substance': 'desloratadine; pseudoephedrine sulphate', 'market_auth_holder': 'N.V. Organon', 'atc_code': 'R06AX27'}"
EU-1-07-401,"{'status': 'ACTIVE', 'name': 'alli', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/401', 'active_substance': 'Orlistat', 'market_auth_holder': 'GlaxoSmithKline Dungarvan Limited', 'atc_code': 'A08AB01'}"
EU-1-07-402,"{'status': 'ACTIVE', 'name': 'INCRELEX', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/402', 'active_substance': 'Mecasermin', 'market_auth_holder': 'Ipsen Pharma', 'atc_code': 'H01AC03'}"
EU-1-07-403,"{'status': 'ACTIVE', 'name': 'Atriance', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/403', 'active_substance': 'nelarabine', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L01BB07'}"
EU-1-07-404,"{'status': 'ACTIVE', 'name': 'Flebogamma DIF', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/404', 'active_substance': 'Human normal immunoglobulin (IVIg)', 'market_auth_holder': 'Instituto Grifols, S.A.', 'atc_code': 'J06BA02'}"
EU-1-07-412,"{'status': 'ACTIVE', 'name': 'Abseamed', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/412', 'active_substance': 'epoetin alfa', 'market_auth_holder': 'Medice Arzneimittel P&#252;tter GmbH &amp; Co KG', 'atc_code': 'B03XA01'}"
EU-1-07-405,"{'status': 'ACTIVE', 'name': 'Rasilez', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/405', 'active_substance': 'aliskiren', 'market_auth_holder': 'Noden Pharma DAC', 'atc_code': 'C09XA02'}"
EU-1-07-410,"{'status': 'ACTIVE', 'name': 'Binocrit', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/410', 'active_substance': 'epoetin alfa', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'B03XA01'}"
EU-1-07-411,"{'status': 'ACTIVE', 'name': 'Epoetin alfa Hexal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/411', 'active_substance': 'epoetin alfa', 'market_auth_holder': 'Hexal AG', 'atc_code': 'B03XA01'}"
EU-1-07-413,"{'status': 'ACTIVE', 'name': 'Gliolan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/413', 'active_substance': '5-aminolevulinic acid hydrochloride', 'market_auth_holder': 'photonamic GmbH &amp; Co. KG', 'atc_code': 'L01XD04'}"
EU-1-07-414,"{'status': 'ACTIVE', 'name': 'Galvus', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/414', 'active_substance': 'vildagliptin', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'A10BH02'}"
EU-1-07-415,"{'status': 'ACTIVE', 'name': 'Zalasta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/415', 'active_substance': 'Olanzapine', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'N05AH03'}"
EU-1-07-416,"{'status': 'ACTIVE', 'name': 'Ecalta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/416', 'active_substance': 'anidulafungin', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'J02AX06'}"
EU-1-07-417,"{'status': 'ACTIVE', 'name': 'Yondelis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/417', 'active_substance': 'Trabectedin', 'market_auth_holder': 'Pharma Mar S.A.', 'atc_code': 'L01CX01'}"
EU-1-07-418,"{'status': 'ACTIVE', 'name': 'Celsentri', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/418', 'active_substance': 'maraviroc', 'market_auth_holder': 'ViiV Healthcare BV', 'atc_code': 'J05AX09'}"
EU-1-07-419,"{'status': 'ACTIVE', 'name': 'Cervarix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/419', 'active_substance': 'Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins', 'market_auth_holder': 'GlaxoSmithKline Biologicals S.A.', 'atc_code': 'J07BM02'}"
EU-1-07-424,"{'status': 'ACTIVE', 'name': 'Torisel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/424', 'active_substance': 'Temsirolimus', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01EG01'}"
EU-1-07-420,"{'status': 'ACTIVE', 'name': 'Cyanokit', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/420', 'active_substance': 'hydroxocobalamin', 'market_auth_holder': 'SERB S.A.', 'atc_code': 'V03AB33'}"
EU-1-07-425,"{'status': 'ACTIVE', 'name': 'Eucreas', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/425', 'active_substance': 'vildagliptin / metformin hydrochloride', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'A10BD08'}"
EU-1-07-422,"{'status': 'ACTIVE', 'name': 'Tasigna', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/422', 'active_substance': 'Nilotinib', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L01XE08'}"
EU-1-07-423,"{'status': 'ACTIVE', 'name': 'Vectibix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/423', 'active_substance': 'panitumumab', 'market_auth_holder': 'Amgen Europe B.V.'}"
EU-1-07-427,"{'status': 'ACTIVE', 'name': 'Olanzapine Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/427', 'active_substance': 'Olanzapine', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'N05AH03'}"
EU-1-07-431,"{'status': 'ACTIVE', 'name': 'Retacrit', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/431', 'active_substance': 'epoetin zeta', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'B03XA01'}"
EU-1-07-432,"{'status': 'ACTIVE', 'name': 'Silapo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/432', 'active_substance': 'epoetin zeta', 'market_auth_holder': 'STADA Arzneimittel AG', 'atc_code': 'B03XA01'}"
EU-1-07-433,"{'status': 'ACTIVE', 'name': 'Nevanac', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/433', 'active_substance': 'nepafenac', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01BC10'}"
EU-1-07-428,"{'status': 'ACTIVE', 'name': 'Abraxane', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/428', 'active_substance': 'paclitaxel', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'L01CD01'}"
EU-1-07-434,"{'status': 'ACTIVE', 'name': 'Avamys', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/434', 'active_substance': 'Fluticasone furoate', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'R01AD12'}"
EU-1-07-436,"{'status': 'ACTIVE', 'name': 'Isentress', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/436', 'active_substance': 'raltegravir', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J05AX08'}"
EU-1-07-438,"{'status': 'ACTIVE', 'name': 'Myfenax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/438', 'active_substance': 'Mycophenolate mofetil', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'L04AA06'}"
EU-1-07-439,"{'status': 'ACTIVE', 'name': 'Mycophenolate mofetil Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/439', 'active_substance': 'Mycophenolate mofetil', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'L04AA06'}"
EU-1-07-440,"{'status': 'ACTIVE', 'name': 'Tyverb', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/440', 'active_substance': 'lapatinib', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L01XE07'}"
EU-1-08-441,"{'status': 'ACTIVE', 'name': 'Effentora', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/441', 'active_substance': 'fentanyl citrate', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'N02AB03'}"
EU-1-08-442,"{'status': 'ACTIVE', 'name': 'Pradaxa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/442', 'active_substance': 'dabigatran etexilate mesilate', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'B01AE07'}"
EU-1-08-446,"{'status': 'ACTIVE', 'name': 'Privigen', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/446', 'active_substance': 'Human normal immunoglobulin (IVIg)', 'market_auth_holder': 'CSL Behring GmbH', 'atc_code': 'J06BA02'}"
EU-1-08-447,"{'status': 'ACTIVE', 'name': 'Adenuric', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/447', 'active_substance': 'febuxostat', 'market_auth_holder': 'Menarini International Operations Luxembourg S.A.', 'atc_code': 'M04AA03'}"
EU-1-95-003,"{'status': 'ACTIVE', 'name': 'Betaferon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/95/003', 'active_substance': 'Interferon beta-1b', 'market_auth_holder': 'Bayer AG', 'atc_code': 'L03AB08'}"
EU-1-95-002,"{'status': 'ACTIVE', 'name': 'Taxotere', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/95/002', 'active_substance': 'Docetaxel', 'market_auth_holder': 'Sanofi Mature IP', 'atc_code': 'L01CD02'}"
EU-1-96-005,"{'status': 'ACTIVE', 'name': 'CellCept', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/005', 'active_substance': 'Mycophenolate mofetil', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L04AA06'}"
EU-1-96-004,"{'status': 'ACTIVE', 'name': 'Fareston', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/004', 'active_substance': 'Toremifene', 'market_auth_holder': 'Orion Corporation', 'atc_code': 'L02BA02'}"
EU-1-96-006,"{'status': 'ACTIVE', 'name': 'NovoSeven', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/006', 'active_substance': 'Eptacog alfa (activated)', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'B02BD08'}"
EU-1-96-007,"{'status': 'ACTIVE', 'name': 'Humalog', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/007', 'active_substance': 'Insulin lispro', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'A10AB04'}"
EU-1-96-008,"{'status': 'ACTIVE', 'name': 'Puregon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/008', 'active_substance': 'follitropin beta', 'market_auth_holder': 'N.V. Organon', 'atc_code': 'G03GA06'}"
EU-1-96-012,"{'status': 'ACTIVE', 'name': 'Bondronat', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/012', 'active_substance': 'Ibandronic acid', 'market_auth_holder': 'Atnahs Pharma Netherlands B.V.', 'atc_code': 'M05BA06'}"
EU-1-97-033,"{'status': 'ACTIVE', 'name': 'Avonex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/033', 'active_substance': 'Interferon Beta - 1a', 'market_auth_holder': 'Biogen Netherlands B.V.', 'atc_code': 'L03AB07'}"
EU-1-96-018,"{'status': 'ACTIVE', 'name': 'Rapilysin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/018', 'active_substance': 'Reteplase', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'B01AD07'}"
EU-1-96-010,"{'status': 'ACTIVE', 'name': 'Rilutek', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/010', 'active_substance': 'Riluzole', 'market_auth_holder': 'Sanofi Mature IP', 'atc_code': 'N07XX02'}"
EU-1-96-020,"{'status': 'ACTIVE', 'name': 'Twinrix Adult', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/020', 'active_substance': 'Hepatitis A and hepatitis B vaccine', 'market_auth_holder': 'GlaxoSmithKline Biologicals S.A.', 'atc_code': 'J07BC20'}"
EU-1-96-022,"{'status': 'ACTIVE', 'name': 'Zyprexa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/022', 'active_substance': 'Olanzapine', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'N05AH03'}"
EU-1-97-031,"{'status': 'ACTIVE', 'name': 'NeoRecormon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/031', 'active_substance': 'Epoetin beta', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'B03XA01'}"
EU-1-96-027,"{'status': 'ACTIVE', 'name': 'Hycamtin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/027', 'active_substance': 'Topotecan hydrochloride', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L01CE01'}"
EU-1-96-015,"{'status': 'ACTIVE', 'name': 'Epivir', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/015', 'active_substance': 'Lamivudine', 'market_auth_holder': 'ViiV Healthcare B.V.', 'atc_code': 'J05AF05'}"
EU-1-96-016,"{'status': 'ACTIVE', 'name': 'Norvir', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/016', 'active_substance': 'Ritonavir', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'J05AE03'}"
EU-1-97-029,"{'status': 'ACTIVE', 'name': 'Twinrix Paediatric', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/029', 'active_substance': 'Hepatitis A and Hepatitis B vaccine', 'market_auth_holder': 'GlaxoSmithKline Biologicals S.A.', 'atc_code': 'J07BC20'}"
EU-1-97-044,"{'status': 'ACTIVE', 'name': 'Tasmar', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/044', 'active_substance': 'Tolcapone', 'market_auth_holder': 'Meda AB', 'atc_code': 'N04BX01'}"
EU-1-97-039,"{'status': 'ACTIVE', 'name': 'Cystagon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/039', 'active_substance': 'Mercaptamine bitartrate', 'market_auth_holder': 'Recordati Rare Diseases', 'atc_code': 'A16AA04'}"
EU-1-97-045,"{'status': 'ACTIVE', 'name': 'Helicobacter Test INFAI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/045', 'active_substance': '&#185;&#179;C - urea', 'market_auth_holder': 'INFAI GmbH', 'atc_code': 'V04CX'}"
EU-1-97-046,"{'status': 'ACTIVE', 'name': 'Aprovel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/046', 'active_substance': 'Irbesartan', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'C09CA04'}"
EU-1-97-047,"{'status': 'ACTIVE', 'name': 'BeneFIX', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/047', 'active_substance': 'Nonacog alfa', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'B02BD04'}"
EU-1-97-049,"{'status': 'ACTIVE', 'name': 'Karvea', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/049', 'active_substance': 'Irbesartan', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'C09CA04'}"
EU-1-97-051,"{'status': 'ACTIVE', 'name': 'Mirapexin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/051', 'active_substance': 'pramipexole', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'N04BC05'}"
EU-1-97-050,"{'status': 'ACTIVE', 'name': 'Sifrol', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/050', 'active_substance': 'pramipexole', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'N04BC05'}"
EU-1-97-053,"{'status': 'ACTIVE', 'name': 'Cerezyme', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/053', 'active_substance': 'imiglucerase', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'A16AB02'}"
EU-1-97-057,"{'status': 'ACTIVE', 'name': 'Quadramet', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/057', 'active_substance': 'Samarium [153 Sm] lexidronam pentasodium', 'market_auth_holder': 'CIS bio international', 'atc_code': 'V10BX02'}"
EU-1-97-055,"{'status': 'ACTIVE', 'name': 'Viramune', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/055', 'active_substance': 'nevirapine', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'J05AG01'}"
EU-1-98-058,"{'status': 'ACTIVE', 'name': 'Combivir', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/058', 'active_substance': 'lamivudine / zidovudine', 'market_auth_holder': 'ViiV Healthcare BV', 'atc_code': 'J05AR01'}"
EU-1-98-064,"{'status': 'ACTIVE', 'name': 'Pylobactell', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/064', 'active_substance': '&#185;&#179;C-urea', 'market_auth_holder': 'Torbet Laboratories Ireland Limited', 'atc_code': 'V04CX'}"
EU-1-98-063,"{'status': 'ACTIVE', 'name': 'Rebif', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/063', 'active_substance': 'Interferon beta-1a', 'market_auth_holder': 'Merck Europe B.V.', 'atc_code': 'L03AB07'}"
EU-1-98-067,"{'status': 'ACTIVE', 'name': 'Mabthera', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/067', 'active_substance': 'Rituximab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01XC02'}"
EU-1-98-065,"{'status': 'ACTIVE', 'name': 'Optison', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/065', 'active_substance': 'Perflutren', 'market_auth_holder': 'GE Healthcare AS', 'atc_code': 'V08DA01'}"
EU-1-98-066,"{'status': 'ACTIVE', 'name': 'Exelon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/066', 'active_substance': 'Rivastigmine', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'N06DA03'}"
EU-1-98-069,"{'status': 'ACTIVE', 'name': 'Plavix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/069', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'B01AC04'}"
EU-1-98-070,"{'status': 'ACTIVE', 'name': 'Iscover', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/070', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'B01AC04'}"
EU-1-98-071,"{'status': 'ACTIVE', 'name': 'Xenical', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/071', 'active_substance': 'Orlistat', 'market_auth_holder': 'CHEPLAPHARM Arzneimittel GmbH', 'atc_code': 'A08AB01'}"
EU-1-98-076,"{'status': 'ACTIVE', 'name': 'NovoNorm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/076', 'active_substance': 'Repaglinide', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10BX02'}"
EU-1-98-073,"{'status': 'ACTIVE', 'name': 'Evista', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/073', 'active_substance': 'Raloxifene hydrochloride', 'market_auth_holder': 'SUBSTIPHARM', 'atc_code': 'G03XC01'}"
EU-1-98-074,"{'status': 'ACTIVE', 'name': 'Optruma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/074', 'active_substance': 'Raloxifene hydrochloride', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'G03XC01'}"
EU-1-98-077,"{'status': 'ACTIVE', 'name': 'Viagra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/077', 'active_substance': 'sildenafil', 'market_auth_holder': 'Upjohn EESV', 'atc_code': 'G04BE03'}"
EU-1-98-080,"{'status': 'ACTIVE', 'name': 'Aldara', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/080', 'active_substance': 'Imiquimod', 'market_auth_holder': 'Meda AB', 'atc_code': 'D06BB10'}"
EU-1-98-081,"{'status': 'ACTIVE', 'name': 'Comtan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/081', 'active_substance': 'entacapone', 'market_auth_holder': 'Orion Corporation', 'atc_code': 'N04BX02'}"
EU-1-98-082,"{'status': 'ACTIVE', 'name': 'Comtess', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/082', 'active_substance': 'entacapone', 'market_auth_holder': 'Orion Corporation', 'atc_code': 'N04BX02'}"
EU-1-98-084,"{'status': 'ACTIVE', 'name': 'Simulect', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/084', 'active_substance': 'basiliximab', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L04AA02'}"
EU-1-98-086,"{'status': 'ACTIVE', 'name': 'CoAprovel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/086', 'active_substance': 'Irbesartan / hydrochlorothiazide', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'C09DA04'}"
EU-1-98-085,"{'status': 'ACTIVE', 'name': 'Karvezide', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/085', 'active_substance': 'Irbesartan / hydrochlorothiazide', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'C09DA04'}"
EU-1-97-030,"{'status': 'ACTIVE', 'name': 'Insuman', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/97/030', 'active_substance': 'human insulin', 'market_auth_holder': 'Sanofi-Aventis Deutschland GmbH', 'atc_code': 'A10AB01'}"
EU-1-98-092,"{'status': 'ACTIVE', 'name': 'Prometax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/092', 'active_substance': 'Rivastigmine', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'N06DA03'}"
EU-1-98-089,"{'status': 'ACTIVE', 'name': 'Pritor', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/089', 'active_substance': 'telmisartan', 'market_auth_holder': 'Bayer AG', 'atc_code': 'C09CA07'}"
EU-1-98-090,"{'status': 'ACTIVE', 'name': 'Micardis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/090', 'active_substance': 'telmisartan', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'C09CA07'}"
EU-1-98-096,"{'status': 'ACTIVE', 'name': 'Temodal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/096', 'active_substance': 'temozolomide', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'L01AX03'}"
EU-1-98-095,"{'status': 'ACTIVE', 'name': 'Emadine', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/98/095', 'active_substance': 'emedastine', 'market_auth_holder': 'Immedica Pharma AB', 'atc_code': 'S01GX06'}"
EU-1-99-097,"{'status': 'ACTIVE', 'name': 'Beromun', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/097', 'active_substance': 'Tasonermin (Tumor Necrosis Factor alfa-1a)', 'market_auth_holder': 'BELPHARMA s.a.', 'atc_code': 'L03AX11'}"
EU-1-99-100,"{'status': 'ACTIVE', 'name': 'Cetrotide', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/100', 'active_substance': 'Cetrorelix (as acetate)', 'market_auth_holder': 'Merck Europe B.V.', 'atc_code': 'H01CC02'}"
EU-1-99-103,"{'status': 'ACTIVE', 'name': 'ReFacto AF', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/103', 'active_substance': 'Moroctocog alfa', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'B02BD02'}"
EU-1-99-107,"{'status': 'ACTIVE', 'name': 'Rebetol', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/107', 'active_substance': 'ribavirin', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J05AP01'}"
EU-1-99-108,"{'status': 'ACTIVE', 'name': 'Ferriprox', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/108', 'active_substance': 'Deferiprone', 'market_auth_holder': 'Chiesi Farmaceutici S.p.A.', 'atc_code': 'V03AC02'}"
EU-1-96-026,"{'status': 'ACTIVE', 'name': 'Invirase', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/026', 'active_substance': 'Saquinavir', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'J05AE01'}"
EU-1-99-110,"{'status': 'ACTIVE', 'name': 'Sustiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/110', 'active_substance': 'efavirenz', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'J05AG03'}"
EU-1-99-111,"{'status': 'ACTIVE', 'name': 'Stocrin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/111', 'active_substance': 'efavirenz', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J05AG03'}"
EU-1-99-109,"{'status': 'ACTIVE', 'name': 'Integrilin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/109', 'active_substance': 'Eptifibatide', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'B01AC16'}"
EU-1-99-112,"{'status': 'ACTIVE', 'name': 'Ziagen', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/112', 'active_substance': 'abacavir sulfate', 'market_auth_holder': 'ViiV Healthcare BV', 'atc_code': 'J05AF06'}"
EU-1-99-114,"{'status': 'ACTIVE', 'name': 'Zeffix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/114', 'active_substance': 'Lamivudine', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'J05AF05'}"
EU-1-99-116,"{'status': 'ACTIVE', 'name': 'Remicade', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/116', 'active_substance': 'infliximab', 'market_auth_holder': 'Janssen Biologics B.V.', 'atc_code': 'L04AB02'}"
EU-1-99-119,"{'status': 'ACTIVE', 'name': 'NovoRapid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/119', 'active_substance': 'Insulin aspart', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AB05'}"
EU-1-99-117,"{'status': 'ACTIVE', 'name': 'Synagis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/117', 'active_substance': 'palivizumab', 'market_auth_holder': 'AstraZeneca AB'}"
EU-1-99-118,"{'status': 'ACTIVE', 'name': 'Arava', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/118', 'active_substance': 'leflunomide', 'market_auth_holder': 'Sanofi-Aventis Deutschland GmbH', 'atc_code': 'L04AA13'}"
EU-1-99-120,"{'status': 'ACTIVE', 'name': 'Ammonaps', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/120', 'active_substance': 'Sodium phenylbutyrate', 'market_auth_holder': 'Immedica Pharma AB', 'atc_code': 'A16AX03'}"
EU-1-99-122,"{'status': 'ACTIVE', 'name': 'Thyrogen', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/122', 'active_substance': 'Thyrotropin alfa', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'H01AB01'}"
EU-1-99-123,"{'status': 'ACTIVE', 'name': 'Renagel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/123', 'active_substance': 'Sevelamer', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'V03AE02'}"
EU-1-99-124,"{'status': 'ACTIVE', 'name': 'Tractocile', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/124', 'active_substance': 'Atosiban', 'market_auth_holder': 'Ferring Pharmaceuticals A/S', 'atc_code': 'G02CX01'}"
EU-1-99-125,"{'status': 'ACTIVE', 'name': 'Zyprexa Velotab', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/125', 'active_substance': 'Olanzapine', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'N05AH03'}"
EU-1-99-126,"{'status': 'ACTIVE', 'name': 'Enbrel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/99/126', 'active_substance': 'Etanercept', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L04AB01'}"
EU-1-00-129,"{'status': 'ACTIVE', 'name': 'Azopt', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/129', 'active_substance': 'Brinzolamide', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01EC04'}"
EU-1-00-130,"{'status': 'ACTIVE', 'name': 'Orgalutran', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/130', 'active_substance': 'ganirelix', 'market_auth_holder': 'N.V. Organon', 'atc_code': 'H01CC01'}"
EU-1-00-134,"{'status': 'ACTIVE', 'name': 'Lantus', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/134', 'active_substance': 'insulin glargine', 'market_auth_holder': 'Sanofi-Aventis Deutschland GmbH', 'atc_code': 'A10AE04'}"
EU-1-00-135,"{'status': 'ACTIVE', 'name': 'DaTSCAN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/135', 'active_substance': 'Ioflupane (123I)', 'market_auth_holder': 'GE Healthcare B.V.', 'atc_code': 'V09AB03'}"
EU-1-00-140,"{'status': 'ACTIVE', 'name': 'Visudyne', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/140', 'active_substance': 'verteporfin', 'market_auth_holder': 'CHEPLAPHARM Arzneimittel GmbH', 'atc_code': 'S01LA01'}"
EU-1-00-142,"{'status': 'ACTIVE', 'name': 'NovoMix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/142', 'active_substance': 'Insulin aspart', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AD05'}"
EU-1-00-143,"{'status': 'ACTIVE', 'name': 'KOGENATE Bayer', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/143', 'active_substance': 'Recombinant coagulation factor VIII (octocog alfa)', 'market_auth_holder': 'Bayer AG', 'atc_code': 'B02BD02'}"
EU-1-00-145,"{'status': 'ACTIVE', 'name': 'Herceptin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/145', 'active_substance': 'trastuzumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01XC03'}"
EU-1-00-146,"{'status': 'ACTIVE', 'name': 'Keppra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/146', 'active_substance': 'levetiracetam', 'market_auth_holder': 'UCB Pharma S.A.', 'atc_code': 'N03AX14'}"
EU-1-00-149,"{'status': 'ACTIVE', 'name': 'Panretin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/149', 'active_substance': 'alitretinoin', 'market_auth_holder': 'Amdipharm Limited', 'atc_code': 'L01XX22'}"
EU-1-00-152,"{'status': 'ACTIVE', 'name': 'Infanrix hexa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/152', 'active_substance': 'diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine (adsorbed)', 'market_auth_holder': 'GlaxoSmithKline Biologicals S.A.', 'atc_code': 'J07CA09'}"
EU-1-00-150,"{'status': 'ACTIVE', 'name': 'Actos', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/150', 'active_substance': 'pioglitazone', 'market_auth_holder': 'CHEPLAPHARM Arzneimittel GmbH', 'atc_code': 'A10BG03'}"
EU-1-00-155,"{'status': 'ACTIVE', 'name': 'Luveris', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/155', 'active_substance': 'Lutropin alfa', 'market_auth_holder': 'Merck Europe B.V.', 'atc_code': 'G03GA07'}"
EU-1-00-156,"{'status': 'ACTIVE', 'name': 'Trizivir', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/156', 'active_substance': 'abacavir, lamivudine, zidovudine', 'market_auth_holder': 'ViiV Healthcare BV', 'atc_code': 'J05AR02'}"
EU-1-00-157,"{'status': 'ACTIVE', 'name': 'Azomyr', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/157', 'active_substance': 'desloratadine', 'market_auth_holder': 'N.V. Organon', 'atc_code': 'R06AX27'}"
EU-1-00-160,"{'status': 'ACTIVE', 'name': 'Aerius', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/160', 'active_substance': 'desloratadine', 'market_auth_holder': 'N.V. Organon', 'atc_code': 'R06AX27'}"
EU-1-00-161,"{'status': 'ACTIVE', 'name': 'Neoclarityn', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/161', 'active_substance': 'desloratadine', 'market_auth_holder': 'N.V. Organon', 'atc_code': 'R06AX27'}"
EU-1-00-162,"{'status': 'ACTIVE', 'name': 'Prandin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/162', 'active_substance': 'Repaglinide', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10BX02'}"
EU-1-00-163,"{'status': 'ACTIVE', 'name': 'Xeloda', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/163', 'active_substance': 'capecitabine', 'market_auth_holder': 'CHEPLAPHARM Arzneimittel GmbH', 'atc_code': 'L01BC06'}"
EU-1-00-166,"{'status': 'ACTIVE', 'name': 'NeuroBloc', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/166', 'active_substance': 'Botulinum Toxin Type B', 'market_auth_holder': 'Sloan Pharma S.a.r.l.', 'atc_code': 'M03AX01'}"
EU-1-00-165,"{'status': 'ACTIVE', 'name': 'Ovitrelle', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/165', 'active_substance': 'Choriogonadotrophin alfa', 'market_auth_holder': 'Merck Europe B.V.', 'atc_code': 'G03GA08'}"
EU-1-00-164,"{'status': 'ACTIVE', 'name': 'NutropinAq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/164', 'active_substance': 'Somatropin', 'market_auth_holder': 'Ipsen Pharma', 'atc_code': 'H01AC01'}"
EU-1-00-169,"{'status': 'ACTIVE', 'name': 'Metalyse', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/169', 'active_substance': 'tenecteplase', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'B01AD11'}"
EU-1-00-170,"{'status': 'ACTIVE', 'name': 'Fasturtec', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/170', 'active_substance': 'rasburicase', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'V03AF07'}"
EU-1-01-171,"{'status': 'ACTIVE', 'name': 'Rapamune', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/171', 'active_substance': 'sirolimus', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L04AA10'}"
EU-1-01-172,"{'status': 'ACTIVE', 'name': 'Kaletra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/172', 'active_substance': 'lopinavir / Ritonavir', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'J05AR10'}"
EU-1-01-173,"{'status': 'ACTIVE', 'name': 'Vaniqa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/173', 'active_substance': 'eflornithine', 'market_auth_holder': 'Almirall, S.A.', 'atc_code': 'D11AX16'}"
EU-1-01-176,"{'status': 'ACTIVE', 'name': 'Zometa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/176', 'active_substance': 'zoledronic acid', 'market_auth_holder': 'Phoenix Labs Unlimited Company', 'atc_code': 'M05BA08'}"
EU-1-01-177,"{'status': 'ACTIVE', 'name': 'SonoVue', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/177', 'active_substance': 'sulphur hexafluoride', 'market_auth_holder': 'Bracco International B.V.', 'atc_code': 'V08DA05'}"
EU-1-01-178,"{'status': 'ACTIVE', 'name': 'Targretin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/178', 'active_substance': 'bexarotene', 'market_auth_holder': 'Eisai GmbH', 'atc_code': 'L01XF03'}"
EU-1-01-183,"{'status': 'ACTIVE', 'name': 'HBVAXPRO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/183', 'active_substance': 'Recombinant Hepatitis B virus small surface antigen (HbsAg)', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J07BC01'}"
EU-1-01-185,"{'status': 'ACTIVE', 'name': 'Aranesp', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/185', 'active_substance': 'darbepoetin alfa', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'B03XA02'}"
EU-1-01-190,"{'status': 'ACTIVE', 'name': 'Ceprotin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/190', 'active_substance': 'Protein C', 'market_auth_holder': 'Baxter AG', 'atc_code': 'B01AD12'}"
EU-1-01-188,"{'status': 'ACTIVE', 'name': 'Fabrazyme', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/188', 'active_substance': 'Agalsidase beta', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'A16AB04'}"
EU-1-01-189,"{'status': 'ACTIVE', 'name': 'Replagal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/189', 'active_substance': 'Agalsidase alfa', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'A16AB03'}"
EU-1-01-194,"{'status': 'ACTIVE', 'name': 'INOmax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/194', 'active_substance': 'Nitric oxide', 'market_auth_holder': 'Linde Healthcare AB', 'atc_code': 'R07AX01'}"
EU-1-01-195,"{'status': 'ACTIVE', 'name': 'Liprolog', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/195', 'active_substance': 'Insulin lispro', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'A10AB04'}"
EU-1-01-196,"{'status': 'ACTIVE', 'name': 'CANCIDAS', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/196', 'active_substance': 'caspofungin', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J02AX04'}"
EU-1-01-197,"{'status': 'ACTIVE', 'name': 'Foscan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/197', 'active_substance': 'temoporfin', 'market_auth_holder': 'biolitec Pharma Ltd', 'atc_code': 'L01XD05'}"
EU-1-01-198,"{'status': 'ACTIVE', 'name': 'Glivec', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/198', 'active_substance': 'Imatinib', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L01EA01'}"
EU-1-01-199,"{'status': 'ACTIVE', 'name': 'Travatan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/199', 'active_substance': 'Travoprost', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01EE04'}"
EU-1-01-200,"{'status': 'ACTIVE', 'name': 'Viread', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/01/200', 'active_substance': 'tenofovir disoproxil fumarate', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AF07'}"
EU-1-02-201,"{'status': 'ACTIVE', 'name': 'Protopic', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/201', 'active_substance': 'Tacrolimus', 'market_auth_holder': 'Leo Pharma A/S', 'atc_code': 'D11AH01'}"
EU-1-02-205,"{'status': 'ACTIVE', 'name': 'Lumigan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/205', 'active_substance': 'Bimatoprost', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'S01EE03'}"
EU-1-02-203,"{'status': 'ACTIVE', 'name': 'Kineret', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/203', 'active_substance': 'Anakinra', 'market_auth_holder': 'Swedish Orphan Biovitrum AB (publ)', 'atc_code': 'L04AC03'}"
EU-1-02-209,"{'status': 'ACTIVE', 'name': 'Dynastat', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/209', 'active_substance': 'Parecoxib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'M01AH04'}"
EU-1-02-206,"{'status': 'ACTIVE', 'name': 'Arixtra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/206', 'active_substance': 'Fondaparinux sodium', 'market_auth_holder': 'Mylan IRE Healthcare Limited', 'atc_code': 'B01AX05'}"
EU-1-02-212,"{'status': 'ACTIVE', 'name': 'Vfend', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/212', 'active_substance': 'voriconazole', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'J02AC03'}"
EU-1-02-214,"{'status': 'ACTIVE', 'name': 'Kinzalkomb', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/214', 'active_substance': 'Telmisartan / hydrochlorothiazide', 'market_auth_holder': 'Bayer AG', 'atc_code': 'C09DA07'}"
EU-1-02-215,"{'status': 'ACTIVE', 'name': 'PritorPlus', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/215', 'active_substance': 'Telmisartan / hydrochlorothiazide', 'market_auth_holder': 'Bayer AG', 'atc_code': 'C09DA07'}"
EU-1-02-213,"{'status': 'ACTIVE', 'name': 'MicardisPlus', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/213', 'active_substance': 'Telmisartan / hydrochlorothiazide', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'C09CA07'}"
EU-1-02-216,"{'status': 'ACTIVE', 'name': 'Invanz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/216', 'active_substance': 'Ertapenem', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J01DH03'}"
EU-1-02-217,"{'status': 'ACTIVE', 'name': 'Opatanol', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/217', 'active_substance': 'Olopatadine', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01GX09'}"
EU-1-02-219,"{'status': 'ACTIVE', 'name': 'Ebixa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/219', 'active_substance': 'Memantine', 'market_auth_holder': 'H. Lundbeck A/S', 'atc_code': 'N06DX01'}"
EU-1-02-218,"{'status': 'ACTIVE', 'name': 'Axura', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/218', 'active_substance': 'Memantine', 'market_auth_holder': 'Merz Pharmaceuticals GmbH', 'atc_code': 'N06DX01'}"
EU-1-02-220,"{'status': 'ACTIVE', 'name': 'Tracleer', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/220', 'active_substance': 'bosentan', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'C02KX01'}"
EU-1-02-221,"{'status': 'ACTIVE', 'name': 'Pegasys', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/221', 'active_substance': 'peginterferon alfa-2a', 'market_auth_holder': 'zr pharma&amp; GmbH', 'atc_code': 'L03AB11'}"
EU-1-02-222,"{'status': 'ACTIVE', 'name': 'Tamiflu', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/222', 'active_substance': 'Oseltamivir', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'J05AH02'}"
EU-1-02-224,"{'status': 'ACTIVE', 'name': 'Ambirix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/224', 'active_substance': 'Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)', 'market_auth_holder': 'GlaxoSmithKline Biologicals S.A.', 'atc_code': 'J07BC20'}"
EU-1-02-223,"{'status': 'ACTIVE', 'name': 'Evra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/223', 'active_substance': 'Norelgestromin / Ethinyl estradiol', 'market_auth_holder': 'Gedeon Richter Plc.', 'atc_code': 'G03AA13'}"
EU-1-02-226,"{'status': 'ACTIVE', 'name': 'InductOs', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/226', 'active_substance': 'Dibotermin alfa', 'market_auth_holder': 'Medtronic BioPharma B.V.', 'atc_code': 'M05BC01'}"
EU-1-02-227,"{'status': 'ACTIVE', 'name': 'Neulasta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/227', 'active_substance': 'Pegfilgrastim', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'L03AA13'}"
EU-1-02-229,"{'status': 'ACTIVE', 'name': 'Actraphane', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/229', 'active_substance': 'Insulin human (rDNA)', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AD01'}"
EU-1-02-230,"{'status': 'ACTIVE', 'name': 'Actrapid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/230', 'active_substance': 'Insulin human (rDNA)', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AB01'}"
EU-1-02-234,"{'status': 'ACTIVE', 'name': 'Protaphane', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/234', 'active_substance': 'Insulin human (rDNA)', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AC01'}"
EU-1-02-233,"{'status': 'ACTIVE', 'name': 'Insulatard', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/233', 'active_substance': 'Insulin human (rDNA)', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AC01'}"
EU-1-02-231,"{'status': 'ACTIVE', 'name': 'Mixtard', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/231', 'active_substance': 'Insulin human (rDNA)', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AD01'}"
EU-1-02-237,"{'status': 'ACTIVE', 'name': 'Cialis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/237', 'active_substance': 'tadalafil', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'G04BE08'}"
EU-1-02-240,"{'status': 'ACTIVE', 'name': 'Somavert', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/240', 'active_substance': 'Pegvisomant', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'H01AX01'}"
EU-1-02-238,"{'status': 'ACTIVE', 'name': 'Zavesca', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/238', 'active_substance': 'Miglustat', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'A16AX06'}"
EU-1-02-246,"{'status': 'ACTIVE', 'name': 'Carbaglu', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/246', 'active_substance': 'Carglumic acid', 'market_auth_holder': 'Recordati Rare Diseases', 'atc_code': 'A16AA05'}"
EU-1-03-248,"{'status': 'ACTIVE', 'name': 'Levitra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/248', 'active_substance': 'Vardenafil', 'market_auth_holder': 'Bayer AG', 'atc_code': 'G04BE09'}"
EU-1-03-251,"{'status': 'ACTIVE', 'name': 'Hepsera', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/251', 'active_substance': 'adefovir dipivoxil', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AF08'}"
EU-1-03-249,"{'status': 'ACTIVE', 'name': 'Vivanza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/249', 'active_substance': 'Vardenafil', 'market_auth_holder': 'Bayer AG', 'atc_code': 'G04BE09'}"
EU-1-03-247,"{'status': 'ACTIVE', 'name': 'Forsteo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/247', 'active_substance': 'Teriparatide', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'H05AA02'}"
EU-1-03-252,"{'status': 'ACTIVE', 'name': 'Fuzeon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/252', 'active_substance': 'Enfuvirtide', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'J05AX07'}"
EU-1-03-253,"{'status': 'ACTIVE', 'name': 'Aldurazyme', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/253', 'active_substance': 'Laronidase', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'A16AB05'}"
EU-1-03-254,"{'status': 'ACTIVE', 'name': 'Busilvex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/254', 'active_substance': 'busulfan', 'market_auth_holder': 'PIERRE FABRE MEDICAMENT', 'atc_code': 'L01AB01'}"
EU-1-03-255,"{'status': 'ACTIVE', 'name': 'Ventavis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/255', 'active_substance': 'Iloprost', 'market_auth_holder': 'Bayer AG', 'atc_code': 'B01AC11'}"
EU-1-03-256,"{'status': 'ACTIVE', 'name': 'Humira', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/256', 'active_substance': 'Adalimumab', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'L04AB04'}"
EU-1-03-260,"{'status': 'ACTIVE', 'name': 'Stalevo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/260', 'active_substance': 'Levodopa,carbidopa,entacapone', 'market_auth_holder': 'Orion Corporation', 'atc_code': 'N04BA03'}"
EU-1-03-262,"{'status': 'ACTIVE', 'name': 'Emend', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/262', 'active_substance': 'aprepitant', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A04AD12'}"
EU-1-03-263,"{'status': 'ACTIVE', 'name': 'Dukoral', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/263', 'active_substance': 'Oral cholera vaccine', 'market_auth_holder': 'Valneva Sweden AB', 'atc_code': 'J07AE01'}"
EU-1-03-261,"{'status': 'ACTIVE', 'name': 'Emtriva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/261', 'active_substance': 'Emtricitabine', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AF09'}"
EU-1-03-264,"{'status': 'ACTIVE', 'name': 'Zevalin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/264', 'active_substance': 'Ibritumomab tiuxetan', 'market_auth_holder': 'Ceft Biopharma s.r.o', 'atc_code': 'V10XX02'}"
EU-1-03-265,"{'status': 'ACTIVE', 'name': 'Bonviva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/265', 'active_substance': 'Ibandronic acid', 'market_auth_holder': 'Atnahs Pharma Netherlands B.V.', 'atc_code': 'M05BA06'}"
EU-1-03-269,"{'status': 'ACTIVE', 'name': 'Faslodex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/269', 'active_substance': 'Fulvestrant', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'L02BA03'}"
EU-1-03-270,"{'status': 'ACTIVE', 'name': 'Kentera', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/270', 'active_substance': 'Oxybutynin', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'G04BD04'}"
EU-1-03-267,"{'status': 'ACTIVE', 'name': 'Reyataz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/267', 'active_substance': 'atazanavir sulphate', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'J05AE08'}"
EU-1-03-268,"{'status': 'ACTIVE', 'name': 'Cholestagel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/268', 'active_substance': 'colesevelam hydrochloride', 'market_auth_holder': 'CHEPLAPHARM Arzneimittel GmbH', 'atc_code': 'C10AC04'}"
EU-1-10-639,"{'status': 'ACTIVE', 'name': 'Telmisartan Actavis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/639', 'active_substance': 'telmisartan', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'C09CA07'}"
EU-1-10-642,"{'status': 'ACTIVE', 'name': 'Ibandronic Acid Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/642', 'active_substance': 'Ibandronic acid', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'M05BA06'}"
EU-1-10-641,"{'status': 'ACTIVE', 'name': 'Ruconest', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/641', 'active_substance': 'Conestat alfa', 'market_auth_holder': 'Pharming Group N.V.', 'atc_code': 'B06AC04'}"
EU-1-10-640,"{'status': 'ACTIVE', 'name': 'Sycrest', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/640', 'active_substance': 'asenapine', 'market_auth_holder': 'Organon N.V.', 'atc_code': 'N05AH05'}"
EU-1-10-643,"{'status': 'ACTIVE', 'name': 'Rapiscan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/643', 'active_substance': 'regadenoson', 'market_auth_holder': 'GE Healthcare AS', 'atc_code': 'C01EB21'}"
EU-1-10-644,"{'status': 'ACTIVE', 'name': 'PecFent', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/644', 'active_substance': 'Fentanyl', 'market_auth_holder': 'Kyowa Kirin Holdings B.V.', 'atc_code': 'N02AB03'}"
EU-1-10-646,"{'status': 'ACTIVE', 'name': 'VPRIV', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/646', 'active_substance': 'Velaglucerase alfa', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'A16AB10'}"
EU-1-10-645,"{'status': 'ACTIVE', 'name': 'Brinavess', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/645', 'active_substance': 'vernakalant hydrochloride', 'market_auth_holder': 'Correvio', 'atc_code': 'C01BG11'}"
EU-1-10-647,"{'status': 'ACTIVE', 'name': 'Myclausen', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/647', 'active_substance': 'mycophenolate mofetil', 'market_auth_holder': 'Passauer Pharma GmbH', 'atc_code': 'L04AA06'}"
EU-1-10-648,"{'status': 'ACTIVE', 'name': 'Twynsta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/648', 'active_substance': 'telmisartan / amlodipine', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'C09DB04'}"
EU-1-10-654,"{'status': 'ACTIVE', 'name': 'Leflunomide ratiopharm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/654', 'active_substance': 'leflunomide', 'market_auth_holder': 'ratiopharm GmbH', 'atc_code': 'L04AA13'}"
EU-1-10-652,"{'status': 'ACTIVE', 'name': 'TOBI Podhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/652', 'active_substance': 'Tobramycin', 'market_auth_holder': 'Mylan IRE Healthcare Ltd', 'atc_code': 'J01GB01'}"
EU-1-10-655,"{'status': 'ACTIVE', 'name': 'Brilique', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/655', 'active_substance': 'ticagrelor', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'B01AC24'}"
EU-1-10-658,"{'status': 'ACTIVE', 'name': 'Aflunov', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/658', 'active_substance': 'Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)', 'market_auth_holder': 'Seqirus S.r.l.', 'atc_code': 'J07BB02'}"
EU-1-10-659,"{'status': 'ACTIVE', 'name': 'Iasibon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/659', 'active_substance': 'Ibandronic acid', 'market_auth_holder': 'Pharmathen S.A.', 'atc_code': 'M05BA06'}"
EU-1-10-660,"{'status': 'ACTIVE', 'name': 'Potactasol', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/660', 'active_substance': 'topotecan', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'L01CE01'}"
EU-1-10-663,"{'status': 'ACTIVE', 'name': 'Lamivudine / Zidovudine Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/663', 'active_substance': 'Lamivudine / Zidovudine', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'J05AR01'}"
EU-1-10-665,"{'status': 'ACTIVE', 'name': 'Entacapone Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/665', 'active_substance': 'entacapone', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'N04BX02'}"
EU-1-11-667,"{'status': 'ACTIVE', 'name': 'Esbriet', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/667', 'active_substance': 'Pirfenidone', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L04AX05'}"
EU-1-11-672,"{'status': 'ACTIVE', 'name': 'Xeplion', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/672', 'active_substance': 'paliperidone', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'N05AX13'}"
EU-1-11-669,"{'status': 'ACTIVE', 'name': 'Teysuno', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/669', 'active_substance': 'Tegafur / gimeracil / oteracil', 'market_auth_holder': 'Nordic Group B.V.', 'atc_code': 'L01BC53'}"
EU-1-13-870,"{'status': 'ACTIVE', 'name': 'Orphacol', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/870', 'active_substance': 'Cholic acid', 'market_auth_holder': 'Laboratoires CTRS', 'atc_code': 'A05AA03'}"
EU-1-11-673,"{'status': 'ACTIVE', 'name': 'Ifirmacombi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/673', 'active_substance': 'Irbesartan / hydrochlorothiazide', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'C09DA04'}"
EU-1-10-637,"{'status': 'ACTIVE', 'name': 'Leflunomide medac', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/637', 'active_substance': 'leflunomide', 'market_auth_holder': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'atc_code': 'L04AA13'}"
EU-1-11-676,"{'status': 'ACTIVE', 'name': 'JEVTANA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/676', 'active_substance': 'cabazitaxel', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'L01CD04'}"
EU-1-11-677,"{'status': 'ACTIVE', 'name': 'Gilenya', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/677', 'active_substance': 'Fingolimod', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L04AA27'}"
EU-1-11-678,"{'status': 'ACTIVE', 'name': 'HALAVEN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/678', 'active_substance': 'eribulin', 'market_auth_holder': 'Eisai GmbH', 'atc_code': 'L01XX41'}"
EU-1-11-679,"{'status': 'ACTIVE', 'name': 'Pravafenix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/679', 'active_substance': 'fenofibrate / pravastatin', 'market_auth_holder': 'LABORATOIRES SMB SA', 'atc_code': 'C10BA03'}"
EU-1-11-682,"{'status': 'ACTIVE', 'name': 'Methylthioninium chloride Proveblue', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/682', 'active_substance': 'methylthioninium chloride', 'market_auth_holder': 'Provepharm S.A.S.', 'atc_code': 'V03AB17'}"
EU-1-11-685,"{'status': 'ACTIVE', 'name': 'Ibandronic acid Sandoz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/685', 'active_substance': 'Ibandronic acid', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'M05BA06'}"
EU-1-11-687,"{'status': 'ACTIVE', 'name': 'Hizentra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/687', 'active_substance': 'human normal immunoglobulin', 'market_auth_holder': 'CSL Behring GmbH', 'atc_code': 'J06BA01'}"
EU-1-11-690,"{'status': 'ACTIVE', 'name': 'Zoely', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/690', 'active_substance': 'nomegestrol / estradiol', 'market_auth_holder': 'Theramex Ireland Limited', 'atc_code': 'G03AA14'}"
EU-1-11-692,"{'status': 'ACTIVE', 'name': 'Yellox', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/692', 'active_substance': 'bromfenac', 'market_auth_holder': 'BAUSCH + LOMB IRELAND LIMITED', 'atc_code': 'S01BC11'}"
EU-1-11-691,"{'status': 'ACTIVE', 'name': 'Eliquis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/691', 'active_substance': 'apixaban', 'market_auth_holder': 'Bristol-Myers Squibb/Pfizer EEIG', 'atc_code': 'B01AF02'}"
EU-1-11-693,"{'status': 'ACTIVE', 'name': 'Rivastigmine Actavis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/693', 'active_substance': 'Rivastigmine', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'N06DA03'}"
EU-1-11-688,"{'status': 'ACTIVE', 'name': 'Cinryze', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/688', 'active_substance': 'C1 inhibitor, human', 'market_auth_holder': 'Takeda Manufacturing Austria AG', 'atc_code': 'B06AC01'}"
EU-1-11-694,"{'status': 'ACTIVE', 'name': 'NULOJIX', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/694', 'active_substance': 'belatacept', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'L04AA28'}"
EU-1-11-697,"{'status': 'ACTIVE', 'name': 'Temozolomide SUN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/697', 'active_substance': 'temozolomide', 'market_auth_holder': 'Sun Pharmaceutical Industries Europe BV', 'atc_code': 'L01AX03'}"
EU-1-11-698,"{'status': 'ACTIVE', 'name': 'YERVOY', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/698', 'active_substance': 'ipilimumab', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG'}"
EU-1-11-699,"{'status': 'ACTIVE', 'name': 'Fampyra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/699', 'active_substance': 'fampridine', 'market_auth_holder': 'Biogen Netherlands B.V.', 'atc_code': 'N07XX07'}"
EU-1-11-700,"{'status': 'ACTIVE', 'name': 'Benlysta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/700', 'active_substance': 'belimumab', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'L04AA26'}"
EU-1-11-701,"{'status': 'ACTIVE', 'name': 'Levetiracetam Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/701', 'active_substance': 'levetiracetam', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'N03AX14'}"
EU-1-11-702,"{'status': 'ACTIVE', 'name': 'Levetiracetam ratiopharm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/702', 'active_substance': 'levetiracetam', 'market_auth_holder': 'ratiopharm GmbH', 'atc_code': 'N03AX14'}"
EU-1-11-703,"{'status': 'ACTIVE', 'name': 'Xgeva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/703', 'active_substance': 'denosumab', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'M05BX04'}"
EU-1-11-707,"{'status': 'ACTIVE', 'name': 'Trajenta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/707', 'active_substance': 'linagliptin', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'A10BH05'}"
EU-1-11-706,"{'status': 'ACTIVE', 'name': 'Levodopa/Carbidopa/Entacapone Orion', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/706', 'active_substance': 'Levodopa,carbidopa,entacapone', 'market_auth_holder': 'Orion Corporation', 'atc_code': 'N04BA03'}"
EU-1-11-708,"{'status': 'ACTIVE', 'name': 'Entacapone Orion', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/708', 'active_substance': 'entacapone', 'market_auth_holder': 'Orion Corporation', 'atc_code': 'N04BX02'}"
EU-1-11-709,"{'status': 'ACTIVE', 'name': 'Buccolam', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/709', 'active_substance': 'midazolam', 'market_auth_holder': 'Laboratorios Lesvi, S.L.', 'atc_code': 'N05CD08'}"
EU-1-11-710,"{'status': 'ACTIVE', 'name': 'Votubia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/710', 'active_substance': 'Everolimus', 'market_auth_holder': 'Novartis Europharm Limited'}"
EU-1-11-713,"{'status': 'ACTIVE', 'name': 'Levetiracetam Actavis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/713', 'active_substance': 'levetiracetam', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'N03AX14'}"
EU-1-11-712,"{'status': 'ACTIVE', 'name': 'Levetiracetam Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/712', 'active_substance': 'levetiracetam', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'N03AX14'}"
EU-1-11-711,"{'status': 'ACTIVE', 'name': 'Matever', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/711', 'active_substance': 'levetiracetam', 'market_auth_holder': 'Pharmathen S.A.', 'atc_code': 'N03AX14'}"
EU-1-11-714,"{'status': 'ACTIVE', 'name': 'Zytiga', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/714', 'active_substance': 'abiraterone', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'L02BX03'}"
EU-1-11-716,"{'status': 'ACTIVE', 'name': 'Eurartesim', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/716', 'active_substance': 'piperaquine tetraphosphate/artenimol', 'market_auth_holder': 'Alfasigma S.p.A.', 'atc_code': 'P01BF05'}"
EU-1-11-719,"{'status': 'ACTIVE', 'name': 'Telmisartan Teva Pharma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/719', 'active_substance': 'telmisartan', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'C09CA07'}"
EU-1-11-717,"{'status': 'ACTIVE', 'name': 'Vyndaqel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/717', 'active_substance': 'tafamidis', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'N07XX08'}"
EU-1-11-718,"{'status': 'ACTIVE', 'name': 'Dexdor', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/718', 'active_substance': 'dexmedetomidine', 'market_auth_holder': 'Orion Corporation', 'atc_code': 'N05CM18'}"
EU-1-11-722,"{'status': 'ACTIVE', 'name': 'Pioglitazone Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/722', 'active_substance': 'pioglitazone', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'A10BG03'}"
EU-1-11-727,"{'status': 'ACTIVE', 'name': 'Xaluprine', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/727', 'active_substance': 'Mercaptopurine', 'market_auth_holder': 'Nova Laboratories Ireland Limited', 'atc_code': 'L01BB02'}"
EU-1-11-715,"{'status': 'ACTIVE', 'name': 'Plenadren', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/715', 'active_substance': 'hydrocortisone', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'H02AB09'}"
EU-1-11-732,"{'status': 'ACTIVE', 'name': 'Desloratadine Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/732', 'active_substance': 'desloratadine', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'R06AX27'}"
EU-1-11-731,"{'status': 'ACTIVE', 'name': 'Komboglyze', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/731', 'active_substance': 'saxagliptin / metformin', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'A10BD10'}"
EU-1-11-734,"{'status': 'ACTIVE', 'name': 'Edarbi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/734', 'active_substance': 'azilsartan medoxomil', 'market_auth_holder': 'Takeda Pharma A/S', 'atc_code': 'C09CA09'}"
EU-1-11-736,"{'status': 'ACTIVE', 'name': 'EDURANT', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/736', 'active_substance': 'rilpivirine', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'J05AG05'}"
EU-1-11-737,"{'status': 'ACTIVE', 'name': 'Eviplera', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/737', 'active_substance': 'emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as fumarate)', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AR08'}"
EU-1-11-733,"{'status': 'ACTIVE', 'name': 'Dificlir', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/733', 'active_substance': 'fidaxomicin', 'market_auth_holder': 'Tillotts Pharma GmbH', 'atc_code': 'A07AA12'}"
EU-1-11-738,"{'status': 'ACTIVE', 'name': 'Levetiracetam Actavis Group', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/738', 'active_substance': 'levetiracetam', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'N03AX14'}"
EU-1-11-739,"{'status': 'ACTIVE', 'name': 'Dasselta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/739', 'active_substance': 'desloratadine', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'R06AX27'}"
EU-1-11-740,"{'status': 'ACTIVE', 'name': 'Ameluz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/740', 'active_substance': '5-Aminolaevulinic acid', 'market_auth_holder': 'Biofrontera Bioscience GmbH', 'atc_code': 'L01XD04'}"
EU-1-11-741,"{'status': 'ACTIVE', 'name': 'Levetiracetam SUN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/741', 'active_substance': 'levetiracetam', 'market_auth_holder': 'Sun Pharmaceutical Industries Europe BV', 'atc_code': 'N03AX14'}"
EU-1-11-742,"{'status': 'ACTIVE', 'name': 'Efavirenz Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/742', 'active_substance': 'efavirenz', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'J05AG03'}"
EU-1-11-743,"{'status': 'ACTIVE', 'name': 'Repaglinide Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/743', 'active_substance': 'Repaglinide', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'A10BX02'}"
EU-1-11-745,"{'status': 'ACTIVE', 'name': 'Desloratadine Actavis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/745', 'active_substance': 'desloratadine', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'R06AX27'}"
EU-1-11-746,"{'status': 'ACTIVE', 'name': 'Desloratadine ratiopharm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/746', 'active_substance': 'desloratadine', 'market_auth_holder': 'ratiopharm GmbH', 'atc_code': 'R06AX27'}"
EU-1-11-749,"{'status': 'ACTIVE', 'name': 'Caprelsa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/749', 'active_substance': 'vandetanib', 'market_auth_holder': 'Genzyme Europe B.V.'}"
EU-1-11-747,"{'status': 'ACTIVE', 'name': 'Colobreathe', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/747', 'active_substance': 'Colistimethate sodium', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'J01XB01'}"
EU-1-12-750,"{'status': 'ACTIVE', 'name': 'Esmya', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/750', 'active_substance': 'Ulipristal Acetate', 'market_auth_holder': 'Gedeon Richter Plc.', 'atc_code': 'G03XB02'}"
EU-1-12-751,"{'status': 'ACTIVE', 'name': 'Zelboraf', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/751', 'active_substance': 'vemurafenib', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01EC01'}"
EU-1-12-753,"{'status': 'ACTIVE', 'name': 'Signifor', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/753', 'active_substance': 'pasireotide', 'market_auth_holder': 'Recordati Rare Diseases', 'atc_code': 'H01CB05'}"
EU-1-12-755,"{'status': 'ACTIVE', 'name': 'Pioglitazone Actavis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/755', 'active_substance': 'pioglitazone', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'A10BG03'}"
EU-1-12-757,"{'status': 'ACTIVE', 'name': 'Pioglitazone Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/757', 'active_substance': 'pioglitazone', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'A10BG03'}"
EU-1-12-759,"{'status': 'ACTIVE', 'name': 'Zoledronic acid Actavis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/759', 'active_substance': 'zoledronic acid', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'M05BA08'}"
EU-1-12-762,"{'status': 'ACTIVE', 'name': 'Capecitabine Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/762', 'active_substance': 'capecitabine', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01BC06'}"
EU-1-12-761,"{'status': 'ACTIVE', 'name': 'Capecitabine Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/761', 'active_substance': 'capecitabine', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'L01BC06'}"
EU-1-12-763,"{'status': 'ACTIVE', 'name': 'Ecansya', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/763', 'active_substance': 'capecitabine', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'L01BC06'}"
EU-1-12-760,"{'status': 'ACTIVE', 'name': 'Bronchitol', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/760', 'active_substance': 'Mannitol', 'market_auth_holder': 'Pharmaxis Europe Limited', 'atc_code': 'R05CB16'}"
EU-1-12-764,"{'status': 'ACTIVE', 'name': 'Pixuvri', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/764', 'active_substance': 'pixantrone', 'market_auth_holder': 'Les Laboratoires Servier', 'atc_code': 'L01DB11'}"
EU-1-12-766,"{'status': 'ACTIVE', 'name': 'SANCUSO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/766', 'active_substance': 'granisetron', 'market_auth_holder': 'Kyowa Kirin Holdings B.V.', 'atc_code': 'A04AA02'}"
EU-1-12-767,"{'status': 'ACTIVE', 'name': 'Nimenrix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/767', 'active_substance': 'Meningococcal group A, C, W-135 and Y conjugate vaccine', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'J07AH08'}"
EU-1-12-768,"{'status': 'ACTIVE', 'name': 'Riluzole Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/768', 'active_substance': 'Riluzole', 'market_auth_holder': 'Zentiva k.s.', 'atc_code': 'N07XX02'}"
EU-1-12-771,"{'status': 'ACTIVE', 'name': 'Zoledronic acid Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/771', 'active_substance': 'zoledronic acid', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'M05BA08'}"
EU-1-12-769,"{'status': 'ACTIVE', 'name': 'Docetaxel Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/769', 'active_substance': 'Docetaxel', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01CD02'}"
EU-1-12-770,"{'status': 'ACTIVE', 'name': 'Docetaxel Kabi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/770', 'active_substance': 'Docetaxel', 'market_auth_holder': 'Fresenius Kabi Deutschland GmbH', 'atc_code': 'L01CD02'}"
EU-1-12-773,"{'status': 'ACTIVE', 'name': 'Jakavi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/773', 'active_substance': 'ruxolitinib', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L01EJ01'}"
EU-1-12-775,"{'status': 'ACTIVE', 'name': 'NovoThirteen', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/775', 'active_substance': 'catridecacog', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'B02BD11'}"
EU-1-12-776,"{'status': 'ACTIVE', 'name': 'Fycompa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/776', 'active_substance': 'Perampanel', 'market_auth_holder': 'Eisai GmbH', 'atc_code': 'N03AX22'}"
EU-1-12-777,"{'status': 'ACTIVE', 'name': 'Inlyta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/777', 'active_substance': 'Axitinib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01EK01'}"
EU-1-12-778,"{'status': 'ACTIVE', 'name': 'Eklira Genuair', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/778', 'active_substance': 'aclidinium bromide', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'R03BB05'}"
EU-1-12-779,"{'status': 'ACTIVE', 'name': 'Zoledronic acid medac', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/779', 'active_substance': 'zoledronic acid', 'market_auth_holder': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'atc_code': 'M05BA08'}"
EU-1-12-780,"{'status': 'ACTIVE', 'name': 'Jentadueto', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/780', 'active_substance': 'linagliptin/metformin hydrochloride', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'A10BD11'}"
EU-1-12-781,"{'status': 'ACTIVE', 'name': 'Bretaris Genuair', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/781', 'active_substance': 'aclidinium bromide', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'R03BB05'}"
EU-1-12-782,"{'status': 'ACTIVE', 'name': 'Kalydeco', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/782', 'active_substance': 'ivacaftor', 'market_auth_holder': 'Vertex Pharmaceuticals (Ireland) Limited', 'atc_code': 'R07AX02'}"
EU-1-12-783,"{'status': 'ACTIVE', 'name': 'Zyclara', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/783', 'active_substance': 'imiquimod', 'market_auth_holder': 'Meda AB', 'atc_code': 'D06BB10'}"
EU-1-12-784,"{'status': 'ACTIVE', 'name': 'Cuprymina', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/784', 'active_substance': 'Copper <sup>64</sup>Cu chloride', 'market_auth_holder': 'A.C.O.M. -ADVANCED CENTER ONCOLOGY MACERATA -S.R.L.'}"
EU-1-12-785,"{'status': 'ACTIVE', 'name': 'Zinforo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/785', 'active_substance': 'ceftaroline fosamil', 'market_auth_holder': 'Pfizer Ireland Pharmaceuticals', 'atc_code': 'J01DI02'}"
EU-1-12-786,"{'status': 'ACTIVE', 'name': 'Zoledronic acid Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/786', 'active_substance': 'zoledronic acid', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'M05BA08'}"
EU-1-12-787,"{'status': 'ACTIVE', 'name': 'Revestive', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/787', 'active_substance': 'teduglutide', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'A16AX08'}"
EU-1-12-788,"{'status': 'ACTIVE', 'name': 'Seebri Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/788', 'active_substance': 'glycopyrronium bromide', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03BB06'}"
EU-1-12-789,"{'status': 'ACTIVE', 'name': 'Enurev Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/789', 'active_substance': 'glycopyrronium bromide', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03BB06'}"
EU-1-12-790,"{'status': 'ACTIVE', 'name': 'Tovanor Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/790', 'active_substance': 'glycopyrronium bromide', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03BB06'}"
EU-1-12-792,"{'status': 'ACTIVE', 'name': 'Dacogen', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/792', 'active_substance': 'Decitabine', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'L01BC08'}"
EU-1-12-793,"{'status': 'ACTIVE', 'name': 'XALKORI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/793', 'active_substance': 'crizotinib', 'market_auth_holder': 'Pfizer Europe MA EEIG'}"
EU-1-12-794,"{'status': 'ACTIVE', 'name': 'ADCETRIS', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/794', 'active_substance': 'Brentuximab vedotin', 'market_auth_holder': 'Takeda Pharma A/S'}"
EU-1-12-795,"{'status': 'ACTIVE', 'name': 'Forxiga', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/795', 'active_substance': 'dapagliflozin', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'A10BX09'}"
EU-1-12-797,"{'status': 'ACTIVE', 'name': 'Eylea', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/797', 'active_substance': 'aflibercept', 'market_auth_holder': 'Bayer AG', 'atc_code': 'S01LA05'}"
EU-1-12-800,"{'status': 'ACTIVE', 'name': 'Zoledronic acid Hospira', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/800', 'active_substance': 'zoledronic acid', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'M05BA08'}"
EU-1-12-801,"{'status': 'ACTIVE', 'name': 'Constella', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/801', 'active_substance': 'linaclotide', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'A06AX04'}"
EU-1-12-798,"{'status': 'ACTIVE', 'name': 'Ibandronic acid Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/798', 'active_substance': 'Ibandronic acid', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'M05BA06'}"
EU-1-12-799,"{'status': 'ACTIVE', 'name': 'Memantine Merz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/799', 'active_substance': 'Memantine', 'market_auth_holder': 'Merz Pharmaceuticals GmbH', 'atc_code': 'N06DX01'}"
EU-1-12-802,"{'status': 'ACTIVE', 'name': 'Capecitabine medac', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/802', 'active_substance': 'capecitabine', 'market_auth_holder': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'atc_code': 'L01BC06'}"
EU-1-12-803,"{'status': 'ACTIVE', 'name': 'NexoBrid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/803', 'active_substance': 'Concentrate of proteolytic enzymes enriched in bromelain', 'market_auth_holder': 'MediWound Germany GmbH', 'atc_code': 'D03BA03'}"
EU-1-12-805,"{'status': 'ACTIVE', 'name': 'Amyvid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/805', 'active_substance': 'Florbetapir (<sup>18</sup>F)', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'V09AX05'}"
EU-1-12-806,"{'status': 'ACTIVE', 'name': 'Ryzodeg', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/806', 'active_substance': 'Insulin degludec/insulin aspart', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AD06'}"
EU-1-12-808,"{'status': 'ACTIVE', 'name': 'Imatinib Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/808', 'active_substance': 'imatinib', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'L01EA01'}"
EU-1-12-807,"{'status': 'ACTIVE', 'name': 'Tresiba', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/807', 'active_substance': 'Insulin degludec', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AE06'}"
EU-1-08-448,"{'status': 'ACTIVE', 'name': 'Mycamine', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/448', 'active_substance': 'micafungin', 'market_auth_holder': 'Astellas Pharma Europe B.V.', 'atc_code': 'J02AX05'}"
EU-1-08-451,"{'status': 'ACTIVE', 'name': 'Volibris', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/451', 'active_substance': 'Ambrisentan', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'C02KX02'}"
EU-1-08-444,"{'status': 'ACTIVE', 'name': 'Ratiograstim', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/444', 'active_substance': 'filgrastim', 'market_auth_holder': 'ratiopharm GmbH', 'atc_code': 'L03AA02'}"
EU-1-08-445,"{'status': 'ACTIVE', 'name': 'Tevagrastim', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/445', 'active_substance': 'filgrastim', 'market_auth_holder': 'Teva GmbH', 'atc_code': 'L03AA02'}"
EU-1-08-454,"{'status': 'ACTIVE', 'name': 'Extavia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/454', 'active_substance': 'Interferon beta-1b', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L03AB08'}"
EU-1-08-462,"{'status': 'ACTIVE', 'name': 'Ranexa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/462', 'active_substance': 'ranolazine', 'market_auth_holder': 'Menarini International Operations Luxembourg S.A.', 'atc_code': 'C01EB18'}"
EU-1-08-463,"{'status': 'ACTIVE', 'name': 'Relistor', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/463', 'active_substance': 'methylnaltrexone bromide', 'market_auth_holder': 'Bausch Health Ireland Limited', 'atc_code': 'A06AH01'}"
EU-1-08-461,"{'status': 'ACTIVE', 'name': 'Firazyr', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/461', 'active_substance': 'icatibant', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'B06AC02'}"
EU-1-08-457,"{'status': 'ACTIVE', 'name': 'Efficib', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/457', 'active_substance': 'sitagliptin / metformin hydrochloride', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BD07'}"
EU-1-08-455,"{'status': 'ACTIVE', 'name': 'Janumet', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/455', 'active_substance': 'sitagliptin / metformin hydrochloride', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BD07'}"
EU-1-08-456,"{'status': 'ACTIVE', 'name': 'Velmetia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/456', 'active_substance': 'sitagliptin / metformin hydrochloride', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BD07'}"
EU-1-08-465,"{'status': 'ACTIVE', 'name': 'Clopidogrel Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/465', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'Zentiva, k.s.', 'atc_code': 'B01AC04'}"
EU-1-08-466,"{'status': 'ACTIVE', 'name': 'Bridion', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/466', 'active_substance': 'sugammadex', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'V03AB35'}"
EU-1-08-468,"{'status': 'ACTIVE', 'name': 'Intelence', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/468', 'active_substance': 'etravirine', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'J05AG04'}"
EU-1-08-469,"{'status': 'ACTIVE', 'name': 'Oprymea', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/469', 'active_substance': 'pramipexole', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'N04BC05'}"
EU-1-08-470,"{'status': 'ACTIVE', 'name': 'Vimpat', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/470', 'active_substance': 'lacosamide', 'market_auth_holder': 'UCB Pharma S.A.', 'atc_code': 'N03AX18'}"
EU-1-08-475,"{'status': 'ACTIVE', 'name': 'Olanzapine Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/475', 'active_substance': 'Olanzapine', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'N05AH03'}"
EU-1-08-472,"{'status': 'ACTIVE', 'name': 'Xarelto', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/472', 'active_substance': 'rivaroxaban', 'market_auth_holder': 'Bayer AG', 'atc_code': 'B01AF01'}"
EU-1-08-473,"{'status': 'ACTIVE', 'name': 'Evicel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/473', 'active_substance': 'human fibrinogen / human thrombin', 'market_auth_holder': 'Omrix Biopharmaceuticals N.V.', 'atc_code': 'B02BC30'}"
EU-1-08-476,"{'status': 'ACTIVE', 'name': 'Adcirca', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/476', 'active_substance': 'tadalafil', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'G04BE08'}"
EU-1-08-477,"{'status': 'ACTIVE', 'name': 'Ceplene', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/477', 'active_substance': 'Histamine dihydrochloride', 'market_auth_holder': 'Laboratoires Delbert', 'atc_code': 'L03AX14'}"
EU-1-08-479,"{'status': 'ACTIVE', 'name': 'Zypadhera', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/479', 'active_substance': 'Olanzapine', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'N05AH03'}"
EU-1-08-480,"{'status': 'ACTIVE', 'name': 'Ifirmasta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/480', 'active_substance': 'Irbesartan', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'C09CA04'}"
EU-1-08-481,"{'status': 'ACTIVE', 'name': 'Kuvan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/481', 'active_substance': 'sapropterin dihydrochloride', 'market_auth_holder': 'BioMarin International Limited', 'atc_code': 'A16AX07'}"
EU-1-08-483,"{'status': 'ACTIVE', 'name': 'Zomarist', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/483', 'active_substance': 'vildagliptin / metformin hydrochloride', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'A10BD08'}"
EU-1-08-482,"{'status': 'ACTIVE', 'name': 'Azarga', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/482', 'active_substance': 'brinzolamide / timolol', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01ED51'}"
EU-1-08-485,"{'status': 'ACTIVE', 'name': 'Jalra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/485', 'active_substance': 'vildagliptin', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'A10BH02'}"
EU-1-08-486,"{'status': 'ACTIVE', 'name': 'Xiliarx', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/486', 'active_substance': 'vildagliptin', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'A10BH02'}"
EU-1-08-484,"{'status': 'ACTIVE', 'name': 'Icandra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/484', 'active_substance': 'vildagliptin / metformin hydrochloride', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'A10BD08'}"
EU-1-08-490,"{'status': 'ACTIVE', 'name': 'Pramipexole Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/490', 'active_substance': 'pramipexole', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'N04BC05'}"
EU-1-08-488,"{'status': 'ACTIVE', 'name': 'Vidaza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/488', 'active_substance': 'Azacitidine', 'market_auth_holder': 'Bristol Myers Squibb Pharma EEIG', 'atc_code': 'L01BC07'}"
EU-1-08-492,"{'status': 'ACTIVE', 'name': 'RoActemra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/492', 'active_substance': 'tocilizumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L04AC07'}"
EU-1-08-494,"{'status': 'ACTIVE', 'name': 'Stelara', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/494', 'active_substance': 'ustekinumab', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'L04AC05'}"
EU-1-08-495,"{'status': 'ACTIVE', 'name': 'Zarzio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/495', 'active_substance': 'Filgrastim', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'L03AA02'}"
EU-1-08-497,"{'status': 'ACTIVE', 'name': 'Nplate', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/497', 'active_substance': 'romiplostim', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'B02BX04'}"
EU-1-08-496,"{'status': 'ACTIVE', 'name': 'Filgrastim Hexal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/496', 'active_substance': 'Filgrastim', 'market_auth_holder': 'Hexal AG', 'atc_code': 'L03AA02'}"
EU-1-08-498,"{'status': 'ACTIVE', 'name': 'Thymanax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/498', 'active_substance': 'agomelatine', 'market_auth_holder': 'Servier (Ireland) Industries Limited', 'atc_code': 'N06AX22'}"
EU-1-08-499,"{'status': 'ACTIVE', 'name': 'Valdoxan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/499', 'active_substance': 'agomelatine', 'market_auth_holder': 'Les Laboratoires Servier', 'atc_code': 'N06AX22'}"
EU-1-08-501,"{'status': 'ACTIVE', 'name': 'Ixiaro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/501', 'active_substance': 'Japanese Encephalitis vaccine (inactivated, adsorbed)', 'market_auth_holder': 'Valneva Austria GmbH', 'atc_code': 'J07BA02'}"
EU-1-08-502,"{'status': 'ACTIVE', 'name': 'Mepact', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/502', 'active_substance': 'mifamurtide', 'market_auth_holder': 'Takeda France SAS', 'atc_code': 'L03AX15'}"
EU-1-08-503,"{'status': 'ACTIVE', 'name': 'Efient', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/503', 'active_substance': 'prasugrel', 'market_auth_holder': 'SUBSTIPHARM', 'atc_code': 'B01AC22'}"
EU-1-08-504,"{'status': 'ACTIVE', 'name': 'Firmagon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/504', 'active_substance': 'degarelix (as acetate)', 'market_auth_holder': 'Amager Strandvej 405, 2770 Kastrup, Danmark', 'atc_code': 'L02BX02'}"
EU-1-09-508,"{'status': 'ACTIVE', 'name': 'Synflorix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/508', 'active_substance': 'Pneumococcal polysaccharide conjugate vaccine (adsorbed)', 'market_auth_holder': 'GlaxoSmithKline Biologicals S.A.', 'atc_code': 'J07AL52'}"
EU-1-09-511,"{'status': 'ACTIVE', 'name': 'Conbriza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/511', 'active_substance': 'bazedoxifene', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'G03XC02'}"
EU-1-09-514,"{'status': 'ACTIVE', 'name': 'Zebinix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/514', 'active_substance': 'eslicarbazepine acetate', 'market_auth_holder': 'Bial - Portela &amp; C&#170;, SA', 'atc_code': 'N03AF04'}"
EU-1-09-515,"{'status': 'ACTIVE', 'name': 'CONTROLOC Control', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/515', 'active_substance': 'pantoprazole', 'market_auth_holder': 'Takeda GmbH', 'atc_code': 'A02BC02'}"
EU-1-09-516,"{'status': 'ACTIVE', 'name': 'SOMAC Control', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/516', 'active_substance': 'pantoprazole', 'market_auth_holder': 'Takeda GmbH', 'atc_code': 'A02BC02'}"
EU-1-09-517,"{'status': 'ACTIVE', 'name': 'PANTOZOL Control', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/517', 'active_substance': 'pantoprazole', 'market_auth_holder': 'Takeda GmbH', 'atc_code': 'A02BC02'}"
EU-1-09-523,"{'status': 'ACTIVE', 'name': 'Modigraf', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/523', 'active_substance': 'Tacrolimus', 'market_auth_holder': 'Astellas Pharma Europe B.V.', 'atc_code': 'L04AD02'}"
EU-1-09-524,"{'status': 'ACTIVE', 'name': 'Qutenza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/524', 'active_substance': 'Capsaicin', 'market_auth_holder': 'Gr&#252;nenthal GmbH', 'atc_code': 'N01BX04'}"
EU-1-09-525,"{'status': 'ACTIVE', 'name': 'Nimvastid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/525', 'active_substance': 'Rivastigmine', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'N06DA03'}"
EU-1-09-521,"{'status': 'ACTIVE', 'name': 'Renvela', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/521', 'active_substance': 'sevelamer (carbonate)', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'V03AE02'}"
EU-1-09-522,"{'status': 'ACTIVE', 'name': 'ellaOne', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/522', 'active_substance': 'ulipristal acetate', 'market_auth_holder': 'Laboratoire HRA Pharma', 'atc_code': 'G03AD02'}"
EU-1-09-526,"{'status': 'ACTIVE', 'name': 'Iressa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/526', 'active_substance': 'gefitinib', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'L01EB01'}"
EU-1-09-528,"{'status': 'ACTIVE', 'name': 'Peyona', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/528', 'active_substance': 'Caffeine citrate', 'market_auth_holder': 'Chiesi Farmaceutici S.p.A.', 'atc_code': 'N06BC01'}"
EU-1-09-529,"{'status': 'ACTIVE', 'name': 'Victoza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/529', 'active_substance': 'liraglutide', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10BJ02'}"
EU-1-09-530,"{'status': 'ACTIVE', 'name': 'Repaglinide Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/530', 'active_substance': 'Repaglinide', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'A10BX02'}"
EU-1-09-531,"{'status': 'ACTIVE', 'name': 'Instanyl', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/531', 'active_substance': 'Fentanyl', 'market_auth_holder': 'Takeda Pharma A/S', 'atc_code': 'N02AB03'}"
EU-1-09-533,"{'status': 'ACTIVE', 'name': 'Vedrop', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/533', 'active_substance': 'tocofersolan', 'market_auth_holder': 'Recordati Rare Diseases', 'atc_code': 'A11HA08'}"
EU-1-09-535,"{'status': 'ACTIVE', 'name': 'Grepid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/535', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'Pharmathen S.A.', 'atc_code': 'B01AC04'}"
EU-1-09-538,"{'status': 'ACTIVE', 'name': 'Afinitor', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/538', 'active_substance': 'everolimus', 'market_auth_holder': 'Novartis Europharm Limited'}"
EU-1-09-537,"{'status': 'ACTIVE', 'name': 'Mozobil', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/537', 'active_substance': 'Plerixafor', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'L03AX16'}"
EU-1-09-539,"{'status': 'ACTIVE', 'name': 'Samsca', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/539', 'active_substance': 'tolvaptan', 'market_auth_holder': 'Otsuka Pharmaceutical Netherlands B.V.', 'atc_code': 'C03XA01'}"
EU-1-09-540,"{'status': 'ACTIVE', 'name': 'Clopidogrel Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/540', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'B01AC04'}"
EU-1-09-546,"{'status': 'ACTIVE', 'name': 'Simponi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/546', 'active_substance': 'golimumab', 'market_auth_holder': 'Janssen Biologics B.V.', 'atc_code': 'L04AB06'}"
EU-1-09-545,"{'status': 'ACTIVE', 'name': 'Onglyza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/545', 'active_substance': 'saxagliptin', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'A10BH03'}"
EU-1-09-544,"{'status': 'ACTIVE', 'name': 'Cimzia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/544', 'active_substance': 'certolizumab pegol', 'market_auth_holder': 'UCB Pharma S.A.', 'atc_code': 'L04AB05'}"
EU-1-09-553,"{'status': 'ACTIVE', 'name': 'Zyllt', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/553', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'B01AC04'}"
EU-1-09-558,"{'status': 'ACTIVE', 'name': 'Clopidogrel BGR', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/558', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'Laboratoires BIOGARAN', 'atc_code': 'B01AC04'}"
EU-1-09-562,"{'status': 'ACTIVE', 'name': 'Clopidogrel Krka d.d.', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/562', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'B01AC04'}"
EU-1-09-556,"{'status': 'ACTIVE', 'name': 'Clopidogrel Krka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/556', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'B01AC04'}"
EU-1-09-543,"{'status': 'ACTIVE', 'name': 'Cayston', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/543', 'active_substance': 'aztreonam', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J01DF01'}"
EU-1-09-555,"{'status': 'ACTIVE', 'name': 'Clopidogrel TAD', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/555', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'TAD Pharma GmbH', 'atc_code': 'B01AC04'}"
EU-1-09-550,"{'status': 'ACTIVE', 'name': 'Javlor', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/550', 'active_substance': 'vinflunine ditartrate', 'market_auth_holder': 'PIERRE FABRE MEDICAMENT', 'atc_code': 'L01CA05'}"
EU-1-09-551,"{'status': 'ACTIVE', 'name': 'Vizarsin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/551', 'active_substance': 'sildenafil', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'G04BE03'}"
EU-1-09-565,"{'status': 'ACTIVE', 'name': 'Biopoin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/565', 'active_substance': 'epoetin theta', 'market_auth_holder': 'Teva GmbH', 'atc_code': 'B03XA01'}"
EU-1-09-566,"{'status': 'ACTIVE', 'name': 'Lamivudine Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/566', 'active_substance': 'Lamivudine', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'J05AF05'}"
EU-1-09-564,"{'status': 'ACTIVE', 'name': 'Ilaris', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/564', 'active_substance': 'Canakinumab', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L04AC08'}"
EU-1-09-573,"{'status': 'ACTIVE', 'name': 'Eporatio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/573', 'active_substance': 'epoetin theta', 'market_auth_holder': 'ratiopharm GmbH', 'atc_code': 'B03XA01'}"
EU-1-09-576,"{'status': 'ACTIVE', 'name': 'Irbesartan Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/576', 'active_substance': 'Irbesartan', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'C09CA04'}"
EU-1-09-577,"{'status': 'ACTIVE', 'name': 'Foclivia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/577', 'active_substance': 'A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen', 'market_auth_holder': 'Seqirus S.r.l.,', 'atc_code': 'J07BB02'}"
EU-1-09-575,"{'status': 'ACTIVE', 'name': 'Copalia HCT', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/575', 'active_substance': 'amlodipine besylate / valsartan / hydrochlorothiazide', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'C09DX01'}"
EU-1-09-574,"{'status': 'ACTIVE', 'name': 'Dafiro HCT', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/574', 'active_substance': 'amlodipine besylate / valsartan / hydrochlorothiazide', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'C09DX01'}"
EU-1-09-579,"{'status': 'ACTIVE', 'name': 'Repaglinide Krka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/579', 'active_substance': 'Repaglinide', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'A10BX02'}"
EU-1-09-569,"{'status': 'ACTIVE', 'name': 'Exforge HCT', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/569', 'active_substance': 'amlodipine besylate / valsartan / hydrochlorothiazide', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'C09DX01'}"
EU-1-09-572,"{'status': 'ACTIVE', 'name': 'Vantavo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/572', 'active_substance': 'alendronic acid / colecalciferol', 'market_auth_holder': 'N.V. Organon', 'atc_code': 'M05BB03'}"
EU-1-09-578,"{'status': 'ACTIVE', 'name': 'Adjupanrix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/578', 'active_substance': 'Purified antigen fractions of inactivated split virions A/VietNam/1194/2004 NIBRG-14 (H5N1)', 'market_auth_holder': 'GlaxoSmithKline Biologicals S.A.', 'atc_code': 'J07BB02'}"
EU-1-09-571,"{'status': 'ACTIVE', 'name': 'Pandemic influenza vaccine H5N1 BAXTER', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/571', 'active_substance': 'Pandemic influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)', 'market_auth_holder': 'Ology Bioservices Ireland LTD', 'atc_code': 'J07BB01'}"
EU-1-09-580,"{'status': 'ACTIVE', 'name': 'Enyglid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/580', 'active_substance': 'Repaglinide', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'A10BX02'}"
EU-1-09-581,"{'status': 'ACTIVE', 'name': 'Resolor', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/581', 'active_substance': 'prucalopride', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'A06AX05'}"
EU-1-09-583,"{'status': 'ACTIVE', 'name': 'Irbesartan / Hydrochlorothiazide Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/583', 'active_substance': 'irbesartan / hydrochlorothiazide', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'C09DA04'}"
EU-1-09-589,"{'status': 'ACTIVE', 'name': 'Rivastigmine HEXAL', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/589', 'active_substance': 'Rivastigmine', 'market_auth_holder': 'Hexal AG', 'atc_code': 'N06DA03'}"
EU-1-09-584,"{'status': 'ACTIVE', 'name': 'Sildenafil Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/584', 'active_substance': 'sildenafil', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'G04BE03'}"
EU-1-09-586,"{'status': 'ACTIVE', 'name': 'Oslif Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/586', 'active_substance': 'indacaterol', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03AC18'}"
EU-1-09-590,"{'status': 'ACTIVE', 'name': 'Prevenar 13', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/590', 'active_substance': 'Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'J07AL02'}"
EU-1-09-585,"{'status': 'ACTIVE', 'name': 'Rivastigmine 1 A Pharma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/585', 'active_substance': 'Rivastigmine', 'market_auth_holder': '1 A Pharma GmbH', 'atc_code': 'N06DA03'}"
EU-1-09-587,"{'status': 'ACTIVE', 'name': 'Olanzapine Glenmark', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/587', 'active_substance': 'Olanzapine', 'market_auth_holder': 'Glenmark Arzneimittel GmbH', 'atc_code': 'N05AH03'}"
EU-1-09-588,"{'status': 'ACTIVE', 'name': 'Olanzapine Glenmark Europe', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/588', 'active_substance': 'Olanzapine', 'market_auth_holder': 'Glenmark Arzneimittel GmbH', 'atc_code': 'N05AH03'}"
EU-1-09-591,"{'status': 'ACTIVE', 'name': 'Multaq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/591', 'active_substance': 'dronedarone', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'C01BD07'}"
EU-1-09-592,"{'status': 'ACTIVE', 'name': 'Olazax Disperzi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/592', 'active_substance': 'Olanzapine', 'market_auth_holder': 'Glenmark Pharmaceuticals s.r.o.', 'atc_code': 'N05AH03'}"
EU-1-09-597,"{'status': 'ACTIVE', 'name': 'Olazax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/597', 'active_substance': 'Olanzapine', 'market_auth_holder': 'Glenmark Pharmaceuticals s.r.o.', 'atc_code': 'N05AH03'}"
EU-1-09-598,"{'status': 'ACTIVE', 'name': 'Nevirapine Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/598', 'active_substance': 'nevirapine', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'J05AG01'}"
EU-1-09-593,"{'status': 'ACTIVE', 'name': 'Onbrez Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/593', 'active_substance': 'indacaterol', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03AC18'}"
EU-1-09-599,"{'status': 'ACTIVE', 'name': 'Rivastigmine Sandoz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/599', 'active_substance': 'Rivastigmine', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'N06DA03'}"
EU-1-09-594,"{'status': 'ACTIVE', 'name': 'Hirobriz Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/594', 'active_substance': 'indacaterol', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03AC18'}"
EU-1-09-600,"{'status': 'ACTIVE', 'name': 'Zutectra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/600', 'active_substance': 'Human Hepatitis B Immunoglobulin', 'market_auth_holder': 'Biotest Pharma GmbH', 'atc_code': 'J06BB04'}"
EU-1-09-596,"{'status': 'ACTIVE', 'name': 'Lamivudine Teva Pharma B.V.', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/596', 'active_substance': 'Lamivudine', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'J05AF05'}"
EU-1-09-595,"{'status': 'ACTIVE', 'name': 'Sildenafil Actavis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/595', 'active_substance': 'Sildenafil', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'G04BE03'}"
EU-1-09-601,"{'status': 'ACTIVE', 'name': 'Firdapse', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/601', 'active_substance': 'amifampridine', 'market_auth_holder': 'SERB S.A.', 'atc_code': 'N07XX05'}"
EU-1-09-603,"{'status': 'ACTIVE', 'name': 'Sildenafil ratiopharm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/603', 'active_substance': 'Sildenafil', 'market_auth_holder': 'ratiopharm GmbH', 'atc_code': 'G04BE03'}"
EU-1-09-602,"{'status': 'ACTIVE', 'name': 'Scintimun', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/602', 'active_substance': 'besilesomab', 'market_auth_holder': 'CIS bio international', 'atc_code': 'V09HA03'}"
EU-1-09-604,"{'status': 'ACTIVE', 'name': 'Leflunomide Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/604', 'active_substance': 'leflunomide', 'market_auth_holder': 'Zentiva k.s.', 'atc_code': 'L04AA13'}"
EU-1-09-605,"{'status': 'ACTIVE', 'name': 'Temomedac', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/605', 'active_substance': 'temozolomide', 'market_auth_holder': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'atc_code': 'L01AX03'}"
EU-1-09-609,"{'status': 'ACTIVE', 'name': 'Elonva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/609', 'active_substance': 'corifollitropin alfa', 'market_auth_holder': 'N.V. Organon', 'atc_code': 'G03GA09'}"
EU-1-09-606,"{'status': 'ACTIVE', 'name': 'Temozolomide Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/606', 'active_substance': 'temozolomide', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'L01AX03'}"
EU-1-09-607,"{'status': 'ACTIVE', 'name': 'Silodyx', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/607', 'active_substance': 'silodosin', 'market_auth_holder': 'Recordati Ireland Ltd', 'atc_code': 'G04CA04'}"
EU-1-09-608,"{'status': 'ACTIVE', 'name': 'Urorec', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/608', 'active_substance': 'silodosin', 'market_auth_holder': 'Recordati Ireland Ltd', 'atc_code': 'G04CA04'}"
EU-1-10-612,"{'status': 'ACTIVE', 'name': 'Revolade', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/612', 'active_substance': 'Eltrombopag', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'B02BX05'}"
EU-1-10-614,"{'status': 'ACTIVE', 'name': 'Menveo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/614', 'active_substance': 'Meningococcal Group A, C, W135 and Y Conjugate Vaccine', 'market_auth_holder': 'GSK Vaccines S.r.l.', 'atc_code': 'J07AH08'}"
EU-1-10-618,"{'status': 'ACTIVE', 'name': 'Prolia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/618', 'active_substance': 'denosumab', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'M05BX04'}"
EU-1-10-619,"{'status': 'ACTIVE', 'name': 'DuoPlavin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/619', 'active_substance': 'clopidogrel / acetylsalicylic acid', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'B01AC30'}"
EU-1-10-622,"{'status': 'ACTIVE', 'name': 'Tepadina', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/622', 'active_substance': 'Thiotepa', 'market_auth_holder': 'ADIENNE S.r.l.S.U.', 'atc_code': 'L01AC01'}"
EU-1-10-620,"{'status': 'ACTIVE', 'name': 'Ristfor', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/620', 'active_substance': 'sitagliptin / metformin hydrochloride', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BD07'}"
EU-1-10-621,"{'status': 'ACTIVE', 'name': 'Ristaben', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/621', 'active_substance': 'sitagliptin', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BH01'}"
EU-1-10-627,"{'status': 'ACTIVE', 'name': 'Raloxifene Teva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/627', 'active_substance': 'Raloxifene hydrochloride', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'G03XC01'}"
EU-1-10-628,"{'status': 'ACTIVE', 'name': 'Votrient', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/628', 'active_substance': 'Pazopanib hydrochloride', 'market_auth_holder': 'Novartis Europharm Limited'}"
EU-1-10-631,"{'status': 'ACTIVE', 'name': 'Nivestim', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/631', 'active_substance': 'Filgrastim', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L03AA02'}"
EU-1-10-632,"{'status': 'ACTIVE', 'name': 'Tolura', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/632', 'active_substance': 'telmisartan', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'C09CA07'}"
EU-1-10-635,"{'status': 'ACTIVE', 'name': 'Olanzapine Apotex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/635', 'active_substance': 'Olanzapine', 'market_auth_holder': 'Apotex Europe B.V.', 'atc_code': 'N05AH03'}"
EU-1-10-633,"{'status': 'ACTIVE', 'name': 'Topotecan Hospira', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/633', 'active_substance': 'topotecan', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01CE01'}"
EU-1-10-636,"{'status': 'ACTIVE', 'name': 'Daxas', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/636', 'active_substance': 'roflumilast', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'R03DX07'}"
EU-1-10-638,"{'status': 'ACTIVE', 'name': 'Ozurdex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/638', 'active_substance': 'dexamethasone', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'S01BA01'}"
EU-1-15-1076,"{'status': 'ACTIVE', 'name': 'Kovaltry', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1076', 'active_substance': 'octocog alfa', 'market_auth_holder': 'Bayer AG', 'atc_code': 'B02BD02'}"
EU-1-15-1078,"{'status': 'ACTIVE', 'name': 'Natpar', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1078', 'active_substance': 'parathyroid hormone', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'H05AA03'}"
EU-1-15-1056,"{'status': 'ACTIVE', 'name': 'Praxbind', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1056', 'active_substance': 'idarucizumab', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'V03AB37'}"
EU-1-16-1086,"{'status': 'ACTIVE', 'name': 'TAGRISSO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1086', 'active_substance': 'osimertinib', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'L01XE35'}"
EU-1-18-1298,"{'status': 'ACTIVE', 'name': 'VEYVONDI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1298', 'active_substance': 'vonicog alfa', 'market_auth_holder': 'Baxalta Innovations GmbH', 'atc_code': 'B02BD10'}"
EU-1-15-1025,"{'status': 'ACTIVE', 'name': 'EVOTAZ', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1025', 'active_substance': 'atazanavir / cobicistat', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'J05AR15'}"
EU-1-18-1273,"{'status': 'ACTIVE', 'name': 'Prasugrel Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1273', 'active_substance': 'prasugrel', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'B01AC22'}"
EU-1-12-809,"{'status': 'ACTIVE', 'name': 'Betmiga', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/809', 'active_substance': 'mirabegron', 'market_auth_holder': 'Astellas Pharma Europe B.V.', 'atc_code': 'G04BD12'}"
EU-1-14-945,"{'status': 'ACTIVE', 'name': 'IMBRUVICA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/945', 'active_substance': 'Ibrutinib', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'L01EL01'}"
EU-1-14-946,"{'status': 'ACTIVE', 'name': 'Accofil', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/946', 'active_substance': 'Filgrastim', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L03AA02'}"
EU-1-12-812,"{'status': 'ACTIVE', 'name': 'Bexsero', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/812', 'active_substance': 'Meningococcal group B Vaccine (rDNA, component, adsorbed)', 'market_auth_holder': 'GlaxoSmithKline Vaccines S.r.l.', 'atc_code': 'J07AH09'}"
EU-1-13-819,"{'status': 'ACTIVE', 'name': 'JETREA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/819', 'active_substance': 'ocriplasmin', 'market_auth_holder': 'Inceptua AB', 'atc_code': 'S01XA22'}"
EU-1-13-884,"{'status': 'ACTIVE', 'name': 'Invokana', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/884', 'active_substance': 'canagliflozin', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'A10BX11'}"
EU-1-13-894,"{'status': 'ACTIVE', 'name': 'Sovaldi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/894', 'active_substance': 'sofosbuvir', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AX15'}"
EU-1-14-918,"{'status': 'ACTIVE', 'name': 'Vokanamet', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/918', 'active_substance': 'canagliflozin / metformin hydrochloride', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'A10BD16'}"
EU-1-13-842,"{'status': 'ACTIVE', 'name': 'Incresync', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/842', 'active_substance': 'alogliptin / pioglitazone', 'market_auth_holder': 'Takeda Pharma A/S', 'atc_code': 'A10BD09'}"
EU-1-13-841,"{'status': 'ACTIVE', 'name': 'Spedra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/841', 'active_substance': 'avanafil', 'market_auth_holder': 'Menarini International Operations Luxembourg S.A.', 'atc_code': 'G04BE10'}"
EU-1-13-843,"{'status': 'ACTIVE', 'name': 'Vipdomet', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/843', 'active_substance': 'alogliptin / metformin', 'market_auth_holder': 'Takeda Pharma A/S', 'atc_code': 'A10BD13'}"
EU-1-13-844,"{'status': 'ACTIVE', 'name': 'Vipidia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/844', 'active_substance': 'alogliptin', 'market_auth_holder': 'Takeda Pharma A/S', 'atc_code': 'A10BH04'}"
EU-1-13-862,"{'status': 'ACTIVE', 'name': 'Ultibro Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/862', 'active_substance': 'indacaterol/glycopyrronium bromide', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03AL04'}"
EU-1-13-863,"{'status': 'ACTIVE', 'name': 'Xoterna Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/863', 'active_substance': 'indacaterol/glycopyrronium bromide', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03AL04'}"
EU-1-13-878,"{'status': 'ACTIVE', 'name': 'Defitelio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/878', 'active_substance': 'defibrotide', 'market_auth_holder': 'Gentium S.r.I.', 'atc_code': 'B01AX01'}"
EU-1-13-865,"{'status': 'ACTIVE', 'name': 'Tafinlar', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/865', 'active_substance': 'DABRAFENIB', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L01XE23'}"
EU-1-13-904,"{'status': 'ACTIVE', 'name': 'Mirvaso', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/904', 'active_substance': 'brimonidine', 'market_auth_holder': 'Galderma International', 'atc_code': 'D11AX21'}"
EU-1-13-858,"{'status': 'ACTIVE', 'name': 'Stivarga', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/858', 'active_substance': 'regorafenib', 'market_auth_holder': 'Bayer AG', 'atc_code': 'L01EX05'}"
EU-1-13-882,"{'status': 'ACTIVE', 'name': 'ABILIFY MAINTENA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/882', 'active_substance': 'Aripiprazole', 'market_auth_holder': 'Otsuka Pharmaceutical Netherlands B.V.', 'atc_code': 'N05AX12'}"
EU-1-14-981,"{'status': 'ACTIVE', 'name': 'Otezla', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/981', 'active_substance': 'apremilast', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'L04AA32'}"
EU-1-14-980,"{'status': 'ACTIVE', 'name': 'Cosentyx', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/980', 'active_substance': 'secukinumab', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L04AC10'}"
EU-1-13-888,"{'status': 'ACTIVE', 'name': 'NovoEight', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/888', 'active_substance': 'turoctocog alfa', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'B02BD02'}"
EU-1-14-915,"{'status': 'ACTIVE', 'name': 'Ebilfumin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/915', 'active_substance': 'oseltamivir', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'J05AH02'}"
EU-1-13-875,"{'status': 'ACTIVE', 'name': 'Deltyba', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/875', 'active_substance': 'delamanid', 'market_auth_holder': 'Otsuka Novel Products GmbH', 'atc_code': 'J04AK06'}"
EU-1-13-877,"{'status': 'ACTIVE', 'name': 'Grastofil', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/877', 'active_substance': 'filgrastim', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L03AA02'}"
EU-1-14-913,"{'status': 'ACTIVE', 'name': 'Latuda', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/913', 'active_substance': 'lurasidone', 'market_auth_holder': 'Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.p.A.', 'atc_code': 'N05AE05'}"
EU-1-14-920,"{'status': 'ACTIVE', 'name': 'DuoResp Spiromax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/920', 'active_substance': 'budesonide / formoterol', 'market_auth_holder': 'Teva Pharma B.V.', 'atc_code': 'R03AK07'}"
EU-1-13-837,"{'status': 'ACTIVE', 'name': 'Tecfidera', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/837', 'active_substance': 'Dimethyl fumarate', 'market_auth_holder': 'Biogen Netherlands B.V.', 'atc_code': 'L04AX07'}"
EU-1-13-838,"{'status': 'ACTIVE', 'name': 'AUBAGIO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/838', 'active_substance': 'Teriflunomide', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'L04AA31'}"
EU-1-14-923,"{'status': 'ACTIVE', 'name': 'Entyvio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/923', 'active_substance': 'vedolizumab', 'market_auth_holder': 'Takeda Pharma A/S', 'atc_code': 'L04AA33'}"
EU-1-14-929,"{'status': 'ACTIVE', 'name': 'Revinty Ellipta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/929', 'active_substance': 'fluticasone furoate / vilanterol', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'R03AK10'}"
EU-1-13-901,"{'status': 'ACTIVE', 'name': 'Sirturo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/901', 'active_substance': 'bedaquiline', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'J04AK05'}"
EU-1-14-931,"{'status': 'ACTIVE', 'name': 'Mekinist', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/931', 'active_substance': 'trametinib', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L01EE01'}"
EU-1-13-834,"{'status': 'ACTIVE', 'name': 'Zoledronic acid Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/834', 'active_substance': 'zoledronic acid', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'M05BA08'}"
EU-1-13-839,"{'status': 'ACTIVE', 'name': 'Iclusig', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/839', 'active_substance': 'ponatinib', 'market_auth_holder': 'Incyte Biosciences Distribution B.V.', 'atc_code': 'L01EA05'}"
EU-1-13-873,"{'status': 'ACTIVE', 'name': 'Xofigo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/873', 'active_substance': 'Radium Ra 223 dichloride', 'market_auth_holder': 'Bayer AG', 'atc_code': 'V10XX03'}"
EU-1-14-969,"{'status': 'ACTIVE', 'name': 'SCENESSE', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/969', 'active_substance': 'afamelanotide', 'market_auth_holder': 'Clinuvel Europe Limited', 'atc_code': 'D02BB02'}"
EU-1-13-820,"{'status': 'ACTIVE', 'name': 'Marixino', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/820', 'active_substance': 'Memantine', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'N06DX01'}"
EU-1-13-817,"{'status': 'ACTIVE', 'name': 'Actelsar HCT', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/817', 'active_substance': 'telmisartan / hydrochlorothiazide', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'C09DA07'}"
EU-1-13-832,"{'status': 'ACTIVE', 'name': 'Stayveer', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/832', 'active_substance': 'bosentan', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'C02KX01'}"
EU-1-13-824,"{'status': 'ACTIVE', 'name': 'Nemdatine', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/824', 'active_substance': 'Memantine', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'N06DX01'}"
EU-1-13-840,"{'status': 'ACTIVE', 'name': 'HyQvia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/840', 'active_substance': 'human normal immunoglobulin', 'market_auth_holder': 'Baxalta Innovations GmbH', 'atc_code': 'J06BA01'}"
EU-1-13-892,"{'status': 'ACTIVE', 'name': 'Tivicay', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/892', 'active_substance': 'dolutegravir', 'market_auth_holder': 'ViiV Healthcare BV'}"
EU-1-13-856,"{'status': 'ACTIVE', 'name': 'Lonquex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/856', 'active_substance': 'lipegfilgrastim', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'L03AA14'}"
EU-1-13-829,"{'status': 'ACTIVE', 'name': 'Hexyon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/829', 'active_substance': 'diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and <i>Haemophilus influenzae</i> type b conjugate vaccine (adsorbed)', 'market_auth_holder': 'Sanofi Pasteur', 'atc_code': 'J07CA09'}"
EU-1-13-828,"{'status': 'ACTIVE', 'name': 'Hexacima', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/828', 'active_substance': 'Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and <i>Haemophilus influenzae</i> type b conjugate vaccine (adsorbed)', 'market_auth_holder': 'Sanofi Pasteur', 'atc_code': 'J07CA09'}"
EU-1-13-818,"{'status': 'ACTIVE', 'name': 'Bosulif', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/818', 'active_substance': 'Bosutinib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01XE14'}"
EU-1-12-811,"{'status': 'ACTIVE', 'name': 'Lyxumia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/811', 'active_substance': 'lixisenatide', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'A10BJ03'}"
EU-1-13-879,"{'status': 'ACTIVE', 'name': 'Giotrif', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/879', 'active_substance': 'afatinib', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'L01EB03'}"
EU-1-13-880,"{'status': 'ACTIVE', 'name': 'Memantine Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/880', 'active_substance': 'memantine', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'N06DX01'}"
EU-1-13-881,"{'status': 'ACTIVE', 'name': 'Fortacin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/881', 'active_substance': 'lidocaine / prilocaine', 'market_auth_holder': 'Recordati Ireland Ltd', 'atc_code': 'N01BB20'}"
EU-1-14-930,"{'status': 'ACTIVE', 'name': 'Jardiance', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/930', 'active_substance': 'Empagliflozin', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'A10BK03'}"
EU-1-14-943,"{'status': 'ACTIVE', 'name': 'Velphoro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/943', 'active_substance': 'mixture of polynuclear iron(iii)-oxyhydroxide, sucrose and starches', 'market_auth_holder': 'Vifor Fresenius Medical Care Renal Pharma France', 'atc_code': 'V03AE05'}"
EU-1-12-814,"{'status': 'ACTIVE', 'name': 'ZALTRAP', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/814', 'active_substance': 'aflibercept', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'L01XX44'}"
EU-1-13-822,"{'status': 'ACTIVE', 'name': 'PHEBURANE', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/822', 'active_substance': 'Sodium Phenylbutyrate', 'market_auth_holder': 'Eurocept International BV', 'atc_code': 'A16AX03'}"
EU-1-13-902,"{'status': 'ACTIVE', 'name': 'Translarna', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/902', 'active_substance': 'ataluren', 'market_auth_holder': 'PTC Therapeutics International Limited', 'atc_code': 'M09AX03'}"
EU-1-14-963,"{'status': 'ACTIVE', 'name': 'Brimica Genuair', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/963', 'active_substance': 'aclidinium bromide / formoterol fumarate dihydrate', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'R03AL05'}"
EU-1-14-964,"{'status': 'ACTIVE', 'name': 'Duaklir Genuair', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/964', 'active_substance': 'aclidinium bromide / formoterol fumarate dihydrate', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'R03AL05'}"
EU-1-13-848,"{'status': 'ACTIVE', 'name': 'Erivedge', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/848', 'active_substance': 'vismodegib', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01XX43'}"
EU-1-13-860,"{'status': 'ACTIVE', 'name': 'Nexium Control', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/860', 'active_substance': 'esomeprazole', 'market_auth_holder': 'GlaxoSmithKline Dungarvan Limited', 'atc_code': 'A02BC05'}"
EU-1-13-861,"{'status': 'ACTIVE', 'name': 'Procysbi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/861', 'active_substance': 'mercaptamine (cysteamine bitartrate)', 'market_auth_holder': 'Chiesi Farmaceutici S.p.A.', 'atc_code': 'A16AA04'}"
EU-1-13-887,"{'status': 'ACTIVE', 'name': 'Fluenz Tetra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/887', 'active_substance': 'influenza vaccine (live attenuated, nasal)', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'J07BB03'}"
EU-1-13-896,"{'status': 'ACTIVE', 'name': 'Granupas', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/896', 'active_substance': 'Para-aminosalicylic acid', 'market_auth_holder': 'Eurocept International B.V.', 'atc_code': 'J04AA01'}"
EU-1-14-899,"{'status': 'ACTIVE', 'name': 'Laventair Ellipta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/899', 'active_substance': 'umeclidinium bromide / vilanterol trifenatate', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'R03AL03'}"
EU-1-13-821,"{'status': 'ACTIVE', 'name': 'Tolucombi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/821', 'active_substance': 'telmisartan/hydrochlorothiazide', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'C09DA07'}"
EU-1-13-852,"{'status': 'ACTIVE', 'name': 'Atosiban SUN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/852', 'active_substance': 'atosiban', 'market_auth_holder': 'Sun Pharmaceutical Industries Europe BV', 'atc_code': 'G02CX01'}"
EU-1-14-914,"{'status': 'ACTIVE', 'name': 'Vimizim', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/914', 'active_substance': 'elosulfase alfa', 'market_auth_holder': 'BioMarin International Limited', 'atc_code': 'A16AB12'}"
EU-1-14-940,"{'status': 'ACTIVE', 'name': 'Triumeq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/940', 'active_substance': 'dolutegravir / abacavir / lamivudine', 'market_auth_holder': 'ViiV Healthcare BV', 'atc_code': 'J05AR13'}"
EU-1-14-957,"{'status': 'ACTIVE', 'name': 'Cyramza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/957', 'active_substance': 'ramucirumab', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'L01XC21'}"
EU-1-14-967,"{'status': 'ACTIVE', 'name': 'Rezolsta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/967', 'active_substance': 'Darunavir/Cobicistat', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'J05AR14'}"
EU-1-13-859,"{'status': 'ACTIVE', 'name': 'Corbilta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/859', 'active_substance': 'levodopa / carbidopa / entacapone', 'market_auth_holder': 'Orion Corporation', 'atc_code': 'N04BA03'}"
EU-1-13-866,"{'status': 'ACTIVE', 'name': 'Cholib', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/866', 'active_substance': 'fenofibrate / simvastatin', 'market_auth_holder': 'Mylan IRE Healthcare Ltd', 'atc_code': 'C10BA04'}"
EU-1-14-919,"{'status': 'ACTIVE', 'name': 'Hemangiol', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/919', 'active_substance': 'propranolol', 'market_auth_holder': 'Pierre Fabre Dermatologie', 'atc_code': 'C07AA05'}"
EU-1-14-952,"{'status': 'ACTIVE', 'name': 'Sevelamer carbonate Winthrop', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/952', 'active_substance': 'Sevelamer carbonate', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'V03AE02'}"
EU-1-14-954,"{'status': 'ACTIVE', 'name': 'Vargatef', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/954', 'active_substance': 'nintedanib', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'L01EX09'}"
EU-1-14-955,"{'status': 'ACTIVE', 'name': 'Lymphoseek', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/955', 'active_substance': 'tilmanocept', 'market_auth_holder': 'Navidea Biopharmaceuticals Europe Ltd.', 'atc_code': 'V09IA09'}"
EU-1-13-855,"{'status': 'ACTIVE', 'name': 'Imvanex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/855', 'active_substance': 'Smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara)', 'market_auth_holder': 'Bavarian Nordic A/S', 'atc_code': 'J07BX'}"
EU-1-14-935,"{'status': 'ACTIVE', 'name': 'Envarsus', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/935', 'active_substance': 'tacrolimus', 'market_auth_holder': 'Chiesi Farmaceutici S.p.A.', 'atc_code': 'L04AD02'}"
EU-1-13-850,"{'status': 'ACTIVE', 'name': 'Imnovid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/850', 'active_substance': 'Pomalidomide', 'market_auth_holder': 'Bristol Myers Squibb Pharma EEIG', 'atc_code': 'L04AX06'}"
EU-1-14-974,"{'status': 'ACTIVE', 'name': 'Cerdelga', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/974', 'active_substance': 'eliglustat', 'market_auth_holder': 'Genzyme Europe B.V.', 'atc_code': 'A16AX10'}"
EU-1-14-975,"{'status': 'ACTIVE', 'name': 'Clopidogrel ratiopharm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/975', 'active_substance': 'clopidogrel', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'B01AC04'}"
EU-1-12-815,"{'status': 'ACTIVE', 'name': 'Selincro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/12/815', 'active_substance': 'nalmefene', 'market_auth_holder': 'H. Lundbeck A/S', 'atc_code': 'N07BB05'}"
EU-1-13-889,"{'status': 'ACTIVE', 'name': 'Levetiracetam Hospira', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/889', 'active_substance': 'levetiracetam', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'N03AX14'}"
EU-1-14-916,"{'status': 'ACTIVE', 'name': 'Pregabalin Pfizer', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/916', 'active_substance': 'pregabalin', 'market_auth_holder': 'Upjohn EESV', 'atc_code': 'N03AX16'}"
EU-1-13-823,"{'status': 'ACTIVE', 'name': 'Adasuve', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/823', 'active_substance': 'loxapine', 'market_auth_holder': 'Ferrer Internacional S.A.', 'atc_code': 'N05AH01'}"
EU-1-13-813,"{'status': 'ACTIVE', 'name': 'Perjeta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/813', 'active_substance': 'pertuzumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01XC13'}"
EU-1-13-857,"{'status': 'ACTIVE', 'name': 'Voncento', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/857', 'active_substance': 'human coagulation factor VIII / human von Willebrand factor', 'market_auth_holder': 'CSL Behring GmbH', 'atc_code': 'B02BD06'}"
EU-1-13-890,"{'status': 'ACTIVE', 'name': 'Cometriq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/890', 'active_substance': 'cabozantinib', 'market_auth_holder': 'Ipsen Pharma', 'atc_code': 'L01EX07'}"
EU-1-13-830,"{'status': 'ACTIVE', 'name': 'Stribild', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/830', 'active_substance': 'elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AR09'}"
EU-1-13-891,"{'status': 'ACTIVE', 'name': 'Brintellix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/891', 'active_substance': 'vortioxetine', 'market_auth_holder': 'H. Lundbeck A/S', 'atc_code': 'N06AX26'}"
EU-1-14-965,"{'status': 'ACTIVE', 'name': 'Ketoconazole HRA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/965', 'active_substance': 'ketoconazole', 'market_auth_holder': 'HRA Pharma Rare Diseases', 'atc_code': 'J02AB02'}"
EU-1-13-906,"{'status': 'ACTIVE', 'name': 'Neuraceq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/906', 'active_substance': 'florbetaben (<sup>18</sup>F)', 'market_auth_holder': 'Life Radiopharma Berlin GmbH', 'atc_code': 'V09AX06'}"
EU-1-14-956,"{'status': 'ACTIVE', 'name': 'Trulicity', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/956', 'active_substance': 'dulaglutide', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'A10BJ05'}"
EU-1-14-951,"{'status': 'ACTIVE', 'name': 'Busulfan Fresenius Kabi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/951', 'active_substance': 'busulfan', 'market_auth_holder': 'Fresenius Kabi Deutschland GmbH', 'atc_code': 'L01AB01'}"
EU-1-14-970,"{'status': 'ACTIVE', 'name': 'Rixubis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/970', 'active_substance': 'nonacog gamma', 'market_auth_holder': 'Baxalta Innovations GmbH', 'atc_code': 'B02BD04'}"
EU-1-14-973,"{'status': 'ACTIVE', 'name': 'Quinsair', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/973', 'active_substance': 'levofloxacin', 'market_auth_holder': 'Chiesi Farmaceutici S.p.A.', 'atc_code': 'J01MA12'}"
EU-1-13-893,"{'status': 'ACTIVE', 'name': 'Opsumit', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/893', 'active_substance': 'macitentan', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'C02KX04'}"
EU-1-13-826,"{'status': 'ACTIVE', 'name': 'Memantine LEK', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/826', 'active_substance': 'Memantine', 'market_auth_holder': 'Pharmathen S.A.', 'atc_code': 'N06DX01'}"
EU-1-14-972,"{'status': 'ACTIVE', 'name': 'Duloxetine Lilly', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/972', 'active_substance': 'duloxetine', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'N06AX21'}"
EU-1-14-977,"{'status': 'ACTIVE', 'name': 'Rasagiline ratiopharm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/977', 'active_substance': 'rasagiline', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'N04BD02'}"
EU-1-14-978,"{'status': 'ACTIVE', 'name': 'Senshio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/978', 'active_substance': 'ospemifene', 'market_auth_holder': 'Shionogi B.V.', 'atc_code': 'G03XC05'}"
EU-1-14-979,"{'status': 'ACTIVE', 'name': 'Ofev', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/979', 'active_substance': 'Nintedanib', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'L01EX09'}"
EU-1-13-869,"{'status': 'ACTIVE', 'name': 'Lemtrada', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/869', 'active_substance': 'Alemtuzumab', 'market_auth_holder': 'Sanofi Belgium', 'atc_code': 'L04AA34'}"
EU-1-14-933,"{'status': 'ACTIVE', 'name': 'Simbrinza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/933', 'active_substance': 'Brinzolamide / Brimonidine tartrate', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01EC54'}"
EU-1-14-934,"{'status': 'ACTIVE', 'name': 'Plegridy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/934', 'active_substance': 'peginterferon beta-1a', 'market_auth_holder': 'Biogen Netherlands B.V.', 'atc_code': 'L03AB13'}"
EU-1-14-936,"{'status': 'ACTIVE', 'name': 'Nuwiq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/936', 'active_substance': 'simoctocog alfa', 'market_auth_holder': 'Octapharma AB', 'atc_code': 'B02BD02'}"
EU-1-13-845,"{'status': 'ACTIVE', 'name': 'Imatinib Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/845', 'active_substance': 'Imatinib', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01EA01'}"
EU-1-13-846,"{'status': 'ACTIVE', 'name': 'Xtandi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/846', 'active_substance': 'enzalutamide', 'market_auth_holder': 'Astellas Pharma Europe B.V.', 'atc_code': 'L02BB04'}"
EU-1-13-836,"{'status': 'ACTIVE', 'name': 'Memantine ratiopharm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/836', 'active_substance': 'memantine', 'market_auth_holder': 'ratiopharm GmbH', 'atc_code': 'N06DX01'}"
EU-1-14-928,"{'status': 'ACTIVE', 'name': 'Sylvant', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/928', 'active_substance': 'siltuximab', 'market_auth_holder': 'EUSA Pharma (Netherlands) B.V.', 'atc_code': 'L04AC11'}"
EU-1-13-853,"{'status': 'ACTIVE', 'name': 'Remsima', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/853', 'active_substance': 'Infliximab', 'market_auth_holder': 'Celltrion Healthcare Hungary Kft.', 'atc_code': 'L04AB02'}"
EU-1-13-854,"{'status': 'ACTIVE', 'name': 'Inflectra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/854', 'active_substance': 'Infliximab', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L04AB02'}"
EU-1-14-960,"{'status': 'ACTIVE', 'name': 'DUAVIVE', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/960', 'active_substance': 'oestrogens conjugated / bazedoxifene', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'G03CC07'}"
EU-1-14-961,"{'status': 'ACTIVE', 'name': 'Tadalafil Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/961', 'active_substance': 'tadalafil', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'G04BE08'}"
EU-1-14-959,"{'status': 'ACTIVE', 'name': 'Lynparza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/959', 'active_substance': 'Olaparib', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'L01XK01'}"
EU-1-14-958,"{'status': 'ACTIVE', 'name': 'Harvoni', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/958', 'active_substance': 'ledipasvir/sofosbuvir', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AP51'}"
EU-1-13-871,"{'status': 'ACTIVE', 'name': 'Ovaleap', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/871', 'active_substance': 'Follitropin alfa', 'market_auth_holder': 'Theramex Ireland Limited', 'atc_code': 'G03GA05'}"
EU-1-13-827,"{'status': 'ACTIVE', 'name': 'Memantine Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/827', 'active_substance': 'Memantine', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'N06DX01'}"
EU-1-14-938,"{'status': 'ACTIVE', 'name': 'Zydelig', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/938', 'active_substance': 'idelalisib', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'L01EM01'}"
EU-1-14-947,"{'status': 'ACTIVE', 'name': 'Xultophy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/947', 'active_substance': 'insulin degludec / liraglutide', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AE56'}"
EU-1-13-885,"{'status': 'ACTIVE', 'name': 'Kadcyla', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/885', 'active_substance': 'Trastuzumab emtansine', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01XC14'}"
EU-1-13-886,"{'status': 'ACTIVE', 'name': 'Relvar Ellipta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/886', 'active_substance': 'fluticasone furoate/vilanterol', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'R03AK10'}"
EU-1-13-900,"{'status': 'ACTIVE', 'name': 'Xigduo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/900', 'active_substance': 'dapagliflozin/metformin', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'A10BD15'}"
EU-1-14-917,"{'status': 'ACTIVE', 'name': 'Ulunar Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/917', 'active_substance': 'indacaterol/glycopyrronium bromide', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03AL04'}"
EU-1-14-921,"{'status': 'ACTIVE', 'name': 'BiResp Spiromax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/921', 'active_substance': 'budesonide / formoterol', 'market_auth_holder': 'Teva Pharma B.V.', 'atc_code': 'R03AK07'}"
EU-1-14-937,"{'status': 'ACTIVE', 'name': 'Gazyvaro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/937', 'active_substance': 'obinutuzumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01XC15'}"
EU-1-13-851,"{'status': 'ACTIVE', 'name': 'Lojuxta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/851', 'active_substance': 'Lomitapide', 'market_auth_holder': 'Amryt Pharmaceuticals DAC', 'atc_code': 'C10AX12'}"
EU-1-13-872,"{'status': 'ACTIVE', 'name': 'Tybost', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/872', 'active_substance': 'cobicistat', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'V03AX03'}"
EU-1-13-905,"{'status': 'ACTIVE', 'name': 'Izba', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/905', 'active_substance': 'travoprost', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01EE04'}"
EU-1-13-907,"{'status': 'ACTIVE', 'name': 'Adempas', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/907', 'active_substance': 'riociguat', 'market_auth_holder': 'Bayer AG', 'atc_code': 'C02KX05'}"
EU-1-13-909,"{'status': 'ACTIVE', 'name': 'Bemfola', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/909', 'active_substance': 'follitropin alfa', 'market_auth_holder': 'Gedeon Richter Plc.', 'atc_code': 'G03GA05'}"
EU-1-14-962,"{'status': 'ACTIVE', 'name': 'Moventig', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/962', 'active_substance': 'naloxegol', 'market_auth_holder': 'Kyowa Kirin Holdings B.V.', 'atc_code': 'A06AH03'}"
EU-1-13-835,"{'status': 'ACTIVE', 'name': 'Voriconazole Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/13/835', 'active_substance': 'voriconazole', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'J02AC03'}"
EU-1-14-941,"{'status': 'ACTIVE', 'name': 'Vizamyl', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/941', 'active_substance': 'flutemetamol (18F)', 'market_auth_holder': 'GE Healthcare AS', 'atc_code': 'V09AX04'}"
EU-1-15-999,"{'status': 'ACTIVE', 'name': 'Zykadia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/999', 'active_substance': 'ceritinib', 'market_auth_holder': 'Novartis Europharm Limited'}"
EU-1-15-1009,"{'status': 'ACTIVE', 'name': 'Aripiprazole Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1009', 'active_substance': 'aripiprazole', 'market_auth_holder': 'Zentiva, k.s.', 'atc_code': 'N05AX12'}"
EU-1-15-1015,"{'status': 'ACTIVE', 'name': 'Strensiq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1015', 'active_substance': 'asfotase alfa', 'market_auth_holder': 'Alexion Europe SAS', 'atc_code': 'A16AB13'}"
EU-1-15-1016,"{'status': 'ACTIVE', 'name': 'Repatha', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1016', 'active_substance': 'evolocumab', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'C10AX13'}"
EU-1-15-997,"{'status': 'ACTIVE', 'name': 'Pregabalin Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/997', 'active_substance': 'pregabalin', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'N03AX16'}"
EU-1-15-1013,"{'status': 'ACTIVE', 'name': 'Lumark', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1013', 'active_substance': 'lutetium, isotope of mass 177', 'market_auth_holder': 'IDB Holland B.V.'}"
EU-1-15-1010,"{'status': 'ACTIVE', 'name': 'Duloxetine Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1010', 'active_substance': 'Duloxetine', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'N06AX21'}"
EU-1-15-1014,"{'status': 'ACTIVE', 'name': 'OPDIVO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1014', 'active_substance': 'nivolumab', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG'}"
EU-1-15-1053,"{'status': 'ACTIVE', 'name': 'Neofordex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1053', 'active_substance': 'dexamethasone', 'market_auth_holder': 'Laboratoires CTRS', 'atc_code': 'H02AB02'}"
EU-1-00-133,"{'status': 'ACTIVE', 'name': 'Toujeo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/133', 'active_substance': 'insulin glargine', 'market_auth_holder': 'Sanofi-Aventis Deutschland GmbH', 'atc_code': 'A10AE04'}"
EU-1-15-1005,"{'status': 'ACTIVE', 'name': 'Aripiprazole Mylan Pharma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1005', 'active_substance': 'aripiprazole', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'N05AX12'}"
EU-1-15-1006,"{'status': 'ACTIVE', 'name': 'Respreeza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1006', 'active_substance': 'human alpha1-proteinase inhibitor', 'market_auth_holder': 'CSL Behring GmbH', 'atc_code': 'B02AB02'}"
EU-1-15-1007,"{'status': 'ACTIVE', 'name': 'Gardasil 9', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1007', 'active_substance': 'human papillomavirus 9-valent vaccine (recombinant, adsorbed)', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J07BM03'}"
EU-1-15-1011,"{'status': 'ACTIVE', 'name': 'Pregabalin Sandoz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1011', 'active_substance': 'pregabalin', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'N03AX16'}"
EU-1-15-1012,"{'status': 'ACTIVE', 'name': 'Pregabalin Sandoz GmbH', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1012', 'active_substance': 'pregabalin', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'N03AX16'}"
EU-1-15-1000,"{'status': 'ACTIVE', 'name': 'Jinarc', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1000', 'active_substance': 'tolvaptan', 'market_auth_holder': 'Otsuka Pharmaceutical Netherlands B.V.', 'atc_code': 'C03XA01'}"
EU-1-15-1001,"{'status': 'ACTIVE', 'name': 'Akynzeo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1001', 'active_substance': 'netupitant/palonosetron or fosnetupitant/palonosetron', 'market_auth_holder': 'Helsinn Birex Pharmaceuticals Ltd', 'atc_code': 'A04AA55'}"
EU-1-15-1002,"{'status': 'ACTIVE', 'name': 'Lenvima', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1002', 'active_substance': 'lenvatinib', 'market_auth_holder': 'Eisai GmbH', 'atc_code': 'L01XE08'}"
EU-1-15-1003,"{'status': 'ACTIVE', 'name': 'Synjardy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1003', 'active_substance': 'empagliflozin / metformin', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'A10BD20'}"
EU-1-15-1018,"{'status': 'ACTIVE', 'name': 'Omidria', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1018', 'active_substance': 'phenylephrine / ketorolac', 'market_auth_holder': 'Omeros Ireland Limited', 'atc_code': 'S01FB51'}"
EU-1-15-1019,"{'status': 'ACTIVE', 'name': 'Bortezomib Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1019', 'active_substance': 'bortezomib', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01XX32'}"
EU-1-15-1020,"{'status': 'ACTIVE', 'name': 'Raxone', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1020', 'active_substance': 'idebenone', 'market_auth_holder': 'Santhera Pharmaceuticals (Deutschland) GmbH', 'atc_code': 'N06BX13'}"
EU-1-15-1043,"{'status': 'ACTIVE', 'name': 'Nucala', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1043', 'active_substance': 'mepolizumab', 'market_auth_holder': 'GlaxoSmithKline Trading Services Limited', 'atc_code': 'R03DX09'}"
EU-1-15-1045,"{'status': 'ACTIVE', 'name': 'Aripiprazole Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1045', 'active_substance': 'aripiprazole', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'N05AX12'}"
EU-1-15-1046,"{'status': 'ACTIVE', 'name': 'Elocta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1046', 'active_substance': 'efmoroctocog alfa', 'market_auth_holder': 'Swedish Orphan Biovitrum AB (publ)', 'atc_code': 'B02BD02'}"
EU-1-15-1047,"{'status': 'ACTIVE', 'name': 'BLINCYTO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1047', 'active_substance': 'blinatumomab', 'market_auth_holder': 'Amgen Europe B.V.'}"
EU-1-15-1048,"{'status': 'ACTIVE', 'name': 'Cotellic', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1048', 'active_substance': 'cobimetinib', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01EE02'}"
EU-1-15-1049,"{'status': 'ACTIVE', 'name': 'Cystadrops', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1049', 'active_substance': 'mercaptamine', 'market_auth_holder': 'Recordati Rare Diseases', 'atc_code': 'S01XA21'}"
EU-1-15-1051,"{'status': 'ACTIVE', 'name': 'Ebymect', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1051', 'active_substance': 'dapagliflozin / metformin', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'A10BD15'}"
EU-1-15-1052,"{'status': 'ACTIVE', 'name': 'Edistride', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1052', 'active_substance': 'dapagliflozin', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'A10BK01'}"
EU-1-14-984,"{'status': 'ACTIVE', 'name': 'Xadago', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/984', 'active_substance': 'safinamide', 'market_auth_holder': 'Zambon S.p.A.', 'atc_code': 'N04BD03'}"
EU-1-15-989,"{'status': 'ACTIVE', 'name': 'Orbactiv', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/989', 'active_substance': 'oritavancin', 'market_auth_holder': 'Menarini International Operations Luxembourg S.A.', 'atc_code': 'J01XA05'}"
EU-1-15-1008,"{'status': 'ACTIVE', 'name': 'Hetlioz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1008', 'active_substance': 'tasimelteon', 'market_auth_holder': 'Vanda Pharmaceuticals Netherlands B.V.', 'atc_code': 'N05CH03'}"
EU-1-10-615,"{'status': 'ACTIVE', 'name': 'Temozolomide Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/10/615', 'active_substance': 'temozolomide', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01AX03'}"
EU-1-16-1097,"{'status': 'ACTIVE', 'name': 'Strimvelis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1097', 'active_substance': 'autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence', 'market_auth_holder': 'Orchard Therapeutics (Netherlands) B.V.', 'atc_code': 'L03AX'}"
EU-1-15-1067,"{'status': 'ACTIVE', 'name': 'Lopinavir/Ritonavir Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1067', 'active_substance': 'lopinavir / ritonavir', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'J05AR10'}"
EU-1-15-1061,"{'status': 'ACTIVE', 'name': 'Genvoya', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1061', 'active_substance': 'elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AR18'}"
EU-1-15-1065,"{'status': 'ACTIVE', 'name': 'Eptifibatide Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1065', 'active_substance': 'eptifibatide', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'B01AC16'}"
EU-1-15-991,"{'status': 'ACTIVE', 'name': 'Sivextro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/991', 'active_substance': 'tedizolid phosphate', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J01XX11'}"
EU-1-14-986,"{'status': 'ACTIVE', 'name': 'Xydalba', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/986', 'active_substance': 'Dalbavancin', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'J01XA04'}"
EU-1-14-987,"{'status': 'ACTIVE', 'name': 'Holoclar', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/987', 'active_substance': 'Ex vivo expanded autologous human corneal epithelial cells containing stem cells', 'market_auth_holder': 'Holostem Terapie Avanzate S.r.l.', 'atc_code': 'S01XA19'}"
EU-1-15-994,"{'status': 'ACTIVE', 'name': 'Kengrexal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/994', 'active_substance': 'cangrelor', 'market_auth_holder': 'Chiesi Farmaceutici S.p.A.', 'atc_code': 'B01AC25'}"
EU-1-15-1071,"{'status': 'ACTIVE', 'name': 'Pemetrexed Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1071', 'active_substance': 'pemetrexed', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01BA04'}"
EU-1-15-1072,"{'status': 'ACTIVE', 'name': 'Spectrila', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1072', 'active_substance': 'asparaginase', 'market_auth_holder': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'atc_code': 'L01XX02'}"
EU-1-15-1073,"{'status': 'ACTIVE', 'name': 'Briviact', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1073', 'active_substance': 'brivaracetam', 'market_auth_holder': 'UCB Pharma S.A.', 'atc_code': 'N03AX23'}"
EU-1-16-1092,"{'status': 'ACTIVE', 'name': 'Amlodipine/Valsartan Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1092', 'active_substance': 'amlodipine/valsartan', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'C09DB01'}"
EU-1-16-1103,"{'status': 'ACTIVE', 'name': 'Neparvis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1103', 'active_substance': 'sacubitril / valsartan', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'C09DX04'}"
EU-1-15-1055,"{'status': 'ACTIVE', 'name': 'Ciambra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1055', 'active_substance': 'pemetrexed', 'market_auth_holder': 'Menarini International Operations Luxembourg S.A.', 'atc_code': 'L01BA04'}"
EU-1-16-1098,"{'status': 'ACTIVE', 'name': 'ALPROLIX', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1098', 'active_substance': 'eftrenonacog alfa', 'market_auth_holder': 'Swedish Orphan Biovitrum AB (publ)', 'atc_code': 'B02BD04'}"
EU-1-15-1036,"{'status': 'ACTIVE', 'name': 'Cresemba', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1036', 'active_substance': 'isavuconazole', 'market_auth_holder': 'Basilea Pharmaceutica Deutschland GmbH', 'atc_code': 'J02AC05'}"
EU-1-16-1102,"{'status': 'ACTIVE', 'name': 'Bortezomib SUN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1102', 'active_substance': 'bortezomib', 'market_auth_holder': 'Sun Pharmaceutical Industries Europe BV', 'atc_code': 'L01XX32'}"
EU-1-14-944,"{'status': 'ACTIVE', 'name': 'Abasaglar', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/944', 'active_substance': 'Insulin glargine', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'A10AE04'}"
EU-1-15-1031,"{'status': 'ACTIVE', 'name': 'Praluent', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1031', 'active_substance': 'alirocumab', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'C10AX14'}"
EU-1-15-1032,"{'status': 'ACTIVE', 'name': 'Zerbaxa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1032', 'active_substance': 'ceftolozane / tazobactam', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J01DI54'}"
EU-1-15-1058,"{'status': 'ACTIVE', 'name': 'Entresto', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1058', 'active_substance': 'sacubitril / valsartan', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'C09DX04'}"
EU-1-15-1059,"{'status': 'ACTIVE', 'name': 'Orkambi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1059', 'active_substance': 'Lumacaftor/Ivacaftor', 'market_auth_holder': 'Vertex Pharmaceuticals (Ireland) Limited', 'atc_code': 'R07AX30'}"
EU-1-15-1060,"{'status': 'ACTIVE', 'name': 'Kyprolis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1060', 'active_substance': 'carfilzomib', 'market_auth_holder': 'Amgen Europe B.V.'}"
EU-1-15-1074,"{'status': 'ACTIVE', 'name': 'Benepali', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1074', 'active_substance': 'etanercept', 'market_auth_holder': 'Samsung Bioepis NL B.V.', 'atc_code': 'L04AB01'}"
EU-1-15-1064,"{'status': 'ACTIVE', 'name': 'Imlygic', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1064', 'active_substance': 'talimogene laherparepvec', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'L01XX51'}"
EU-1-16-1099,"{'status': 'ACTIVE', 'name': 'Descovy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1099', 'active_substance': 'emtricitabine / tenofovir alafenamide', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AR17'}"
EU-1-15-1029,"{'status': 'ACTIVE', 'name': 'Aripiprazole Sandoz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1029', 'active_substance': 'Aripiprazole', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'N05AX12'}"
EU-1-15-1068,"{'status': 'ACTIVE', 'name': 'Wakix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1068', 'active_substance': 'Pitolisant hydrochloride', 'market_auth_holder': 'Bioprojet Pharma', 'atc_code': 'N07XX11'}"
EU-1-15-1040,"{'status': 'ACTIVE', 'name': 'Intuniv', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1040', 'active_substance': 'guanfacine', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'C02AC02'}"
EU-1-15-1041,"{'status': 'ACTIVE', 'name': 'Ivabradine Anpharm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1041', 'active_substance': 'ivabradine', 'market_auth_holder': 'ANPHARM Przedsibiorstwo Farmaceutyczne S.A.', 'atc_code': 'C01EB17'}"
EU-1-16-1094,"{'status': 'ACTIVE', 'name': 'Ninlaro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1094', 'active_substance': 'ixazomib', 'market_auth_holder': 'Takeda Pharma A/S', 'atc_code': 'L01XG03'}"
EU-1-16-1087,"{'status': 'ACTIVE', 'name': 'Coagadex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1087', 'active_substance': 'human coagulation factor X', 'market_auth_holder': 'BPL Bioproducts Laboratory GmbH', 'atc_code': 'B02BD13'}"
EU-1-16-1088,"{'status': 'ACTIVE', 'name': 'Empliciti', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1088', 'active_substance': 'elotuzumab', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG'}"
EU-1-16-1093,"{'status': 'ACTIVE', 'name': 'Zonisamide Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1093', 'active_substance': 'zonisamide', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'N03AX15'}"
EU-1-16-1090,"{'status': 'ACTIVE', 'name': 'Rasagiline Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1090', 'active_substance': 'rasagiline', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'N04BD02'}"
EU-1-16-1096,"{'status': 'ACTIVE', 'name': 'Lonsurf', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1096', 'active_substance': 'trifluridine / tipiracil', 'market_auth_holder': 'Les Laboratoires Servier', 'atc_code': 'L01BC59'}"
EU-1-14-988,"{'status': 'ACTIVE', 'name': 'Mysimba', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/988', 'active_substance': 'naltrexone / bupropion', 'market_auth_holder': 'Orexigen Therapeutics Ireland Limited', 'atc_code': 'A08AA62'}"
EU-1-15-1063,"{'status': 'ACTIVE', 'name': 'Armisarte', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1063', 'active_substance': 'pemetrexed', 'market_auth_holder': 'Actavis Group PTC ehf.', 'atc_code': 'L01BA04'}"
EU-1-15-992,"{'status': 'ACTIVE', 'name': 'Saxenda', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/992', 'active_substance': 'liraglutide', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10BX07'}"
EU-1-15-993,"{'status': 'ACTIVE', 'name': 'Lixiana', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/993', 'active_substance': 'edoxaban', 'market_auth_holder': 'Daiichi Sankyo Europe GmbH', 'atc_code': 'B01AF03'}"
EU-1-16-1091,"{'status': 'ACTIVE', 'name': 'Atazanavir Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1091', 'active_substance': 'atazanavir', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'J05AE08'}"
EU-1-15-1027,"{'status': 'ACTIVE', 'name': 'Pregabalin Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1027', 'active_substance': 'pregabalin', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'N03AX16'}"
EU-1-15-1028,"{'status': 'ACTIVE', 'name': 'Duloxetine Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1028', 'active_substance': 'duloxetine', 'market_auth_holder': 'Zentiva, k.s.', 'atc_code': 'N06AX21'}"
EU-1-15-1037,"{'status': 'ACTIVE', 'name': 'Pemetrexed Sandoz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1037', 'active_substance': 'pemetrexed', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'L01BA04'}"
EU-1-15-1038,"{'status': 'ACTIVE', 'name': 'Pemetrexed medac', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1038', 'active_substance': 'Pemetrexed', 'market_auth_holder': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'atc_code': 'L01BA04'}"
EU-1-15-1030,"{'status': 'ACTIVE', 'name': 'Odomzo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1030', 'active_substance': 'sonidegib', 'market_auth_holder': 'Sun Pharmaceutical Industries Europe BV'}"
EU-1-15-1083,"{'status': 'ACTIVE', 'name': 'Uptravi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1083', 'active_substance': 'selexipag', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'B01AC27'}"
EU-1-16-1095,"{'status': 'ACTIVE', 'name': 'IDELVION', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1095', 'active_substance': 'albutrepenonacog alfa', 'market_auth_holder': 'CSL Behring GmbH', 'atc_code': 'B02BD04'}"
EU-1-15-1024,"{'status': 'ACTIVE', 'name': 'KEYTRUDA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1024', 'active_substance': 'pembrolizumab', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.'}"
EU-1-15-1054,"{'status': 'ACTIVE', 'name': 'Cinacalcet Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1054', 'active_substance': 'cinacalcet', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'H05BX01'}"
EU-1-15-1082,"{'status': 'ACTIVE', 'name': 'Galafold', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1082', 'active_substance': 'migalastat', 'market_auth_holder': 'Amicus Therapeutics Europe Limited', 'atc_code': 'A16AX14'}"
EU-1-15-1066,"{'status': 'ACTIVE', 'name': 'Ongentys', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1066', 'active_substance': 'opicapone', 'market_auth_holder': 'Bial - Portela &amp; C&#170;, SA', 'atc_code': 'N04BX04'}"
EU-1-15-990,"{'status': 'ACTIVE', 'name': 'IKERVIS', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/990', 'active_substance': 'Ciclosporin', 'market_auth_holder': 'Santen Oy', 'atc_code': 'S01XA18'}"
EU-1-15-1070,"{'status': 'ACTIVE', 'name': 'Oncaspar', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1070', 'active_substance': 'pegaspargase', 'market_auth_holder': 'Les Laboratoires Servier', 'atc_code': 'L01XX24'}"
EU-1-15-1021,"{'status': 'ACTIVE', 'name': 'Pregabalin Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1021', 'active_substance': 'pregabalin', 'market_auth_holder': 'Zentiva, k.s.', 'atc_code': 'N03AX16'}"
EU-1-15-1023,"{'status': 'ACTIVE', 'name': 'Farydak', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1023', 'active_substance': 'panobinostat', 'market_auth_holder': 'Secura Bio Limited'}"
EU-1-15-1085,"{'status': 'ACTIVE', 'name': 'Taltz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1085', 'active_substance': 'ixekizumab', 'market_auth_holder': 'Eli Lilly and Company (Ireland) Limited', 'atc_code': 'L04AC13'}"
EU-1-16-1101,"{'status': 'ACTIVE', 'name': 'Darzalex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1101', 'active_substance': 'daratumumab', 'market_auth_holder': 'Janssen-Cilag International NV'}"
EU-1-15-1075,"{'status': 'ACTIVE', 'name': 'Feraccru', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1075', 'active_substance': 'ferric maltol', 'market_auth_holder': 'Norgine B.V.', 'atc_code': 'B03AB10'}"
EU-1-15-1079,"{'status': 'ACTIVE', 'name': 'Vaxelis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1079', 'active_substance': 'Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)', 'market_auth_holder': 'MCM Vaccine B.V.', 'atc_code': 'J07CA09'}"
EU-1-15-1062,"{'status': 'ACTIVE', 'name': 'Ravicti', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1062', 'active_substance': 'Glycerol phenylbutyrate', 'market_auth_holder': 'Immedica Pharma AB', 'atc_code': 'A16AX09'}"
EU-1-14-982,"{'status': 'ACTIVE', 'name': 'Viekirax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/982', 'active_substance': 'ombitasvir / paritaprevir / ritonavir', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'J05AP53'}"
EU-1-14-983,"{'status': 'ACTIVE', 'name': 'Exviera', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/983', 'active_substance': 'dasabuvir', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'J05AP09'}"
EU-1-16-1104,"{'status': 'ACTIVE', 'name': 'Palonosetron Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1104', 'active_substance': 'palonosetron', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'A04AA05'}"
EU-1-15-1033,"{'status': 'ACTIVE', 'name': 'Kanuma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1033', 'active_substance': 'sebelipase alfa', 'market_auth_holder': 'Alexion Europe SAS', 'atc_code': 'A16AB14'}"
EU-1-16-1119,"{'status': 'ACTIVE', 'name': 'Zepatier', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1119', 'active_substance': 'elbasvir / grazoprevir', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J05AP54'}"
EU-1-16-1125,"{'status': 'ACTIVE', 'name': 'Cinqaero', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1125', 'active_substance': 'reslizumab', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'R03DX08'}"
EU-1-16-1152,"{'status': 'ACTIVE', 'name': 'Roteas', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1152', 'active_substance': 'edoxaban', 'market_auth_holder': 'Berlin-Chemie AG', 'atc_code': 'B01AF03'}"
EU-1-17-1182,"{'status': 'ACTIVE', 'name': 'Emtricitabine /Tenofovir disoproxil Krka d.d.', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1182', 'active_substance': 'emtricitabine / tenofovir disoproxil', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'J05AR03'}"
EU-1-17-1184,"{'status': 'ACTIVE', 'name': 'Riximyo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1184', 'active_substance': 'rituximab', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'L01XC02'}"
EU-1-17-1187,"{'status': 'ACTIVE', 'name': 'Trumenba', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1187', 'active_substance': 'meningococcal group B vaccine (recombinant, adsorbed)', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'J07AH09'}"
EU-1-17-1197,"{'status': 'ACTIVE', 'name': 'OXERVATE', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1197', 'active_substance': 'cenegermin', 'market_auth_holder': 'Domp&#233; farmaceutici S.p.A.', 'atc_code': 'S01XA24'}"
EU-1-17-1234,"{'status': 'ACTIVE', 'name': 'Tremfya', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1234', 'active_substance': 'Guselkumab', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'L04AC'}"
EU-1-17-1255,"{'status': 'ACTIVE', 'name': 'Intrarosa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1255', 'active_substance': 'prasterone', 'market_auth_holder': 'Endoceutics S.A.', 'atc_code': 'G03XX01'}"
EU-1-17-1229,"{'status': 'ACTIVE', 'name': 'Dupixent', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1229', 'active_substance': 'dupilumab', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'D11AH05'}"
EU-1-17-1230,"{'status': 'ACTIVE', 'name': 'Lacosamide Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1230', 'active_substance': 'lacosamide', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'N03AX18'}"
EU-1-17-1262,"{'status': 'ACTIVE', 'name': 'CRYSVITA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1262', 'active_substance': 'Burosumab', 'market_auth_holder': 'Kyowa Kirin Holdings B.V.', 'atc_code': 'M05BX'}"
EU-1-16-1124,"{'status': 'ACTIVE', 'name': 'Nordimet', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1124', 'active_substance': 'methotrexate', 'market_auth_holder': 'Nordic Group B.V.', 'atc_code': 'L04AX03'}"
EU-1-16-1141,"{'status': 'ACTIVE', 'name': 'SomaKit TOC', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1141', 'active_substance': 'edotreotide', 'market_auth_holder': 'Advanced Accelerator Applications', 'atc_code': 'V09IX09'}"
EU-1-16-1146,"{'status': 'ACTIVE', 'name': 'Glyxambi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1146', 'active_substance': 'empagliflozin/linagliptin', 'market_auth_holder': 'Boehringer Ingelheim International GmbH', 'atc_code': 'A10BD19'}"
EU-1-16-1147,"{'status': 'ACTIVE', 'name': 'IBRANCE', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1147', 'active_substance': 'palbociclib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01XE33'}"
EU-1-17-1215,"{'status': 'ACTIVE', 'name': 'Fotivda', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1215', 'active_substance': 'tivozanib', 'market_auth_holder': 'EUSA Pharma (Netherlands) B.V.', 'atc_code': 'L01EK03'}"
EU-1-17-1216,"{'status': 'ACTIVE', 'name': 'Imraldi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1216', 'active_substance': 'adalimumab', 'market_auth_holder': 'Samsung Bioepis NL B.V.', 'atc_code': 'L04AB04'}"
EU-1-17-1218,"{'status': 'ACTIVE', 'name': 'Rydapt', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1218', 'active_substance': 'Midostaurin', 'market_auth_holder': 'Novartis Europharm Limited'}"
EU-1-16-1110,"{'status': 'ACTIVE', 'name': 'Chenodeoxycholic acid Leadiant', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1110', 'active_substance': 'chenodeoxycholic acid', 'market_auth_holder': 'Leadiant GmbH', 'atc_code': 'A05AA01'}"
EU-1-17-1212,"{'status': 'ACTIVE', 'name': 'MAVENCLAD', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1212', 'active_substance': 'cladribine', 'market_auth_holder': 'Merck Europe B.V.', 'atc_code': 'L01BB04'}"
EU-1-17-1222,"{'status': 'ACTIVE', 'name': 'Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1222', 'active_substance': 'Efavirenz / emtricitabine / tenofovir disoproxil', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'J05AR06'}"
EU-1-16-1134,"{'status': 'ACTIVE', 'name': 'Mysildecard', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1134', 'active_substance': 'sildenafil', 'market_auth_holder': 'Viatris Limited', 'atc_code': 'G04BE03'}"
EU-1-14-971,"{'status': 'ACTIVE', 'name': 'Trevicta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/971', 'active_substance': 'paliperidone', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'N05AX13'}"
EU-1-16-1137,"{'status': 'ACTIVE', 'name': 'Granpidam', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1137', 'active_substance': 'sildenafil', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'G04BE03'}"
EU-1-16-1140,"{'status': 'ACTIVE', 'name': 'Darunavir Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1140', 'active_substance': 'darunavir', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'J05AE10'}"
EU-1-16-1148,"{'status': 'ACTIVE', 'name': 'Emtricitabine/Tenofovir disoproxil Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1148', 'active_substance': 'emtricitabine / tenofovir disoproxil', 'market_auth_holder': 'Zentiva, k.s.', 'atc_code': 'J05AR03'}"
EU-1-16-1132,"{'status': 'ACTIVE', 'name': 'Inhixa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1132', 'active_substance': 'enoxaparin sodium', 'market_auth_holder': 'Techdow Pharma Netherlands B.V.', 'atc_code': 'B01AB05'}"
EU-1-16-1142,"{'status': 'ACTIVE', 'name': 'Parsabiv', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1142', 'active_substance': 'etelcalcetide', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'H05BX04'}"
EU-1-16-1127,"{'status': 'ACTIVE', 'name': 'Tenofovir disoproxil Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1127', 'active_substance': 'tenofovir disoproxil', 'market_auth_holder': 'Zentiva, k.s.', 'atc_code': 'J05AF07'}"
EU-1-16-1105,"{'status': 'ACTIVE', 'name': 'EndolucinBeta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1105', 'active_substance': 'Lutetium (<sup>177</sup> Lu) chloride', 'market_auth_holder': 'ITM Medical Isotopes GmbH', 'atc_code': 'V10X'}"
EU-1-16-1114,"{'status': 'ACTIVE', 'name': 'Bortezomib Hospira', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1114', 'active_substance': 'bortezomib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01XG01'}"
EU-1-16-1154,"{'status': 'ACTIVE', 'name': 'Vemlidy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1154', 'active_substance': 'tenofovir alafenamide', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AF13'}"
EU-1-16-1160,"{'status': 'ACTIVE', 'name': 'Fiasp', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1160', 'active_substance': 'insulin aspart', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10AB05'}"
EU-1-16-1161,"{'status': 'ACTIVE', 'name': 'Movymia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1161', 'active_substance': 'teriparatide', 'market_auth_holder': 'STADA Arzneimittel AG', 'atc_code': 'H05AA02'}"
EU-1-17-1178,"{'status': 'ACTIVE', 'name': 'Xeljanz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1178', 'active_substance': 'Tofacitinib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L04AA29'}"
EU-1-16-1151,"{'status': 'ACTIVE', 'name': 'Emtricitabine/Tenofovir disoproxil Krka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1151', 'active_substance': 'emtricitabine / tenofovir disoproxil', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'J05AR03'}"
EU-1-17-1172,"{'status': 'ACTIVE', 'name': 'Jylamvo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1172', 'active_substance': 'methotrexate', 'market_auth_holder': 'Therakind (Europe) Limited', 'atc_code': 'L01BA01'}"
EU-1-17-1214,"{'status': 'ACTIVE', 'name': 'Bavencio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1214', 'active_substance': 'avelumab', 'market_auth_holder': 'Merck Europe B.V.'}"
EU-1-16-1153,"{'status': 'ACTIVE', 'name': 'Talmanco', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1153', 'active_substance': 'tadalafil', 'market_auth_holder': 'Viatris Limited', 'atc_code': 'G04BE08'}"
EU-1-16-1128,"{'status': 'ACTIVE', 'name': 'Kisplyx', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1128', 'active_substance': 'lenvatinib', 'market_auth_holder': 'Eisai GmbH', 'atc_code': 'L01XE08'}"
EU-1-16-1144,"{'status': 'ACTIVE', 'name': 'Ivabradine Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1144', 'active_substance': 'ivabradine', 'market_auth_holder': 'Zentiva, k.s.', 'atc_code': 'C01EB17'}"
EU-1-16-1116,"{'status': 'ACTIVE', 'name': 'Epclusa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1116', 'active_substance': 'sofosbuvir/velpatasvir', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AX69'}"
EU-1-17-1193,"{'status': 'ACTIVE', 'name': 'Refixia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1193', 'active_substance': 'nonacog beta pegol', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'B02BD04'}"
EU-1-17-1199,"{'status': 'ACTIVE', 'name': 'Cuprior', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1199', 'active_substance': 'trientine', 'market_auth_holder': 'Orphalan', 'atc_code': 'A16AX12'}"
EU-1-17-1200,"{'status': 'ACTIVE', 'name': 'Besponsa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1200', 'active_substance': 'inotuzumab ozogamicin', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01XC26'}"
EU-1-17-1201,"{'status': 'ACTIVE', 'name': 'Skilarence', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1201', 'active_substance': 'dimethyl fumarate', 'market_auth_holder': 'Almirall, S.A.'}"
EU-1-17-1211,"{'status': 'ACTIVE', 'name': 'Entecavir Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1211', 'active_substance': 'entecavir', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'J05AF10'}"
EU-1-17-1223,"{'status': 'ACTIVE', 'name': 'Vosevi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1223', 'active_substance': 'sofosbuvir / velpatasvir / voxilaprevir', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AP56'}"
EU-1-17-1227,"{'status': 'ACTIVE', 'name': 'Entecavir Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1227', 'active_substance': 'entecavir', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'J05AF10'}"
EU-1-17-1195,"{'status': 'ACTIVE', 'name': 'Erelzi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1195', 'active_substance': 'etanercept', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'L04AB01'}"
EU-1-17-1196,"{'status': 'ACTIVE', 'name': 'Kevzara', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1196', 'active_substance': 'sarilumab', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'L04AC14'}"
EU-1-17-1225,"{'status': 'ACTIVE', 'name': 'Symtuza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1225', 'active_substance': 'darunavir / cobicistat / emtricitabine / tenofovir alafenamide', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'J05AR22'}"
EU-1-17-1228,"{'status': 'ACTIVE', 'name': 'TOOKAD', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1228', 'active_substance': 'padeliporfin', 'market_auth_holder': 'Steba Biotech S.A', 'atc_code': 'L01XD07'}"
EU-1-18-1265,"{'status': 'ACTIVE', 'name': 'Segluromet', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1265', 'active_substance': 'ertugliflozin / metformin hydrochloride', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BD23'}"
EU-1-18-1266,"{'status': 'ACTIVE', 'name': 'Steglujan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1266', 'active_substance': 'ertugliflozin / sitagliptin', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BD24'}"
EU-1-18-1267,"{'status': 'ACTIVE', 'name': 'Steglatro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1267', 'active_substance': 'ertugliflozin', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BK04'}"
EU-1-18-1270,"{'status': 'ACTIVE', 'name': 'Semglee', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1270', 'active_substance': 'Insulin glargine', 'market_auth_holder': 'Viatris Limited', 'atc_code': 'A10AE04'}"
EU-1-18-1276,"{'status': 'ACTIVE', 'name': 'Myalepta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1276', 'active_substance': 'metreleptin', 'market_auth_holder': 'Amryt Pharmaceuticals DAC', 'atc_code': 'A16AA07'}"
EU-1-17-1219,"{'status': 'ACTIVE', 'name': 'Verkazia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1219', 'active_substance': 'ciclosporin', 'market_auth_holder': 'Santen Oy', 'atc_code': 'S01XA18'}"
EU-1-17-1220,"{'status': 'ACTIVE', 'name': 'Tecentriq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1220', 'active_substance': 'atezolizumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01XC32'}"
EU-1-17-1221,"{'status': 'ACTIVE', 'name': 'Kisqali', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1221', 'active_substance': 'ribociclib', 'market_auth_holder': 'Novartis Europharm Limited'}"
EU-1-17-1236,"{'status': 'ACTIVE', 'name': 'Trelegy Ellipta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1236', 'active_substance': 'fluticasone furoate/umeclidinium/vilanterol', 'market_auth_holder': 'GlaxoSmithKline Trading Services Limited', 'atc_code': 'R03AL08'}"
EU-1-17-1237,"{'status': 'ACTIVE', 'name': 'Elebrato Ellipta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1237', 'active_substance': 'fluticasone furoate/umeclidinium/vilanterol', 'market_auth_holder': 'GlaxoSmithKline Trading Services Limited', 'atc_code': 'R03AL08'}"
EU-1-17-1238,"{'status': 'ACTIVE', 'name': 'Nyxoid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1238', 'active_substance': 'naloxone', 'market_auth_holder': 'Mundipharma Corporation (Ireland) Limited', 'atc_code': 'V03AB15'}"
EU-1-16-1168,"{'status': 'ACTIVE', 'name': 'Vihuma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1168', 'active_substance': 'simoctocog alfa', 'market_auth_holder': 'Octapharma AB', 'atc_code': 'B02BD02'}"
EU-1-17-1175,"{'status': 'ACTIVE', 'name': 'Daptomycin Hospira', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1175', 'active_substance': 'daptomycin', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'J01XX09'}"
EU-1-16-1169,"{'status': 'ACTIVE', 'name': 'Alecensa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1169', 'active_substance': 'alectinib', 'market_auth_holder': 'Roche Registration GmbH'}"
EU-1-16-1133,"{'status': 'ACTIVE', 'name': 'Emtricitabine/Tenofovir disoproxil Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1133', 'active_substance': 'emtricitabine / tenofovir disoproxil', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'J05AR03'}"
EU-1-17-1188,"{'status': 'ACTIVE', 'name': 'Spinraza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1188', 'active_substance': 'nusinersen', 'market_auth_holder': 'Biogen Netherlands B.V.', 'atc_code': 'M09AX07'}"
EU-1-17-1173,"{'status': 'ACTIVE', 'name': 'Lokelma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1173', 'active_substance': 'sodium zirconium cyclosilicate', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'V03AE10'}"
EU-1-17-1205,"{'status': 'ACTIVE', 'name': 'Blitzima', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1205', 'active_substance': 'rituximab', 'market_auth_holder': 'Celltrion Healthcare Hungary Kft.'}"
EU-1-17-1226,"{'status': 'ACTIVE', 'name': 'Lutathera', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1226', 'active_substance': 'lutetium (<sup>177</sup>Lu) oxodotreotide', 'market_auth_holder': 'Advanced Accelerator Applications', 'atc_code': 'V10XX04'}"
EU-1-16-1106,"{'status': 'ACTIVE', 'name': 'Flixabi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1106', 'active_substance': 'infliximab', 'market_auth_holder': 'Samsung Bioepis NL B.V.', 'atc_code': 'L04AB02'}"
EU-1-16-1108,"{'status': 'ACTIVE', 'name': 'Qtern', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1108', 'active_substance': 'saxagliptin / dapagliflozin', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'A10BD21'}"
EU-1-16-1109,"{'status': 'ACTIVE', 'name': 'Zavicefta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1109', 'active_substance': 'ceftazidime/avibactam', 'market_auth_holder': 'Pfizer Ireland Pharmaceuticals', 'atc_code': 'J01DD52'}"
EU-1-16-1155,"{'status': 'ACTIVE', 'name': 'Kyntheum', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1155', 'active_substance': 'brodalumab', 'market_auth_holder': 'Leo Pharma A/S', 'atc_code': 'L04AC12'}"
EU-1-16-1157,"{'status': 'ACTIVE', 'name': 'Suliqua', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1157', 'active_substance': 'insulin glargine / lixisenatide', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'A10AE54'}"
EU-1-17-1176,"{'status': 'ACTIVE', 'name': 'Yargesa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1176', 'active_substance': 'miglustat', 'market_auth_holder': 'Piramal Critical Care B.V.', 'atc_code': 'A16AX06'}"
EU-1-16-1138,"{'status': 'ACTIVE', 'name': 'Venclyxto', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1138', 'active_substance': 'venetoclax', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'L01XX52'}"
EU-1-16-1164,"{'status': 'ACTIVE', 'name': 'AMGEVITA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1164', 'active_substance': 'adalimumab', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'L04AB04'}"
EU-1-17-1194,"{'status': 'ACTIVE', 'name': 'Febuxostat Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1194', 'active_substance': 'febuxostat', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'M04AA03'}"
EU-1-17-1203,"{'status': 'ACTIVE', 'name': 'Insulin lispro Sanofi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1203', 'active_substance': 'insulin lispro', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'A10AB04'}"
EU-1-17-1202,"{'status': 'ACTIVE', 'name': 'Ucedane', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1202', 'active_substance': 'carglumic acid', 'market_auth_holder': 'Eurocept International B.V.', 'atc_code': 'A16AA05'}"
EU-1-17-1224,"{'status': 'ACTIVE', 'name': 'Xermelo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1224', 'active_substance': 'telotristat', 'market_auth_holder': 'SERB SAS', 'atc_code': 'A16AX15'}"
EU-1-17-1251,"{'status': 'ACTIVE', 'name': 'Ozempic', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1251', 'active_substance': 'semaglutide', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10BJ06'}"
EU-1-16-1150,"{'status': 'ACTIVE', 'name': 'Rekovelle', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1150', 'active_substance': 'follitropin delta', 'market_auth_holder': 'Ferring Pharmaceuticals A/S', 'atc_code': 'G03GA10'}"
EU-1-16-1158,"{'status': 'ACTIVE', 'name': 'AFSTYLA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1158', 'active_substance': 'lonoctocog alfa', 'market_auth_holder': 'CSL Behring GmbH', 'atc_code': 'B02BD02'}"
EU-1-16-1159,"{'status': 'ACTIVE', 'name': 'Terrosa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1159', 'active_substance': 'teriparatide', 'market_auth_holder': 'Gedeon Richter Plc.', 'atc_code': 'H05AA02'}"
EU-1-17-1179,"{'status': 'ACTIVE', 'name': 'Veltassa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1179', 'active_substance': 'patiromer', 'market_auth_holder': 'Vifor Fresenius Medical Care Renal Pharma France', 'atc_code': 'V03AE09'}"
EU-1-17-1213,"{'status': 'ACTIVE', 'name': 'Maviret', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1213', 'active_substance': 'glecaprevir / pibrentasvir', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'J05AP57'}"
EU-1-16-1112,"{'status': 'ACTIVE', 'name': 'Odefsey', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1112', 'active_substance': 'emtricitabine / rilpivirine / tenofovir alafenamide', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AR19'}"
EU-1-16-1129,"{'status': 'ACTIVE', 'name': 'Tenofovir disoproxil Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1129', 'active_substance': 'Tenofovir disoproxil', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'J05AF07'}"
EU-1-16-1135,"{'status': 'ACTIVE', 'name': 'Sialanar', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1135', 'active_substance': 'glycopyrronium bromide', 'market_auth_holder': 'Proveca Pharma Limited', 'atc_code': 'A03AB02'}"
EU-1-17-1185,"{'status': 'ACTIVE', 'name': 'Rixathon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1185', 'active_substance': 'rituximab', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'L01XC02'}"
EU-1-17-1210,"{'status': 'ACTIVE', 'name': 'Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1210', 'active_substance': 'efavirenz / emtricitabine / tenofovir disoproxil', 'market_auth_holder': 'Zentiva, k.s.', 'atc_code': 'J05AR06'}"
EU-1-17-1253,"{'status': 'ACTIVE', 'name': 'Fulvestrant Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1253', 'active_substance': 'fulvestrant', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'L02BA03'}"
EU-1-17-1256,"{'status': 'ACTIVE', 'name': 'Anagrelide Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1256', 'active_substance': 'anagrelide', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'L01XX35'}"
EU-1-16-1156,"{'status': 'ACTIVE', 'name': 'ZINPLAVA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1156', 'active_substance': 'bezlotoxumab', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J06BB21'}"
EU-1-17-1177,"{'status': 'ACTIVE', 'name': 'Tadalafil Lilly', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1177', 'active_substance': 'tadalafil', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'G04BE08'}"
EU-1-17-1181,"{'status': 'ACTIVE', 'name': 'Spherox', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1181', 'active_substance': 'spheroids of human autologous matrix-associated chondrocytes', 'market_auth_holder': 'CO.DON AG', 'atc_code': 'M09AX02'}"
EU-1-17-1232,"{'status': 'ACTIVE', 'name': 'Miglustat Gen.Orph', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1232', 'active_substance': 'Miglustat', 'market_auth_holder': 'Gen.Orph', 'atc_code': 'A16AX06'}"
EU-1-17-1233,"{'status': 'ACTIVE', 'name': 'Zubsolv', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1233', 'active_substance': 'buprenorphine / naloxone', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'N07BC51'}"
EU-1-17-1235,"{'status': 'ACTIVE', 'name': 'Zejula', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1235', 'active_substance': 'niraparib', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'L01XK02'}"
EU-1-16-1166,"{'status': 'ACTIVE', 'name': 'Pregabalin Zentiva k.s', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1166', 'active_substance': 'pregabalin', 'market_auth_holder': 'Zentiva, k.s.', 'atc_code': 'N03AX16'}"
EU-1-16-1170,"{'status': 'ACTIVE', 'name': 'Olumiant', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1170', 'active_substance': 'baricitinib', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'L04AA37'}"
EU-1-16-1171,"{'status': 'ACTIVE', 'name': 'Ledaga', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1171', 'active_substance': 'chlormethine', 'market_auth_holder': 'Helsinn Birex Pharmaceuticals Ltd.', 'atc_code': 'L01AA05'}"
EU-1-17-1244,"{'status': 'ACTIVE', 'name': 'Tacforius', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1244', 'active_substance': 'tacrolimus', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'L04AD02'}"
EU-1-17-1263,"{'status': 'ACTIVE', 'name': 'Efavirenz/Emtricitabine/Tenofovir disoproxil Krka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1263', 'active_substance': 'efavirenz / emtricitabine / tenofovir disoproxil', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'J05AR06'}"
EU-1-18-1274,"{'status': 'ACTIVE', 'name': 'Trydonis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1274', 'active_substance': 'beclometasone / formoterol / glycopyrronium bromide', 'market_auth_holder': 'Chiesi Farmaceutici S.p.A.', 'atc_code': 'R03AL'}"
EU-1-18-1275,"{'status': 'ACTIVE', 'name': 'Riarify', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1275', 'active_substance': 'beclometasone / formoterol / glycopyrronium bromide', 'market_auth_holder': 'Chiesi Farmaceutici S.p.A.', 'atc_code': 'R03AL'}"
EU-1-17-1239,"{'status': 'ACTIVE', 'name': 'VeraSeal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1239', 'active_substance': 'human fibrinogen / human thrombin', 'market_auth_holder': 'Instituto Grifols, S.A.', 'atc_code': 'B02BC'}"
EU-1-17-1245,"{'status': 'ACTIVE', 'name': 'PREVYMIS', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1245', 'active_substance': 'letermovir', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J05AX18'}"
EU-1-17-1246,"{'status': 'ACTIVE', 'name': 'Mvasi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1246', 'active_substance': 'bevacizumab', 'market_auth_holder': 'Amgen Technology (Ireland) UC', 'atc_code': 'L01XC07'}"
EU-1-17-1250,"{'status': 'ACTIVE', 'name': 'Rubraca', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1250', 'active_substance': 'rucaparib', 'market_auth_holder': 'Clovis Oncology Ireland Limited', 'atc_code': 'L01XK03'}"
EU-1-17-1257,"{'status': 'ACTIVE', 'name': 'Herzuma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1257', 'active_substance': 'trastuzumab', 'market_auth_holder': 'Celltrion Healthcare Hungary Kft.'}"
EU-1-17-1258,"{'status': 'ACTIVE', 'name': 'Lamzede', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1258', 'active_substance': 'velmanase alfa', 'market_auth_holder': 'Chiesi Farmaceutici S.p.A.', 'atc_code': 'A16AB'}"
EU-1-17-1260,"{'status': 'ACTIVE', 'name': 'Alkindi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1260', 'active_substance': 'hydrocortisone', 'market_auth_holder': 'Diurnal Europe B.V.', 'atc_code': 'H02AB09'}"
EU-1-17-1261,"{'status': 'ACTIVE', 'name': 'Alofisel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1261', 'active_substance': 'Darvadstrocel', 'market_auth_holder': 'Takeda Pharma A/S', 'atc_code': 'L04AX08'}"
EU-1-17-1190,"{'status': 'ACTIVE', 'name': 'Ivabradine Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1190', 'active_substance': 'ivabradine', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'C01EB17'}"
EU-1-17-1254,"{'status': 'ACTIVE', 'name': 'Jorveza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1254', 'active_substance': 'budesonide', 'market_auth_holder': 'Dr Falk Pharma GmbH', 'atc_code': 'A07EA06'}"
EU-1-17-1208,"{'status': 'ACTIVE', 'name': 'Trimbow', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1208', 'active_substance': 'beclometasone / formoterol / glycopyrronium bromide', 'market_auth_holder': 'Chiesi Farmaceutici S.p.A.', 'atc_code': 'R03AL09'}"
EU-1-16-1089,"{'status': 'ACTIVE', 'name': 'Pandemic influenza vaccine H5N1 AstraZeneca', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1089', 'active_substance': 'Pandemic influenza vaccine (H5N1) (live attenuated, nasal)', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'J07BB03'}"
EU-1-17-1231,"{'status': 'ACTIVE', 'name': 'Ocrevus', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1231', 'active_substance': 'ocrelizumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L04AA36'}"
EU-1-17-1241,"{'status': 'ACTIVE', 'name': 'Ontruzant', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1241', 'active_substance': 'trastuzumab', 'market_auth_holder': 'Samsung Bioepis NL B.V.'}"
EU-1-17-1242,"{'status': 'ACTIVE', 'name': 'Ritonavir Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1242', 'active_substance': 'ritonavir', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'J05AE03'}"
EU-1-17-1186,"{'status': 'ACTIVE', 'name': 'Axumin', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1186', 'active_substance': 'fluciclovine (<sup>18</sup>F)', 'market_auth_holder': 'Blue Earth Diagnostics Ireland Ltd', 'atc_code': 'V09IX12'}"
EU-1-18-1264,"{'status': 'ACTIVE', 'name': 'Alunbrig', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1264', 'active_substance': 'brigatinib', 'market_auth_holder': 'Takeda Pharma A/S'}"
EU-1-18-1271,"{'status': 'ACTIVE', 'name': 'Hemlibra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1271', 'active_substance': 'emicizumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'B02BX06'}"
EU-1-18-1272,"{'status': 'ACTIVE', 'name': 'Shingrix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1272', 'active_substance': 'herpes zoster vaccine (recombinant, adjuvanted)', 'market_auth_holder': 'GlaxoSmithKline Biologicals S.A.', 'atc_code': 'J07BK03'}"
EU-1-15-1004,"{'status': 'ACTIVE', 'name': 'Voriconazole Hikma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1004', 'active_substance': 'voriconazole', 'market_auth_holder': 'Hikma Farmac&#234;utica (Portugal), S.A.', 'atc_code': 'J02AC03'}"
EU-1-17-1209,"{'status': 'ACTIVE', 'name': 'Reagila', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1209', 'active_substance': 'cariprazine', 'market_auth_holder': 'Gedeon Richter Plc.', 'atc_code': 'N05AX15'}"
EU-1-17-1249,"{'status': 'ACTIVE', 'name': 'Darunavir Krka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1249', 'active_substance': 'darunavir', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'J05AE10'}"
EU-1-17-1252,"{'status': 'ACTIVE', 'name': 'Fasenra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1252', 'active_substance': 'benralizumab', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'R03DX10'}"
EU-1-16-1167,"{'status': 'ACTIVE', 'name': 'Truxima', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1167', 'active_substance': 'rituximab', 'market_auth_holder': 'Celltrion Healthcare Hungary Kft.'}"
EU-1-17-1247,"{'status': 'ACTIVE', 'name': 'ADYNOVI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1247', 'active_substance': 'rurioctocog alfa pegol', 'market_auth_holder': 'Baxalta Innovations GmbH', 'atc_code': 'B02BD02'}"
EU-1-18-1269,"{'status': 'ACTIVE', 'name': 'Alpivab', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1269', 'active_substance': 'peramivir', 'market_auth_holder': 'BioCryst Ireland Limited', 'atc_code': 'J05AH03'}"
EU-1-16-1115,"{'status': 'ACTIVE', 'name': 'Pemetrexed Fresenius Kabi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1115', 'active_substance': 'pemetrexed', 'market_auth_holder': 'Fresenius Kabi Deutschland GmbH', 'atc_code': 'L01BA04'}"
EU-1-16-1136,"{'status': 'ACTIVE', 'name': 'CABOMETYX', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1136', 'active_substance': 'cabozantinib', 'market_auth_holder': 'Ipsen Pharma', 'atc_code': 'L01EX07'}"
EU-1-17-1192,"{'status': 'ACTIVE', 'name': 'Brineura', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1192', 'active_substance': 'cerliponase alfa', 'market_auth_holder': 'BioMarin International Limited', 'atc_code': 'A16AB'}"
EU-1-17-1217,"{'status': 'ACTIVE', 'name': 'Nitisinone MDK', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1217', 'active_substance': 'nitisinone', 'market_auth_holder': 'MendeliKABS Europe Limited', 'atc_code': 'A16AX04'}"
EU-1-18-1278,"{'status': 'ACTIVE', 'name': 'Carmustine Obvius', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1278', 'active_substance': 'carmustine', 'market_auth_holder': 'Obvius Investment B.V.', 'atc_code': 'L01AD01'}"
EU-1-18-1279,"{'status': 'ACTIVE', 'name': 'AMGLIDIA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1279', 'active_substance': 'glibenclamide', 'market_auth_holder': 'AMMTeK', 'atc_code': 'A10BB01'}"
EU-1-18-1277,"{'status': 'ACTIVE', 'name': 'Mylotarg', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1277', 'active_substance': 'gemtuzumab ozogamicin', 'market_auth_holder': 'Pfizer Europe MA EEIG'}"
EU-1-18-1281,"{'status': 'ACTIVE', 'name': 'KANJINTI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1281', 'active_substance': 'trastuzumab', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'L01XC03'}"
EU-1-18-1282,"{'status': 'ACTIVE', 'name': 'Juluca', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1282', 'active_substance': 'dolutegravir / rilpivirine', 'market_auth_holder': 'ViiV Healthcare B.V.', 'atc_code': 'J05AR21'}"
EU-1-18-1280,"{'status': 'ACTIVE', 'name': 'Zessly', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1280', 'active_substance': 'infliximab', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'L04AB02'}"
EU-1-18-1283,"{'status': 'ACTIVE', 'name': 'Pemetrexed Krka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1283', 'active_substance': 'pemetrexed', 'market_auth_holder': 'KRKA, d.d.', 'atc_code': 'L01BA04'}"
EU-1-19-1410,"{'status': 'ACTIVE', 'name': 'Spravato', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1410', 'active_substance': 'esketamine', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'N06AX27'}"
EU-1-20-1459,"{'status': 'ACTIVE', 'name': 'Veklury', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1459', 'active_substance': 'remdesivir', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AB16'}"
EU-1-19-1404,"{'status': 'ACTIVE', 'name': 'Rinvoq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1404', 'active_substance': 'upadacitinib', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'L04AA44'}"
EU-1-19-1405,"{'status': 'ACTIVE', 'name': 'TAVLESSE', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1405', 'active_substance': 'fostamatinib', 'market_auth_holder': 'Instituto Grifols, S.A.', 'atc_code': 'B02BX09'}"
EU-1-19-1392,"{'status': 'ACTIVE', 'name': 'Ervebo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1392', 'active_substance': 'Ebola Zaire Vaccine (rVSVG-ZEBOV-GP, live)', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J07BX02'}"
EU-1-19-1393,"{'status': 'ACTIVE', 'name': 'Quofenix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1393', 'active_substance': 'delafloxacin', 'market_auth_holder': 'A. Menarini - Industrie Farmaceutiche Riunite - s.r.l.', 'atc_code': 'J01MA23'}"
EU-1-19-1394,"{'status': 'ACTIVE', 'name': 'Tigecycline Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1394', 'active_substance': 'tigecycline', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'J01AA12'}"
EU-1-20-1447,"{'status': 'ACTIVE', 'name': 'Insulin aspart Sanofi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1447', 'active_substance': 'insulin aspart', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'A10AB05'}"
EU-1-19-1396,"{'status': 'ACTIVE', 'name': 'Ivozall', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1396', 'active_substance': 'clofarabine', 'market_auth_holder': 'ORPHELIA Pharma SAS', 'atc_code': 'L01BB06'}"
EU-1-19-1397,"{'status': 'ACTIVE', 'name': 'Bortezomib Fresenius Kabi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1397', 'active_substance': 'bortezomib', 'market_auth_holder': 'Fresenius Kabi Deutschland GmbH', 'atc_code': 'L01XG01'}"
EU-1-20-1460,"{'status': 'ACTIVE', 'name': 'Rozlytrek', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1460', 'active_substance': 'entrectinib', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01EX14'}"
EU-1-20-1474,"{'status': 'ACTIVE', 'name': 'BLENREP', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1474', 'active_substance': 'belantamab mafodotin', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited'}"
EU-1-20-1475,"{'status': 'ACTIVE', 'name': 'Arsenic trioxide medac', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1475', 'active_substance': 'arsenic trioxide', 'market_auth_holder': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'atc_code': 'L01XX27'}"
EU-1-20-1476,"{'status': 'ACTIVE', 'name': 'Adakveo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1476', 'active_substance': 'crizanlizumab', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'B06AX01'}"
EU-1-19-1371,"{'status': 'ACTIVE', 'name': 'Ultomiris', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1371', 'active_substance': 'Ravulizumab', 'market_auth_holder': 'Alexion Europe SAS', 'atc_code': 'L04AA'}"
EU-1-19-1372,"{'status': 'ACTIVE', 'name': 'Striascan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1372', 'active_substance': 'ioflupane (<sup>123</sup>I)', 'market_auth_holder': 'CIS bio international', 'atc_code': 'V09AB03'}"
EU-1-19-1373,"{'status': 'ACTIVE', 'name': 'Doptelet', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1373', 'active_substance': 'avatrombopag', 'market_auth_holder': 'Swedish Orphan Biovitrum AB (publ)', 'atc_code': 'B02BX08'}"
EU-1-19-1374,"{'status': 'ACTIVE', 'name': 'Esperoct', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1374', 'active_substance': 'turoctocog alfa pegol', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'B02BD02'}"
EU-1-19-1375,"{'status': 'ACTIVE', 'name': 'Grasustek', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1375', 'active_substance': 'pegfilgrastim', 'market_auth_holder': 'Juta Pharma GmbH', 'atc_code': 'L03AA13'}"
EU-1-19-1376,"{'status': 'ACTIVE', 'name': 'LIBTAYO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1376', 'active_substance': 'cemiplimab', 'market_auth_holder': 'Regeneron Ireland Designated Activity Company (DAC)', 'atc_code': 'L01XC33'}"
EU-1-19-1356,"{'status': 'ACTIVE', 'name': 'Idacio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1356', 'active_substance': 'adalimumab', 'market_auth_holder': 'Fresenius Kabi Deutschland GmbH', 'atc_code': 'L04AB04'}"
EU-1-19-1365,"{'status': 'ACTIVE', 'name': 'Cufence', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1365', 'active_substance': 'trientine dihydrochloride', 'market_auth_holder': 'Univar Solutions B.V.', 'atc_code': 'A16AX12'}"
EU-1-19-1377,"{'status': 'ACTIVE', 'name': 'Talzenna', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1377', 'active_substance': 'talazoparib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01XX60'}"
EU-1-19-1370,"{'status': 'ACTIVE', 'name': 'Dovato', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1370', 'active_substance': 'dolutegravir/lamivudine', 'market_auth_holder': 'ViiV Healthcare BV', 'atc_code': 'J05AR25'}"
EU-1-20-1450,"{'status': 'ACTIVE', 'name': 'Fingolimod Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1450', 'active_substance': 'fingolimod', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L04AA27'}"
EU-1-18-1334,"{'status': 'ACTIVE', 'name': 'Vaborem', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1334', 'active_substance': 'meropenem/vaborbactam', 'market_auth_holder': 'Menarini International Operations Luxembourg S.A.', 'atc_code': 'J01DH52'}"
EU-1-17-1174,"{'status': 'ACTIVE', 'name': 'Rolufta Ellipta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1174', 'active_substance': 'umeclidinium', 'market_auth_holder': 'GlaxoSmithKline Trading Services Limited', 'atc_code': 'R03BB07'}"
EU-1-20-1454,"{'status': 'ACTIVE', 'name': 'Aybintio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1454', 'active_substance': 'bevacizumab', 'market_auth_holder': 'Samsung Bioepis NL B.V.'}"
EU-1-20-1455,"{'status': 'ACTIVE', 'name': 'Piqray', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1455', 'active_substance': 'alpelisib', 'market_auth_holder': 'Novartis Europharm Limited'}"
EU-1-20-1456,"{'status': 'ACTIVE', 'name': 'Zercepac', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1456', 'active_substance': 'trastuzumab', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01XC03'}"
EU-1-19-1368,"{'status': 'ACTIVE', 'name': 'Ambrisentan Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1368', 'active_substance': 'ambrisentan', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'C02KX02'}"
EU-1-19-1408,"{'status': 'ACTIVE', 'name': 'Sunosi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1408', 'active_substance': 'solriamfetol', 'market_auth_holder': 'TMC Pharma (EU) Limited', 'atc_code': 'N06BA14'}"
EU-1-20-1473,"{'status': 'ACTIVE', 'name': 'AYVAKYT', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1473', 'active_substance': 'avapritinib', 'market_auth_holder': 'Blueprint Medicines (Netherlands) B.V.', 'atc_code': 'L01EX18'}"
EU-1-19-1364,"{'status': 'ACTIVE', 'name': 'NUCEIVA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1364', 'active_substance': 'botulinum toxin type A', 'market_auth_holder': 'Evolus Pharma B.V.', 'atc_code': 'M03AX01'}"
EU-1-20-1471,"{'status': 'ACTIVE', 'name': 'Idefirix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1471', 'active_substance': 'imlifidase', 'market_auth_holder': 'Hansa Biopharma AB', 'atc_code': 'L04AA'}"
EU-1-19-1366,"{'status': 'ACTIVE', 'name': 'Xromi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1366', 'active_substance': 'hydroxycarbamide', 'market_auth_holder': 'Nova Laboratories Ireland Limited', 'atc_code': 'L01XX05'}"
EU-1-19-1400,"{'status': 'ACTIVE', 'name': 'Rhokiinsa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1400', 'active_substance': 'netarsudil', 'market_auth_holder': 'Santen Oy', 'atc_code': 'S01EX05'}"
EU-1-19-1406,"{'status': 'ACTIVE', 'name': 'Baqsimi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1406', 'active_substance': 'Glucagon', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'H04AA01'}"
EU-1-20-1462,"{'status': 'ACTIVE', 'name': 'Livogiva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1462', 'active_substance': 'teriparatide', 'market_auth_holder': 'Theramex Ireland Limited', 'atc_code': 'H05AA02'}"
EU-1-19-1411,"{'status': 'ACTIVE', 'name': 'Evenity', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1411', 'active_substance': 'romosozumab', 'market_auth_holder': 'UCB Pharma S.A.', 'atc_code': 'M05BX'}"
EU-1-20-1465,"{'status': 'ACTIVE', 'name': 'Gencebok', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1465', 'active_substance': 'caffeine citrate', 'market_auth_holder': 'Gennisium Pharma', 'atc_code': 'N06BC01'}"
EU-1-20-1451,"{'status': 'ACTIVE', 'name': 'Daurismo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1451', 'active_substance': 'glasdegib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01XJ03'}"
EU-1-20-1452,"{'status': 'ACTIVE', 'name': 'Reblozyl', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1452', 'active_substance': 'luspatercept', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'B03XA06'}"
EU-1-20-1468,"{'status': 'ACTIVE', 'name': 'Kaftrio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1468', 'active_substance': 'ivacaftor / tezacaftor / elexacaftor', 'market_auth_holder': 'Vertex Pharmaceuticals (Ireland) Limited', 'atc_code': 'R07AX32'}"
EU-1-19-1362,"{'status': 'ACTIVE', 'name': 'Palynziq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1362', 'active_substance': 'pegvaliase', 'market_auth_holder': 'BioMarin International Limited', 'atc_code': 'A16AB19'}"
EU-1-20-1480,"{'status': 'ACTIVE', 'name': 'Jyseleca', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1480', 'active_substance': 'filgotinib', 'market_auth_holder': 'Galapagos NV', 'atc_code': 'L04AA45'}"
EU-1-18-1292,"{'status': 'ACTIVE', 'name': 'Apealea', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1292', 'active_substance': 'paclitaxel', 'market_auth_holder': 'Inceptua AB', 'atc_code': 'L01CD01'}"
EU-1-19-1398,"{'status': 'ACTIVE', 'name': 'Arsenic Trioxide Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1398', 'active_substance': 'arsenic trioxide', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01XX27'}"
EU-1-20-1448,"{'status': 'ACTIVE', 'name': 'Cabazitaxel Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1448', 'active_substance': 'cabazitaxel', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01CD04'}"
EU-1-19-1390,"{'status': 'ACTIVE', 'name': 'Inbrija', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1390', 'active_substance': 'levodopa', 'market_auth_holder': 'Acorda Therapeutics Ireland Limited', 'atc_code': 'N04BA01'}"
EU-1-19-1409,"{'status': 'ACTIVE', 'name': 'Cegfila', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1409', 'active_substance': 'pegfilgrastim', 'market_auth_holder': 'Mundipharma Corporation (Ireland) Limited', 'atc_code': 'L03AA13'}"
EU-1-20-1469,"{'status': 'ACTIVE', 'name': 'ARIKAYCE liposomal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1469', 'active_substance': 'amikacin', 'market_auth_holder': 'Insmed Netherlands B.V.', 'atc_code': 'J01GB06'}"
EU-1-19-1395,"{'status': 'ACTIVE', 'name': 'Clopidogrel/Acetylsalicylic acid Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1395', 'active_substance': 'clopidogrel / acetylsalicylic acid', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'B01AC30'}"
EU-1-19-1361,"{'status': 'ACTIVE', 'name': 'Skyrizi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1361', 'active_substance': 'risankizumab', 'market_auth_holder': 'AbbVie Deutschland GmbH &amp; Co. KG', 'atc_code': 'L04AC'}"
EU-1-19-1385,"{'status': 'ACTIVE', 'name': 'VITRAKVI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1385', 'active_substance': 'larotrectinib', 'market_auth_holder': 'Bayer AG', 'atc_code': 'L01EX12'}"
EU-1-19-1386,"{'status': 'ACTIVE', 'name': 'Deferasirox Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1386', 'active_substance': 'deferasirox', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'V03AC03'}"
EU-1-21-1539,"{'status': 'ACTIVE', 'name': 'Abecma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1539', 'active_substance': 'idecabtagene vicleucel', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'L01'}"
EU-1-21-1540,"{'status': 'ACTIVE', 'name': 'Dasatinib Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1540', 'active_substance': 'dasatinib', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01EA02'}"
EU-1-21-1541,"{'status': 'ACTIVE', 'name': 'Dasatinib Accordpharma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1541', 'active_substance': 'dasatinib', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01EA02'}"
EU-1-19-1389,"{'status': 'ACTIVE', 'name': 'Epidyolex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1389', 'active_substance': 'cannabidiol', 'market_auth_holder': 'GW Pharma (International) B.V.', 'atc_code': 'N03AX24'}"
EU-1-18-1284,"{'status': 'ACTIVE', 'name': 'Dzuveo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1284', 'active_substance': 'sufentanil', 'market_auth_holder': 'Laboratoire Aguettant', 'atc_code': 'N01AH03'}"
EU-1-19-1388,"{'status': 'ACTIVE', 'name': 'Polivy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1388', 'active_substance': 'polatuzumab vedotin', 'market_auth_holder': 'Roche Registration GmbH'}"
EU-1-95-001,"{'status': 'ACTIVE', 'name': 'GONAL-f', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/95/001', 'active_substance': 'Follitropin alfa', 'market_auth_holder': 'Merck Europe B.V.', 'atc_code': 'G03GA05'}"
EU-1-18-1302,"{'status': 'ACTIVE', 'name': 'Kigabeq', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1302', 'active_substance': 'vigabatrin', 'market_auth_holder': 'ORPHELIA Pharma SAS', 'atc_code': 'N03AG04'}"
EU-1-19-1358,"{'status': 'ACTIVE', 'name': 'AJOVY', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1358', 'active_substance': 'fremanezumab', 'market_auth_holder': 'Teva GmbH', 'atc_code': 'N02CD03'}"
EU-1-19-1360,"{'status': 'ACTIVE', 'name': 'Waylivra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1360', 'active_substance': 'volanesorsen', 'market_auth_holder': 'Akcea Therapeutics Ireland Limited', 'atc_code': 'C10AX18'}"
EU-1-19-1387,"{'status': 'ACTIVE', 'name': 'Senstend', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1387', 'active_substance': 'lidocaine / prilocaine', 'market_auth_holder': 'Plethora Pharma Solutions Ltd.', 'atc_code': 'N01BB20'}"
EU-1-18-1290,"{'status': 'ACTIVE', 'name': 'Nityr', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1290', 'active_substance': 'nitisinone', 'market_auth_holder': 'Cycle Pharmaceuticals (Europe) Ltd', 'atc_code': 'A16AX04'}"
EU-1-18-1296,"{'status': 'ACTIVE', 'name': 'Tegsedi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1296', 'active_substance': 'inotersen', 'market_auth_holder': 'Akcea Therapeutics Ireland Ltd', 'atc_code': 'N07XX15'}"
EU-1-18-1297,"{'status': 'ACTIVE', 'name': 'Kymriah', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1297', 'active_substance': 'tisagenlecleucel', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L01XX71'}"
EU-1-19-1353,"{'status': 'ACTIVE', 'name': 'Atazanavir Krka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1353', 'active_substance': 'atazanavir', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'J05AE08'}"
EU-1-19-1354,"{'status': 'ACTIVE', 'name': 'Vizimpro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1354', 'active_substance': 'dacomitinib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01EB07'}"
EU-1-19-1355,"{'status': 'ACTIVE', 'name': 'Lorviqua', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1355', 'active_substance': 'lorlatinib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01ED05'}"
EU-1-20-1477,"{'status': 'ACTIVE', 'name': 'Fampridine Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1477', 'active_substance': 'fampridine', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'N07XX07'}"
EU-1-20-1479,"{'status': 'ACTIVE', 'name': 'Calquence', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1479', 'active_substance': 'acalabrutinib', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'L01XE'}"
EU-1-19-1359,"{'status': 'ACTIVE', 'name': 'Trogarzo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1359', 'active_substance': 'ibalizumab', 'market_auth_holder': 'Theratechnologies Europe Limited', 'atc_code': 'J05AX23'}"
EU-1-18-1289,"{'status': 'ACTIVE', 'name': 'Biktarvy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1289', 'active_substance': 'bictegravir / emtricitabine / tenofovir alafenamide', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AR20'}"
EU-1-18-1294,"{'status': 'ACTIVE', 'name': 'RXULTI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1294', 'active_substance': 'brexpiprazole', 'market_auth_holder': 'Otsuka Pharmaceutical Netherlands B.V.', 'atc_code': 'N05AX16'}"
EU-1-18-1299,"{'status': 'ACTIVE', 'name': 'Yescarta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1299', 'active_substance': 'axicabtagene ciloleucel', 'market_auth_holder': 'Kite Pharma EU B.V.'}"
EU-1-19-1399,"{'status': 'ACTIVE', 'name': 'Xospata', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1399', 'active_substance': 'gilteritinib', 'market_auth_holder': 'Astellas Pharma Europe B.V.', 'atc_code': 'L01EX13'}"
EU-1-19-1407,"{'status': 'ACTIVE', 'name': 'Isturisa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1407', 'active_substance': 'osilodrostat', 'market_auth_holder': 'Recordati Rare Diseases', 'atc_code': 'H02CA02'}"
EU-1-18-1287,"{'status': 'ACTIVE', 'name': 'Hefiya', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1287', 'active_substance': 'adalimumab', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'L04AB04'}"
EU-1-19-1369,"{'status': 'ACTIVE', 'name': 'Sixmo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1369', 'active_substance': 'buprenorphine', 'market_auth_holder': 'L. Molteni &amp; C. dei F.lli Alitti Soc.Es.S.p.A', 'atc_code': 'N07BC01'}"
EU-1-20-1457,"{'status': 'ACTIVE', 'name': 'Xenleta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1457', 'active_substance': 'lefamulin', 'market_auth_holder': 'Nabriva Therapeutics Ireland DAC', 'atc_code': 'J01XX12'}"
EU-1-20-1458,"{'status': 'ACTIVE', 'name': 'Apixaban Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1458', 'active_substance': 'apixaban', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'B01AF02'}"
EU-1-19-1403,"{'status': 'ACTIVE', 'name': 'Budesonide/Formoterol Teva Pharma B.V.', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1403', 'active_substance': 'budesonide / formoterol fumarate dihydrate', 'market_auth_holder': 'Teva Pharma B.V.', 'atc_code': 'R03AK07'}"
EU-1-20-1478,"{'status': 'ACTIVE', 'name': 'Zynrelef', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1478', 'active_substance': 'bupivacaine/meloxicam', 'market_auth_holder': 'Heron Therapeutics, B.V.'}"
EU-1-18-1328,"{'status': 'ACTIVE', 'name': 'Pelmeg', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1328', 'active_substance': 'pegfilgrastim', 'market_auth_holder': 'Mundipharma Corporation (Ireland) Limited', 'atc_code': 'L03AA13'}"
EU-1-18-1329,"{'status': 'ACTIVE', 'name': 'Fulphila', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1329', 'active_substance': 'pegfilgrastim', 'market_auth_holder': 'Viatris Limited', 'atc_code': 'L03AA13'}"
EU-1-18-1330,"{'status': 'ACTIVE', 'name': 'Emgality', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1330', 'active_substance': 'galcanezumab', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'N02CD02'}"
EU-1-18-1351,"{'status': 'ACTIVE', 'name': 'Trecondi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1351', 'active_substance': 'treosulfan', 'market_auth_holder': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'atc_code': 'L01AB02'}"
EU-1-18-1352,"{'status': 'ACTIVE', 'name': 'Besremi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1352', 'active_substance': 'ropeginterferon alfa-2b', 'market_auth_holder': 'AOP Orphan Pharmaceuticals GmbH,', 'atc_code': 'L03AB15'}"
EU-1-20-1442,"{'status': 'ACTIVE', 'name': 'Zeposia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1442', 'active_substance': 'ozanimod', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'L04AA38'}"
EU-1-20-1492,"{'status': 'ACTIVE', 'name': 'Tecartus', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1492', 'active_substance': 'brexucabtagene autoleucel', 'market_auth_holder': 'Kite Pharma EU B.V.', 'atc_code': 'L01X'}"
EU-1-20-1493,"{'status': 'ACTIVE', 'name': 'Libmeldy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1493', 'active_substance': 'atidarsagene autotemcel', 'market_auth_holder': 'Orchard Therapeutics (Netherlands) B.V.'}"
EU-1-21-1535,"{'status': 'ACTIVE', 'name': 'Pemazyre', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1535', 'active_substance': 'pemigatinib', 'market_auth_holder': 'Incyte Biosciences Distribution B.V.', 'atc_code': 'L01EX20'}"
EU-1-21-1536,"{'status': 'ACTIVE', 'name': 'Thiotepa Riemser', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1536', 'active_substance': 'thiotepa', 'market_auth_holder': 'Esteve Pharmaceuticals GmbH', 'atc_code': 'L01AC01'}"
EU-1-18-1312,"{'status': 'ACTIVE', 'name': 'Xerava', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1312', 'active_substance': 'Eravacycline', 'market_auth_holder': 'PAION Deutschland GmbH', 'atc_code': 'J01AA13'}"
EU-1-18-1324,"{'status': 'ACTIVE', 'name': 'Jivi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1324', 'active_substance': 'damoctocog alfa pegol', 'market_auth_holder': 'Bayer AG', 'atc_code': 'B02BD02'}"
EU-1-19-1417,"{'status': 'ACTIVE', 'name': 'Beovu', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1417', 'active_substance': 'brolucizumab', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01LA06'}"
EU-1-18-1348,"{'status': 'ACTIVE', 'name': 'Mulpleo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1348', 'active_substance': 'lusutrombopag', 'market_auth_holder': 'Shionogi B.V.', 'atc_code': 'B02BX07'}"
EU-1-19-1418,"{'status': 'ACTIVE', 'name': 'Dexmedetomidine Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1418', 'active_substance': 'dexmedetomidine', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'N05CM18'}"
EU-1-18-1318,"{'status': 'ACTIVE', 'name': 'Slenyto', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1318', 'active_substance': 'melatonin', 'market_auth_holder': 'RAD Neurim Pharmaceuticals EEC SARL', 'atc_code': 'N05CH01'}"
EU-1-18-1321,"{'status': 'ACTIVE', 'name': 'Gefitinib Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1321', 'active_substance': 'gefitinib', 'market_auth_holder': 'Mylan Pharmaceuticals Limited', 'atc_code': 'L01EB01'}"
EU-1-18-1344,"{'status': 'ACTIVE', 'name': 'Zirabev', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1344', 'active_substance': 'bevacizumab', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01XC07'}"
EU-1-18-1345,"{'status': 'ACTIVE', 'name': 'Ondexxya', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1345', 'active_substance': 'andexanet alfa', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'V03AB38'}"
EU-1-20-1499,"{'status': 'ACTIVE', 'name': 'Onbevzi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1499', 'active_substance': 'bevacizumab', 'market_auth_holder': 'Samsung Bioepis NL B.V.'}"
EU-1-20-1496,"{'status': 'ACTIVE', 'name': 'Oxlumo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1496', 'active_substance': 'lumasiran', 'market_auth_holder': 'Alnylam Netherlands B.V.', 'atc_code': 'A16AX18'}"
EU-1-20-1518,"{'status': 'ACTIVE', 'name': 'Rukobia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1518', 'active_substance': 'fostemsavir', 'market_auth_holder': 'ViiV Healthcare BV', 'atc_code': 'J05AX29'}"
EU-1-18-1313,"{'status': 'ACTIVE', 'name': 'Pelgraz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1313', 'active_substance': 'pegfilgrastim', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L03AA13'}"
EU-1-18-1331,"{'status': 'ACTIVE', 'name': 'Luxturna', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1331', 'active_substance': 'voretigene neparvovec', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'S01XA27'}"
EU-1-18-1332,"{'status': 'ACTIVE', 'name': 'Pifeltro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1332', 'active_substance': 'doravirine', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J05AG06'}"
EU-1-18-1333,"{'status': 'ACTIVE', 'name': 'Delstrigo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1333', 'active_substance': 'doravirine / lamivudine / tenofovir disoproxil', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J05AR24'}"
EU-1-20-1424,"{'status': 'ACTIVE', 'name': 'Nustendi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1424', 'active_substance': 'bempedoic acid / ezetimibe', 'market_auth_holder': 'Daiichi Sankyo Europe GmbH'}"
EU-1-20-1425,"{'status': 'ACTIVE', 'name': 'Nilemdo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1425', 'active_substance': 'bempedoic acid', 'market_auth_holder': 'Daiichi Sankyo Europe GmbH', 'atc_code': 'C10AX15'}"
EU-1-20-1482,"{'status': 'ACTIVE', 'name': 'REKAMBYS', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1482', 'active_substance': 'rilpivirine', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'J05AG05'}"
EU-1-18-1311,"{'status': 'ACTIVE', 'name': 'Nerlynx', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1311', 'active_substance': 'neratinib', 'market_auth_holder': 'Pierre Fabre M&#233;dicament', 'atc_code': 'L01EH02'}"
EU-1-18-1293,"{'status': 'ACTIVE', 'name': 'Aimovig', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1293', 'active_substance': 'erenumab', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'N02C'}"
EU-1-19-1379,"{'status': 'ACTIVE', 'name': 'Posaconazole Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1379', 'active_substance': 'posaconazole', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'J02AC04'}"
EU-1-19-1380,"{'status': 'ACTIVE', 'name': 'Posaconazole AHCL', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1380', 'active_substance': 'posaconazole', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'J02AC04'}"
EU-1-21-1538,"{'status': 'ACTIVE', 'name': 'JEMPERLI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1538', 'active_substance': 'dostarlimab', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited'}"
EU-1-18-1325,"{'status': 'ACTIVE', 'name': 'Namuscla', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1325', 'active_substance': 'Mexiletine', 'market_auth_holder': 'Lupin Europe GmbH', 'atc_code': 'C01BB02'}"
EU-1-18-1326,"{'status': 'ACTIVE', 'name': 'Flucelvax Tetra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1326', 'active_substance': 'influenza vaccine (surface antigen, inactivated, prepared in cell cultures)', 'market_auth_holder': 'Seqirus Netherlands B.V.', 'atc_code': 'J07BB02'}"
EU-1-18-1340,"{'status': 'ACTIVE', 'name': 'TAKHZYRO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1340', 'active_substance': 'lanadelumab', 'market_auth_holder': 'Takeda Pharmaceuticals International AG Ireland Branch', 'atc_code': 'B06AC05'}"
EU-1-18-1341,"{'status': 'ACTIVE', 'name': 'Ogivri', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1341', 'active_substance': 'trastuzumab', 'market_auth_holder': 'Viatris Limited', 'atc_code': 'L01XC03'}"
EU-1-18-1306,"{'status': 'ACTIVE', 'name': 'Symkevi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1306', 'active_substance': 'tezacaftor/ivacaftor', 'market_auth_holder': 'Vertex Pharmaceuticals (Ireland) Limited', 'atc_code': 'R07AX31'}"
EU-1-18-1307,"{'status': 'ACTIVE', 'name': 'Verzenios', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1307', 'active_substance': 'abemaciclib', 'market_auth_holder': 'Eli Lilly Nederland B.V.'}"
EU-1-14-922,"{'status': 'ACTIVE', 'name': 'Incruse Ellipta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/922', 'active_substance': 'umeclidinium bromide', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'R03BB07'}"
EU-1-18-1349,"{'status': 'ACTIVE', 'name': 'Dectova', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1349', 'active_substance': 'zanamivir', 'market_auth_holder': 'GlaxoSmithKline Trading Services Limited', 'atc_code': 'J05AH01'}"
EU-1-20-1426,"{'status': 'ACTIVE', 'name': 'Azacitidine Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1426', 'active_substance': 'Azacitidine', 'market_auth_holder': 'Mylan Ireland Limited', 'atc_code': 'L01BC07'}"
EU-1-20-1427,"{'status': 'ACTIVE', 'name': 'Arsenic trioxide Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1427', 'active_substance': 'arsenic trioxide', 'market_auth_holder': 'Mylan Ireland Limited', 'atc_code': 'L01XX27'}"
EU-1-16-1130,"{'status': 'ACTIVE', 'name': 'Onivyde pegylated liposomal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1130', 'active_substance': 'irinotecan', 'market_auth_holder': 'Les Laboratoires Servier', 'atc_code': 'L01CE02'}"
EU-1-96-011,"{'status': 'ACTIVE', 'name': 'Caelyx pegylated liposomal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/96/011', 'active_substance': 'Doxorubicin hydrochloride', 'market_auth_holder': 'Baxter Holding B.V.', 'atc_code': 'L01DB01'}"
EU-1-20-1515,"{'status': 'ACTIVE', 'name': 'Abevmy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1515', 'active_substance': 'bevacizumab', 'market_auth_holder': 'Mylan IRE Healthcare Limited', 'atc_code': 'L01XC07'}"
EU-1-20-1488,"{'status': 'ACTIVE', 'name': 'Rivaroxaban Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1488', 'active_substance': 'rivaroxaban', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'B01AF01'}"
EU-1-20-1490,"{'status': 'ACTIVE', 'name': 'Lenalidomide Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1490', 'active_substance': 'lenalidomide', 'market_auth_holder': 'Mylan Ireland Limited', 'atc_code': 'L04AX04'}"
EU-1-20-1527,"{'status': 'ACTIVE', 'name': 'Retsevmo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1527', 'active_substance': 'selpercatinib', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'L01EX22'}"
EU-1-02-204,"{'status': 'ACTIVE', 'name': 'TRISENOX', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/02/204', 'active_substance': 'Arsenic trioxide', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'L01XX27'}"
EU-1-19-1412,"{'status': 'ACTIVE', 'name': 'Deferasirox Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1412', 'active_substance': 'deferasirox', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'V03AC03'}"
EU-1-20-1486,"{'status': 'ACTIVE', 'name': 'Nyvepria', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1486', 'active_substance': 'pegfilgrastim', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L03AA13'}"
EU-1-20-1487,"{'status': 'ACTIVE', 'name': 'PHELINUN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1487', 'active_substance': 'melphalan', 'market_auth_holder': 'ADIENNE S.r.l.S.U.', 'atc_code': 'L01AA03'}"
EU-1-14-898,"{'status': 'ACTIVE', 'name': 'Anoro Ellipta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/14/898', 'active_substance': 'umeclidinium bromide / vilanterol trifenatate', 'market_auth_holder': 'GlaxoSmithKline (Ireland) Limited', 'atc_code': 'R03AL03'}"
EU-1-20-1497,"{'status': 'ACTIVE', 'name': 'Phesgo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1497', 'active_substance': 'pertuzumab / trastuzumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01XY02'}"
EU-1-20-1495,"{'status': 'ACTIVE', 'name': 'Palforzia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1495', 'active_substance': 'defatted powder of Arachis hypogaea L., semen (peanuts)', 'market_auth_holder': 'Aimmune Therapeutics Ireland Limited', 'atc_code': 'V01AA08'}"
EU-1-20-1524,"{'status': 'ACTIVE', 'name': 'Vazkepa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1524', 'active_substance': 'icosapent ethyl', 'market_auth_holder': 'Amarin Pharmaceuticals Ireland Limited', 'atc_code': 'C10AX'}"
EU-1-18-1295,"{'status': 'ACTIVE', 'name': 'Trazimera', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1295', 'active_substance': 'trastuzumab', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01XC03'}"
EU-1-17-1191,"{'status': 'ACTIVE', 'name': 'Qarziba', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1191', 'active_substance': 'dinutuximab beta', 'market_auth_holder': 'EUSA Pharma (Netherlands) B.V.', 'atc_code': 'L01XC16'}"
EU-1-20-1501,"{'status': 'ACTIVE', 'name': 'Sogroya', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1501', 'active_substance': 'somapacitan', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'H01AC07'}"
EU-1-18-1319,"{'status': 'ACTIVE', 'name': 'Hulio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1319', 'active_substance': 'adalimumab', 'market_auth_holder': 'Viatris Limited', 'atc_code': 'L04AB04'}"
EU-1-19-1413,"{'status': 'ACTIVE', 'name': 'Azacitidine Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1413', 'active_substance': 'Azacitidine', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01BC07'}"
EU-1-19-1416,"{'status': 'ACTIVE', 'name': 'Azacitidine Betapharm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1416', 'active_substance': 'Azacitidine', 'market_auth_holder': 'betapharm Arzneimittel GmbH', 'atc_code': 'L01BC07'}"
EU-1-20-1437,"{'status': 'ACTIVE', 'name': 'Dovprela', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1437', 'active_substance': 'pretomanid', 'market_auth_holder': 'Mylan IRE Healthcare Limited'}"
EU-1-21-1533,"{'status': 'ACTIVE', 'name': 'Seffalair Spiromax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1533', 'active_substance': 'salmeterol / fluticasone propionate', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'R03AK06'}"
EU-1-21-1534,"{'status': 'ACTIVE', 'name': 'BroPair Spiromax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1534', 'active_substance': 'salmeterol / fluticasone propionate', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'R03AK06'}"
EU-1-21-1537,"{'status': 'ACTIVE', 'name': 'NEXPOVIO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1537', 'active_substance': 'selinexor', 'market_auth_holder': 'Stemline Therapeutics B.V.', 'atc_code': 'L01XX66'}"
EU-1-18-1314,"{'status': 'ACTIVE', 'name': 'Braftovi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1314', 'active_substance': 'encorafenib', 'market_auth_holder': 'Pierre Fabre M&#233;dicament', 'atc_code': 'L01EC03'}"
EU-1-18-1315,"{'status': 'ACTIVE', 'name': 'Mektovi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1315', 'active_substance': 'binimetinib', 'market_auth_holder': 'Pierre Fabre M&#233;dicament', 'atc_code': 'L01EE03'}"
EU-1-18-1316,"{'status': 'ACTIVE', 'name': 'Lenalidomide Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1316', 'active_substance': 'lenalidomide', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L04AX04'}"
EU-1-18-1338,"{'status': 'ACTIVE', 'name': 'Dengvaxia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1338', 'active_substance': 'dengue tetravalent vaccine (live, attenuated)', 'market_auth_holder': 'Sanofi Pasteur', 'atc_code': 'J07BX'}"
EU-1-18-1342,"{'status': 'ACTIVE', 'name': 'Erleada', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1342', 'active_substance': 'apalutamide', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'L02BB05'}"
EU-1-20-1526,"{'status': 'ACTIVE', 'name': 'TUKYSA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1526', 'active_substance': 'tucatinib', 'market_auth_holder': 'Seagen B.V.', 'atc_code': 'L01EH03'}"
EU-1-19-1381,"{'status': 'ACTIVE', 'name': 'LysaKare', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1381', 'active_substance': 'arginine/lysine', 'market_auth_holder': 'Advanced Accelerator Applications', 'atc_code': 'V03AF11'}"
EU-1-19-1383,"{'status': 'ACTIVE', 'name': 'Lacosamide UCB', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1383', 'active_substance': 'lacosamide', 'market_auth_holder': 'UCB Pharma S.A.', 'atc_code': 'N03AX18'}"
EU-1-20-1438,"{'status': 'ACTIVE', 'name': 'Enerzair Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1438', 'active_substance': 'indacaterol / glycopyrronium / mometasone furoate', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03AL12'}"
EU-1-20-1439,"{'status': 'ACTIVE', 'name': 'Atectura Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1439', 'active_substance': 'indacaterol / mometasone furoate', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03AK14'}"
EU-1-20-1440,"{'status': 'ACTIVE', 'name': 'Zimbus Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1440', 'active_substance': 'indacaterol / glycopyrronium / mometasone furoate', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03AL12'}"
EU-1-20-1441,"{'status': 'ACTIVE', 'name': 'Bemrist Breezhaler', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1441', 'active_substance': 'indacaterol / mometasone furoate', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'R03AK'}"
EU-1-18-1310,"{'status': 'ACTIVE', 'name': 'Deferiprone Lipomed', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1310', 'active_substance': 'Deferiprone', 'market_auth_holder': 'Lipomed GmbH', 'atc_code': 'V03AC02'}"
EU-1-18-1343,"{'status': 'ACTIVE', 'name': 'Silodosin Recordati', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1343', 'active_substance': 'silodosin', 'market_auth_holder': 'Recordati Ireland Ltd', 'atc_code': 'G04CA04'}"
EU-1-19-1419,"{'status': 'ACTIVE', 'name': 'Trepulmix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1419', 'active_substance': 'treprostinil sodium', 'market_auth_holder': 'SciPharm S&#224;rl', 'atc_code': 'B01AC21'}"
EU-1-20-1423,"{'status': 'ACTIVE', 'name': 'Vaxchora', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1423', 'active_substance': 'Cholera vaccine (recombinant, live, oral)', 'market_auth_holder': 'Emergent Netherlands B.V.', 'atc_code': 'J07AE02'}"
EU-1-20-1517,"{'status': 'ACTIVE', 'name': 'Sibnayal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1517', 'active_substance': 'potassium citrate/potassium hydrogen carbonate', 'market_auth_holder': 'ADVICENNE', 'atc_code': 'A12BA30'}"
EU-1-20-1528,"{'status': 'ACTIVE', 'name': 'Comirnaty', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1528', 'active_substance': 'tozinameran, COVID-19 mRNA vaccine (nucleoside-modified)', 'market_auth_holder': 'BioNTech Manufacturing GmbH', 'atc_code': 'J07BX03'}"
EU-1-18-1320,"{'status': 'ACTIVE', 'name': 'Onpattro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1320', 'active_substance': 'patisiran', 'market_auth_holder': 'Alnylam Netherlands B.V.', 'atc_code': 'N07XX12'}"
EU-1-20-1429,"{'status': 'ACTIVE', 'name': 'Cinacalcet Accordpharma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1429', 'active_substance': 'cinacalcet', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'H05BX01'}"
EU-1-20-1430,"{'status': 'ACTIVE', 'name': 'Rybelsus', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1430', 'active_substance': 'semaglutide', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10BJ06'}"
EU-1-20-1433,"{'status': 'ACTIVE', 'name': 'Fluad Tetra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1433', 'active_substance': 'influenza vaccine (surface antigen, inactivated, adjuvanted)', 'market_auth_holder': 'Seqirus Netherlands B.V.', 'atc_code': 'J07BB02'}"
EU-1-20-1502,"{'status': 'ACTIVE', 'name': 'Roclanda', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1502', 'active_substance': 'Latanoprost / netarsudil', 'market_auth_holder': 'Santen Oy', 'atc_code': 'S01EE51'}"
EU-1-20-1504,"{'status': 'ACTIVE', 'name': 'ELZONRIS', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1504', 'active_substance': 'tagraxofusp', 'market_auth_holder': 'Stemline Therapeutics B.V.', 'atc_code': 'L01XX67'}"
EU-1-18-1335,"{'status': 'ACTIVE', 'name': 'Poteligeo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1335', 'active_substance': 'Mogamulizumab', 'market_auth_holder': 'Kyowa Kirin Holdings B.V.'}"
EU-1-20-1503,"{'status': 'ACTIVE', 'name': 'Heplisav B', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1503', 'active_substance': 'hepatitis B surface antigen', 'market_auth_holder': 'Dynavax GmbH', 'atc_code': 'J07BC01'}"
EU-1-18-1286,"{'status': 'ACTIVE', 'name': 'Hyrimoz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1286', 'active_substance': 'adalimumab', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'L04AB04'}"
EU-1-20-1498,"{'status': 'ACTIVE', 'name': 'TRIXEO AEROSPHERE', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1498', 'active_substance': 'Formoterol / glycopyrronium bromide / budesonide', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'R03AL11'}"
EU-1-16-1139,"{'status': 'ACTIVE', 'name': 'Ocaliva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/16/1139', 'active_substance': 'obeticholic acid', 'market_auth_holder': 'Intercept Pharma International Limited', 'atc_code': 'A05AA04'}"
EU-1-20-1435,"{'status': 'ACTIVE', 'name': 'Sarclisa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1435', 'active_substance': 'isatuximab', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'L01XC38'}"
EU-1-18-1322,"{'status': 'ACTIVE', 'name': 'Imfinzi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1322', 'active_substance': 'durvalumab', 'market_auth_holder': 'AstraZeneca AB'}"
EU-1-20-1446,"{'status': 'ACTIVE', 'name': 'Hepcludex', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1446', 'active_substance': 'bulevirtide', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'J05AX28'}"
EU-1-20-1505,"{'status': 'ACTIVE', 'name': 'Byfavo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1505', 'active_substance': 'remimazolam', 'market_auth_holder': 'PAION Deutschland GmbH', 'atc_code': 'N05CD14'}"
EU-1-20-1508,"{'status': 'ACTIVE', 'name': 'Enhertu', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1508', 'active_substance': 'trastuzumab deruxtecan', 'market_auth_holder': 'Daiichi Sankyo Europe GmbH'}"
EU-1-20-1509,"{'status': 'ACTIVE', 'name': 'Alymsys', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1509', 'active_substance': 'bevacizumab', 'market_auth_holder': 'Mabxience Research SL'}"
EU-1-20-1510,"{'status': 'ACTIVE', 'name': 'Oyavas', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1510', 'active_substance': 'bevacizumab', 'market_auth_holder': 'STADA Arzneimittel AG'}"
EU-1-20-1511,"{'status': 'ACTIVE', 'name': 'Sunitinib Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1511', 'active_substance': 'sunitinib', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01EX01'}"
EU-1-20-1512,"{'status': 'ACTIVE', 'name': 'Abiraterone Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1512', 'active_substance': 'abiraterone acetate', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L02BX03'}"
EU-1-18-1323,"{'status': 'ACTIVE', 'name': 'Ilumetri', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1323', 'active_substance': 'tildrakizumab', 'market_auth_holder': 'Almirall, S.A.', 'atc_code': 'L04AC17'}"
EU-1-00-141,"{'status': 'ACTIVE', 'name': 'Myocet liposomal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/00/141', 'active_substance': 'Doxorubicin', 'market_auth_holder': 'Teva B.V.', 'atc_code': 'L01DB01'}"
EU-1-21-1530,"{'status': 'ACTIVE', 'name': 'Ontozry', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1530', 'active_substance': 'cenobamate', 'market_auth_holder': 'Angelini Pharma S.p.A', 'atc_code': 'N03AX25'}"
EU-1-18-1339,"{'status': 'ACTIVE', 'name': 'Bevespi Aerosphere', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1339', 'active_substance': 'glycopyrronium bromide / formoterol', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'R03AL07'}"
EU-1-20-1489,"{'status': 'ACTIVE', 'name': 'EXPAREL liposomal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1489', 'active_substance': 'bupivacaine', 'market_auth_holder': 'Pacira Ireland Ltd', 'atc_code': 'N01BB01'}"
EU-1-20-1521,"{'status': 'ACTIVE', 'name': 'Lenalidomide Krka d.d.', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1521', 'active_substance': 'lenalidomide', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'L04AX04'}"
EU-1-20-1523,"{'status': 'ACTIVE', 'name': 'Ogluo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1523', 'active_substance': 'glucagon', 'market_auth_holder': 'Tetris Pharma B.V', 'atc_code': 'H04AA01'}"
EU-1-18-1346,"{'status': 'ACTIVE', 'name': 'Miglustat Dipharma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1346', 'active_substance': 'miglustat', 'market_auth_holder': 'Dipharma B.V.', 'atc_code': 'A16AX06'}"
EU-1-19-1384,"{'status': 'ACTIVE', 'name': 'Giapreza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1384', 'active_substance': 'angiotensin II acetate', 'market_auth_holder': 'PAION Deutschland GmbH', 'atc_code': 'C01CX09'}"
EU-1-19-1421,"{'status': 'ACTIVE', 'name': 'Staquis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1421', 'active_substance': 'crisaborole', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'D11AH06'}"
EU-1-20-1422,"{'status': 'ACTIVE', 'name': 'Lyumjev', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1422', 'active_substance': 'Insulin lispro', 'market_auth_holder': 'Eli Lilly Nederland B.V.', 'atc_code': 'A10AB04'}"
EU-1-18-1301,"{'status': 'ACTIVE', 'name': 'Mepsevii', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1301', 'active_substance': 'vestronidase alfa', 'market_auth_holder': 'Ultragenyx Germany GmbH', 'atc_code': 'A16AB18'}"
EU-1-20-1513,"{'status': 'ACTIVE', 'name': 'Yuflyma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1513', 'active_substance': 'adalimumab', 'market_auth_holder': 'Celltrion Healthcare Hungary Kft.', 'atc_code': 'L04AB04'}"
EU-1-18-1327,"{'status': 'ACTIVE', 'name': 'Ziextenzo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1327', 'active_substance': 'pegfilgrastim', 'market_auth_holder': 'Sandoz GmbH', 'atc_code': 'L03AA13'}"
EU-1-20-1436,"{'status': 'ACTIVE', 'name': 'Nepexto', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1436', 'active_substance': 'etanercept', 'market_auth_holder': 'Mylan IRE Healthcare Limited', 'atc_code': 'L04AB01'}"
EU-1-20-1491,"{'status': 'ACTIVE', 'name': 'Fintepla', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1491', 'active_substance': 'fenfluramine', 'market_auth_holder': 'Zogenix ROI Limited', 'atc_code': 'N03AX'}"
EU-1-19-1414,"{'status': 'ACTIVE', 'name': 'Mayzent', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1414', 'active_substance': 'siponimod', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'L04AA42'}"
EU-1-20-1500,"{'status': 'ACTIVE', 'name': 'Xofluza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1500', 'active_substance': 'baloxavir marboxil', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'J05AX25'}"
EU-1-20-1514,"{'status': 'ACTIVE', 'name': 'Inrebic', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1514', 'active_substance': 'fedratinib', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'L01EJ02'}"
EU-1-19-1415,"{'status': 'ACTIVE', 'name': 'Amsparity', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1415', 'active_substance': 'adalimumab', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L04AB04'}"
EU-1-18-1305,"{'status': 'ACTIVE', 'name': 'Cablivi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1305', 'active_substance': 'caplacizumab', 'market_auth_holder': 'Ablynx N.V.', 'atc_code': 'B01AX07'}"
EU-1-18-1317,"{'status': 'ACTIVE', 'name': 'Pazenir', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1317', 'active_substance': 'paclitaxel', 'market_auth_holder': 'ratiopharm GmbH', 'atc_code': 'L01CD01'}"
EU-1-18-1347,"{'status': 'ACTIVE', 'name': 'Febuxostat Krka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1347', 'active_substance': 'febuxostat', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'M04AA03'}"
EU-1-20-1483,"{'status': 'ACTIVE', 'name': 'MenQuadfi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1483', 'active_substance': 'Meningococcal group A, C, W and Y conjugate vaccine', 'market_auth_holder': 'Sanofi Pasteur', 'atc_code': 'J07AH08'}"
EU-1-20-1484,"{'status': 'ACTIVE', 'name': 'Supemtek', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1484', 'active_substance': 'quadrivalent influenza vaccine (recombinant, prepared in cell culture)', 'market_auth_holder': 'Sanofi Pasteur', 'atc_code': 'J07BB02'}"
EU-1-20-1485,"{'status': 'ACTIVE', 'name': 'Obiltoxaximab SFL', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1485', 'active_substance': 'obiltoxaximab', 'market_auth_holder': 'SFL Pharmaceuticals Deutschland GmbH', 'atc_code': 'J06BB22'}"
EU-1-20-1470,"{'status': 'ACTIVE', 'name': 'Lumeblue', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1470', 'active_substance': 'methylthioninium chloride', 'market_auth_holder': 'Alfasigma S.p.A.', 'atc_code': 'V04CX'}"
EU-1-21-1531,"{'status': 'ACTIVE', 'name': 'Evrysdi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1531', 'active_substance': 'risdiplam', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'M09AX10'}"
EU-1-21-1532,"{'status': 'ACTIVE', 'name': 'Kesimpta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1532', 'active_substance': 'ofatumumab', 'market_auth_holder': 'Novartis Ireland Limited', 'atc_code': 'L04AA52'}"
EU-1-18-1336,"{'status': 'ACTIVE', 'name': 'Buvidal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1336', 'active_substance': 'buprenorphine', 'market_auth_holder': 'Camurus AB', 'atc_code': 'N07BC01'}"
EU-1-11-696,"{'status': 'ACTIVE', 'name': 'Bydureon', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/11/696', 'active_substance': 'exenatide', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'A10BJ01'}"
EU-1-20-1428,"{'status': 'ACTIVE', 'name': 'Givlaari', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1428', 'active_substance': 'givosiran', 'market_auth_holder': 'Alnylam Netherlands B.V.', 'atc_code': 'A16AX16'}"
EU-1-20-1481,"{'status': 'ACTIVE', 'name': 'Vocabria', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1481', 'active_substance': 'cabotegravir', 'market_auth_holder': 'ViiV Healthcare BV', 'atc_code': 'J05AJ04'}"
EU-1-18-1308,"{'status': 'ACTIVE', 'name': 'Vyxeos liposomal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1308', 'active_substance': 'daunorubicin / cytarabine', 'market_auth_holder': 'Jazz Pharmaceuticals Ireland Ltd', 'atc_code': 'L01XY01'}"
EU-1-19-1420,"{'status': 'ACTIVE', 'name': 'Recarbrio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/19/1420', 'active_substance': 'imipenem / cilastatin / relebactam', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J01DH56'}"
EU-1-20-1431,"{'status': 'ACTIVE', 'name': 'Ruxience', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1431', 'active_substance': 'rituximab', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01XC02'}"
EU-1-20-1434,"{'status': 'ACTIVE', 'name': 'Fetcroja', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1434', 'active_substance': 'cefiderocol', 'market_auth_holder': 'Shionogi B.V.', 'atc_code': 'J01DI04'}"
EU-1-20-1444,"{'status': 'ACTIVE', 'name': 'Zabdeno', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1444', 'active_substance': 'Ebola vaccine (Ad26.ZEBOV-GP [recombinant])', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'J07BX02'}"
EU-1-20-1445,"{'status': 'ACTIVE', 'name': 'Mvabea', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1445', 'active_substance': 'Ebola vaccine (MVA-BN-Filo [recombinant])', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'J07BX02'}"
EU-1-20-1432,"{'status': 'ACTIVE', 'name': 'NUBEQA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1432', 'active_substance': 'darolutamide', 'market_auth_holder': 'Bayer AG', 'atc_code': 'L02BB06'}"
EU-1-20-1443,"{'status': 'ACTIVE', 'name': 'Zolgensma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1443', 'active_substance': 'onasemnogene abeparvovec', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'M09AX09'}"
EU-1-20-1494,"{'status': 'ACTIVE', 'name': 'Leqvio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1494', 'active_substance': 'inclisiran', 'market_auth_holder': 'Novartis Europharm Limited', 'atc_code': 'C10AX16'}"
EU-1-18-1291,"{'status': 'ACTIVE', 'name': 'Rizmoic', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1291', 'active_substance': 'naldemedine', 'market_auth_holder': 'Shionogi B.V.', 'atc_code': 'A06AH05'}"
EU-1-21-1589,"{'status': 'ACTIVE', 'name': 'Hukyndra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1589', 'active_substance': 'adalimumab', 'market_auth_holder': 'STADA Arzneimittel AG', 'atc_code': 'L04AB04'}"
EU-1-21-1590,"{'status': 'ACTIVE', 'name': 'Libmyris', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1590', 'active_substance': 'adalimumab', 'market_auth_holder': 'STADA Arzneimittel AG', 'atc_code': 'L04AB04'}"
EU-1-22-1644,"{'status': 'ACTIVE', 'name': 'Inpremzia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1644', 'active_substance': 'insulin human (rDNA)', 'market_auth_holder': 'Baxter Holding B.V.', 'atc_code': 'A10AB01'}"
EU-1-08-443,"{'status': 'ACTIVE', 'name': 'Thalidomide BMS', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/08/443', 'active_substance': 'Thalidomide', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'L04AX02'}"
EU-1-21-1561,"{'status': 'ACTIVE', 'name': 'Verquvo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1561', 'active_substance': 'vericiguat', 'market_auth_holder': 'Bayer AG', 'atc_code': 'C01DX22'}"
EU-1-21-1588,"{'status': 'ACTIVE', 'name': 'Rivaroxaban Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1588', 'active_substance': 'rivaroxaban', 'market_auth_holder': 'Mylan Ireland Limited', 'atc_code': 'B01AF01'}"
EU-1-20-1519,"{'status': 'ACTIVE', 'name': 'Lenalidomide Krka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1519', 'active_substance': 'lenalidomide', 'market_auth_holder': 'KRKA, d.d., Novo mesto', 'atc_code': 'L04AX04'}"
EU-1-20-1520,"{'status': 'ACTIVE', 'name': 'Lenalidomide Krka d.d. Novo mesto', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1520', 'active_substance': 'lenalidomide', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'L04AX04'}"
EU-1-21-1597,"{'status': 'ACTIVE', 'name': 'Regkirona', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1597', 'active_substance': 'regdanvimab', 'market_auth_holder': 'Celltrion Healthcare Hungary Kft.'}"
EU-1-21-1598,"{'status': 'ACTIVE', 'name': 'Sitagliptin SUN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1598', 'active_substance': 'sitagliptin fumarate', 'market_auth_holder': 'Sun Pharmaceutical Industries Europe BV', 'atc_code': 'A10BH01'}"
EU-1-21-1612,"{'status': 'ACTIVE', 'name': 'Apexxnar', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1612', 'active_substance': 'pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'J07AL02'}"
EU-1-21-1542,"{'status': 'ACTIVE', 'name': 'Copiktra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1542', 'active_substance': 'duvelisib', 'market_auth_holder': 'Secura Bio Limited', 'atc_code': 'L01EM04'}"
EU-1-21-1547,"{'status': 'ACTIVE', 'name': 'Drovelis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1547', 'active_substance': 'drospirenone / estetrol', 'market_auth_holder': 'Gedeon Richter Plc.', 'atc_code': 'G03AA18'}"
EU-1-21-1548,"{'status': 'ACTIVE', 'name': 'Lydisilka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1548', 'active_substance': 'drospirenone / estetrol', 'market_auth_holder': 'Estetra SRL', 'atc_code': 'G03AA18'}"
EU-1-21-1593,"{'status': 'ACTIVE', 'name': 'Cibinqo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1593', 'active_substance': 'abrocitinib', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'D11AH'}"
EU-1-21-1594,"{'status': 'ACTIVE', 'name': 'Rybrevant', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1594', 'active_substance': 'amivantamab', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'L01FX18'}"
EU-1-21-1600,"{'status': 'ACTIVE', 'name': 'Tecovirimat SIGA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1600', 'active_substance': 'tecovirimat', 'market_auth_holder': 'SIGA Technologies Netherlands B.V.', 'atc_code': 'J05AX24'}"
EU-1-21-1608,"{'status': 'ACTIVE', 'name': 'Wegovy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1608', 'active_substance': 'semaglutide', 'market_auth_holder': 'Novo Nordisk A/S', 'atc_code': 'A10BJ06'}"
EU-1-21-1546,"{'status': 'ACTIVE', 'name': 'Ozawade', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1546', 'active_substance': 'pitolisant', 'market_auth_holder': 'Bioprojet Pharma', 'atc_code': 'N07XX11'}"
EU-1-21-1550,"{'status': 'ACTIVE', 'name': 'Ponvory', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1550', 'active_substance': 'ponesimod', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'L04AA'}"
EU-1-21-1551,"{'status': 'ACTIVE', 'name': 'Evkeeza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1551', 'active_substance': 'evinacumab', 'market_auth_holder': 'Ultragenyx Germany GmbH'}"
EU-1-21-1596,"{'status': 'ACTIVE', 'name': 'Tepmetko', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1596', 'active_substance': 'tepotinib', 'market_auth_holder': 'Merck Europe B.V.'}"
EU-1-03-271,"{'status': 'ACTIVE', 'name': 'ADVATE', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/03/271', 'active_substance': 'octocog alfa', 'market_auth_holder': 'Takeda Manufacturing Austria AG', 'atc_code': 'B02BD02'}"
EU-1-21-1555,"{'status': 'ACTIVE', 'name': 'GAVRETO', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1555', 'active_substance': 'pralsetinib', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01EX23'}"
EU-1-21-1556,"{'status': 'ACTIVE', 'name': 'Onureg', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1556', 'active_substance': 'azacitidine', 'market_auth_holder': 'Bristol-Myers Squibb Pharma EEIG', 'atc_code': 'L01BC07'}"
EU-1-21-1576,"{'status': 'ACTIVE', 'name': 'Brukinsa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1576', 'active_substance': 'zanubrutinib', 'market_auth_holder': 'BeiGene Ireland Limited', 'atc_code': 'L01EL03'}"
EU-1-21-1601,"{'status': 'ACTIVE', 'name': 'Ronapreve', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1601', 'active_substance': 'casirivimab / imdevimab', 'market_auth_holder': 'Roche Registration GmbH'}"
EU-1-21-1602,"{'status': 'ACTIVE', 'name': 'Uplizna', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1602', 'active_substance': 'inebilizumab', 'market_auth_holder': 'Horizon Therapeutics Ireland DAC', 'atc_code': 'L04AA'}"
EU-1-21-1587,"{'status': 'ACTIVE', 'name': 'RAYVOW', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1587', 'active_substance': 'lasmiditan', 'market_auth_holder': 'Eli Lilly Nederland B.V.'}"
EU-1-21-1591,"{'status': 'ACTIVE', 'name': 'Vaxneuvance', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1591', 'active_substance': 'Pneumococcal polysaccharide conjugate vaccine (15valent, adsorbed)', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'J07AL'}"
EU-1-21-1606,"{'status': 'ACTIVE', 'name': 'Yselty', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1606', 'active_substance': 'linzagolix choline', 'market_auth_holder': 'ObsEva Ireland Ltd.'}"
EU-1-21-1607,"{'status': 'ACTIVE', 'name': 'Lonapegsomatropin Ascendis Pharma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1607', 'active_substance': 'Lonapegsomatropin', 'market_auth_holder': 'Ascendis Pharma Endocrinology Division A/S'}"
EU-1-22-1634,"{'status': 'ACTIVE', 'name': 'Dimethyl fumarate Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1634', 'active_substance': 'dimethyl fumarate', 'market_auth_holder': 'Mylan Ireland Limited', 'atc_code': 'L04AX07'}"
EU-1-22-1635,"{'status': 'ACTIVE', 'name': 'Dimethyl fumarate Polpharma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1635', 'active_substance': 'dimethyl fumarate', 'market_auth_holder': 'Zakady Farmaceutyczne POLPHARMA S.A.', 'atc_code': 'L04AX07'}"
EU-1-22-1637,"{'status': 'ACTIVE', 'name': 'Dimethyl fumarate Neuraxpharm', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1637', 'active_substance': 'dimethyl fumarate', 'market_auth_holder': 'Laboratorios Lesvi, S.L.', 'atc_code': 'L04AX07'}"
EU-1-22-1638,"{'status': 'ACTIVE', 'name': 'QUVIVIQ', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1638', 'active_substance': 'daridorexant', 'market_auth_holder': 'Idorsia Pharmaceuticals Deutschland GmbH'}"
EU-1-22-1645,"{'status': 'ACTIVE', 'name': 'Vydura', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1645', 'active_substance': 'rimegepant', 'market_auth_holder': 'Biohaven Pharmaceutical Ireland DAC', 'atc_code': 'N02CD'}"
EU-1-21-1553,"{'status': 'ACTIVE', 'name': 'Abiraterone Krka', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1553', 'active_substance': 'abiraterone acetate', 'market_auth_holder': 'KRKA d d., Novo mesto', 'atc_code': 'L02BX03'}"
EU-1-21-1554,"{'status': 'ACTIVE', 'name': 'Adtralza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1554', 'active_substance': 'tralokinumab', 'market_auth_holder': 'Leo Pharma A/S', 'atc_code': 'D11AH07'}"
EU-1-17-1189,"{'status': 'ACTIVE', 'name': 'elmiron', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/17/1189', 'active_substance': 'pentosan polysulfate sodium', 'market_auth_holder': 'bene-Arzneimittel GmbH', 'atc_code': 'G04BX15'}"
EU-1-21-1604,"{'status': 'ACTIVE', 'name': 'Riltrava Aerosphere', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1604', 'active_substance': 'formoterol / glycopyrronium bromide / budesonide', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'R03AL11'}"
EU-1-21-1605,"{'status': 'ACTIVE', 'name': 'Tavneos', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1605', 'active_substance': 'avacopan', 'market_auth_holder': 'Vifor Fresenius Medical Care Renal Pharma France'}"
EU-1-21-1618,"{'status': 'ACTIVE', 'name': 'Nuvaxovid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1618', 'active_substance': 'COVID-19 Vaccine (recombinant, adjuvanted)', 'market_auth_holder': 'Novavax CZ, a.s.', 'atc_code': 'J07BX03'}"
EU-1-21-1573,"{'status': 'ACTIVE', 'name': 'Fingolimod Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1573', 'active_substance': 'fingolimod', 'market_auth_holder': 'Mylan Ireland Limited', 'atc_code': 'L04AA27'}"
EU-1-21-1615,"{'status': 'ACTIVE', 'name': 'Padcev', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1615', 'active_substance': 'enfortumab vedotin', 'market_auth_holder': 'Astellas Pharma Europe B.V.'}"
EU-1-21-1616,"{'status': 'ACTIVE', 'name': 'Kerendia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1616', 'active_substance': 'finerenone', 'market_auth_holder': 'Bayer AG'}"
EU-1-21-1617,"{'status': 'ACTIVE', 'name': 'Ngenla', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1617', 'active_substance': 'somatrogon', 'market_auth_holder': 'Pfizer Europe MA EEIG'}"
EU-1-21-1622,"{'status': 'ACTIVE', 'name': 'Oxbryta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1622', 'active_substance': 'voxelotor', 'market_auth_holder': 'Global Blood Therapeutics Netherlands B.V.', 'atc_code': 'B06AX'}"
EU-1-22-1663,"{'status': 'ACTIVE', 'name': 'Sugammadex Fresenius Kabi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1663', 'active_substance': 'sugammadex', 'market_auth_holder': 'Fresenius Kabi Deutschland GmbH', 'atc_code': 'V03AB35'}"
EU-1-21-1552,"{'status': 'ACTIVE', 'name': 'Koselugo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1552', 'active_substance': 'selumetinib', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'L01EE04'}"
EU-1-21-1568,"{'status': 'ACTIVE', 'name': 'Imatinib Koanaa', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1568', 'active_substance': 'imatinib', 'market_auth_holder': 'Koanaa Healthcare GmbH', 'atc_code': 'L01EA01'}"
EU-1-21-1569,"{'status': 'ACTIVE', 'name': 'QINLOCK', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1569', 'active_substance': 'ripretinib', 'market_auth_holder': 'Deciphera Pharmaceuticals (Netherlands) B.V.', 'atc_code': 'L01EX19'}"
EU-1-21-1572,"{'status': 'ACTIVE', 'name': 'Byooviz', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1572', 'active_substance': 'ranibizumab', 'market_auth_holder': 'Samsung Bioepis NL B.V.', 'atc_code': 'S01LA04'}"
EU-1-21-1599,"{'status': 'ACTIVE', 'name': 'Vyepti', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1599', 'active_substance': 'eptinezumab', 'market_auth_holder': 'H. Lundbeck A/S', 'atc_code': 'N02CD05'}"
EU-1-18-1337,"{'status': 'ACTIVE', 'name': 'GHRYVELIN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1337', 'active_substance': 'macimorelin', 'market_auth_holder': 'Consilient Health Ltd', 'atc_code': 'V04CD06'}"
EU-1-21-1624,"{'status': 'ACTIVE', 'name': 'COVID-19 Vaccine (inactivated, adjuvanted) Valneva', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1624', 'active_substance': 'COVID-19 vaccine (inactivated, adjuvanted, adsorbed)', 'market_auth_holder': 'Valneva Austria GmbH', 'atc_code': 'J07BX03'}"
EU-1-22-1656,"{'status': 'ACTIVE', 'name': 'Ertapenem SUN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1656', 'active_substance': 'ertapenem', 'market_auth_holder': 'Sun Pharmaceutical Industries Europe B.V.', 'atc_code': 'J01DH03'}"
EU-1-21-1574,"{'status': 'ACTIVE', 'name': 'Evrenzo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1574', 'active_substance': 'roxadustat', 'market_auth_holder': 'Astellas Pharma Europe B.V.', 'atc_code': 'B03XA05'}"
EU-1-21-1577,"{'status': 'ACTIVE', 'name': 'Voxzogo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1577', 'active_substance': 'vosoritide', 'market_auth_holder': 'BioMarin International Limited', 'atc_code': 'M05BX07'}"
EU-1-21-1623,"{'status': 'ACTIVE', 'name': 'Saphnelo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1623', 'active_substance': 'anifrolumab', 'market_auth_holder': 'AstraZeneca AB'}"
EU-1-22-1631,"{'status': 'ACTIVE', 'name': 'Breyanzi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1631', 'active_substance': 'lisocabtagene maraleucel', 'market_auth_holder': 'Bristol Myers Squibb Pharma EEIG'}"
EU-1-22-1632,"{'status': 'ACTIVE', 'name': 'Stimufend', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1632', 'active_substance': 'pegfilgrastim', 'market_auth_holder': 'Fresenius Kabi Deutschland GmbH', 'atc_code': 'L03AA13'}"
EU-1-22-1633,"{'status': 'ACTIVE', 'name': 'Sitagliptin Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1633', 'active_substance': 'Sitagliptin', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'A10BH01'}"
EU-1-22-1639,"{'status': 'ACTIVE', 'name': 'Truvelog Mix 30', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1639', 'active_substance': 'insulin aspart', 'market_auth_holder': 'Sanofi-Aventis groupe', 'atc_code': 'A10AD05'}"
EU-1-22-1640,"{'status': 'ACTIVE', 'name': 'Amversio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1640', 'active_substance': 'betaine anhydrous', 'market_auth_holder': 'SERB S.A.', 'atc_code': 'A16AA06'}"
EU-1-21-1583,"{'status': 'ACTIVE', 'name': 'Sugammadex Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1583', 'active_substance': 'sugammadex', 'market_auth_holder': 'Mylan Ireland Limited', 'atc_code': 'V03AB35'}"
EU-1-20-1453,"{'status': 'ACTIVE', 'name': 'BYANNLI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1453', 'active_substance': 'paliperidone', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'N05AX13'}"
EU-1-21-1603,"{'status': 'ACTIVE', 'name': 'Lumykras', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1603', 'active_substance': 'sotorasib', 'market_auth_holder': 'Amgen Europe B.V.', 'atc_code': 'L01XX73'}"
EU-1-21-1621,"{'status': 'ACTIVE', 'name': 'OKEDI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1621', 'active_substance': 'risperidone', 'market_auth_holder': 'Laboratorios Farmac&#233;uticos Rovi, S.A.'}"
EU-1-22-1641,"{'status': 'ACTIVE', 'name': 'PreHevbri', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1641', 'active_substance': 'Hepatitis B vaccine (recombinant, adsorbed)', 'market_auth_holder': 'VBI Vaccines B.V.', 'atc_code': 'J07BC01'}"
EU-1-22-1642,"{'status': 'ACTIVE', 'name': 'Orgovyx', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1642', 'active_substance': 'relugolix', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L02BX04'}"
EU-1-20-1507,"{'status': 'ACTIVE', 'name': 'Spikevax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1507', 'active_substance': 'elasomeran', 'market_auth_holder': 'MODERNA BIOTECH SPAIN, S.L.', 'atc_code': 'J07BX03'}"
EU-1-22-1643,"{'status': 'ACTIVE', 'name': 'Kapruvia', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1643', 'active_substance': 'difelikefalin', 'market_auth_holder': 'Vifor Fresenius Medical Care Renal Pharma France'}"
EU-1-22-1664,"{'status': 'ACTIVE', 'name': 'Cevenfacta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1664', 'active_substance': 'eptacog beta (activated)', 'market_auth_holder': 'Laboratoire fran&#231;ais du Fractionnement et des Biotechnologies', 'atc_code': 'B02BD08'}"
EU-1-21-1570,"{'status': 'ACTIVE', 'name': 'Minjuvi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1570', 'active_substance': 'tafasitamab', 'market_auth_holder': 'Incyte Biosciences Distribution B.V.'}"
EU-1-21-1571,"{'status': 'ACTIVE', 'name': 'Abiraterone Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1571', 'active_substance': 'abiraterone acetate', 'market_auth_holder': 'Mylan Ireland Limited', 'atc_code': 'L02BX03'}"
EU-1-22-1666,"{'status': 'ACTIVE', 'name': 'Celdoxome pegylated liposomal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1666', 'active_substance': 'doxorubicin hydrochloride', 'market_auth_holder': 'YES Pharmaceutical Development Services GmbH', 'atc_code': 'L01DB01'}"
EU-1-22-1667,"{'status': 'ACTIVE', 'name': 'VEGZELMA', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1667', 'active_substance': 'bevacizumab', 'market_auth_holder': 'Celltrion Healthcare Hungary Kft.', 'atc_code': 'L01XC07'}"
EU-1-22-1668,"{'status': 'ACTIVE', 'name': 'Roctavian', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1668', 'active_substance': 'valoctocogene roxaparvovec', 'market_auth_holder': 'BioMarin International Limited'}"
EU-1-22-1669,"{'status': 'ACTIVE', 'name': 'Pepaxti', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1669', 'active_substance': 'melphalan flufenamide', 'market_auth_holder': 'Oncopeptides AB (publ)'}"
EU-1-22-1670,"{'status': 'ACTIVE', 'name': 'Scemblix', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1670', 'active_substance': 'asciminib', 'market_auth_holder': 'Novartis Europharm Limited'}"
EU-1-21-1611,"{'status': 'ACTIVE', 'name': 'Vildagliptin/Metformin hydrochloride Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1611', 'active_substance': 'vildagliptin / metformin hydrochloride', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'A10BD08'}"
EU-1-22-1652,"{'status': 'ACTIVE', 'name': 'Filsuvez', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1652', 'active_substance': 'birch bark extract', 'market_auth_holder': 'Amryt Pharmaceuticals DAC', 'atc_code': 'D03AX13'}"
EU-1-22-1653,"{'status': 'ACTIVE', 'name': 'Upstaza', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1653', 'active_substance': 'eladocagene exuparvovec', 'market_auth_holder': 'PTC Therapeutics International Limited'}"
EU-1-07-437,"{'status': 'ACTIVE', 'name': 'IVEMEND', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/437', 'active_substance': 'fosaprepitant', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A04AD12'}"
EU-1-22-1658,"{'status': 'ACTIVE', 'name': 'Ganirelix Gedeon Richter', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1658', 'active_substance': 'ganirelix', 'market_auth_holder': 'Gedeon Richter Plc.', 'atc_code': 'H01CC01'}"
EU-1-21-1582,"{'status': 'ACTIVE', 'name': 'Artesunate Amivas', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1582', 'active_substance': 'artesunate', 'market_auth_holder': 'Amivas Ireland Limited', 'atc_code': 'P01BE03'}"
EU-1-21-1592,"{'status': 'ACTIVE', 'name': 'Trodelvy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1592', 'active_substance': 'sacituzumab govitecan', 'market_auth_holder': 'Gilead Sciences Ireland UC', 'atc_code': 'L01FX17'}"
EU-1-21-1549,"{'status': 'ACTIVE', 'name': 'Efmody', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1549', 'active_substance': 'hydrocortisone', 'market_auth_holder': 'Diurnal Europe B.V.', 'atc_code': 'H02AB09'}"
EU-1-21-1564,"{'status': 'ACTIVE', 'name': 'Imcivree', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1564', 'active_substance': 'setmelanotide', 'market_auth_holder': 'Rhythm Pharmaceuticals Netherlands B.V.', 'atc_code': 'A08AA12'}"
EU-1-21-1575,"{'status': 'ACTIVE', 'name': 'Bimzelx', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1575', 'active_substance': 'bimekizumab', 'market_auth_holder': 'UCB Pharma S.A.', 'atc_code': 'L04AC21'}"
EU-1-22-1629,"{'status': 'ACTIVE', 'name': 'ZOLSKETIL pegylated liposomal', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1629', 'active_substance': 'doxorubicin', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L01DB01'}"
EU-1-22-1630,"{'status': 'ACTIVE', 'name': 'KIMMTRAK', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1630', 'active_substance': 'tebentafusp', 'market_auth_holder': 'Immunocore Ireland Limited'}"
EU-1-22-1651,"{'status': 'ACTIVE', 'name': 'EVUSHELD', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1651', 'active_substance': 'tixagevimab / cilgavimab', 'market_auth_holder': 'AstraZeneca AB'}"
EU-1-21-1595,"{'status': 'ACTIVE', 'name': 'ASPAVELI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1595', 'active_substance': 'pegcetacoplan', 'market_auth_holder': 'Swedish Orphan Biovitrum AB (publ)', 'atc_code': 'L04AA54'}"
EU-1-21-1619,"{'status': 'ACTIVE', 'name': 'Sitagliptin/Metformin hydrochloride Mylan', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1619', 'active_substance': 'sitagliptin/metformin hydrochloride', 'market_auth_holder': 'Mylan Ireland Limited', 'atc_code': 'A10BD07'}"
EU-1-21-1620,"{'status': 'ACTIVE', 'name': 'Sapropterin Dipharma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1620', 'active_substance': 'sapropterin', 'market_auth_holder': 'Dipharma B.V.', 'atc_code': 'A16AX07'}"
EU-1-21-1544,"{'status': 'ACTIVE', 'name': 'Orladeyo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1544', 'active_substance': 'berotralstat', 'market_auth_holder': 'Biocryst Ireland Limited', 'atc_code': 'B06AC'}"
EU-1-21-1557,"{'status': 'ACTIVE', 'name': 'Jayempi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1557', 'active_substance': 'azathioprine', 'market_auth_holder': 'Nova Laboratories Ireland Limited', 'atc_code': 'L04AX01'}"
EU-1-21-1558,"{'status': 'ACTIVE', 'name': 'Klisyri', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1558', 'active_substance': 'tirbanibulin', 'market_auth_holder': 'Almirall, S.A.', 'atc_code': 'D06BX03'}"
EU-1-21-1578,"{'status': 'ACTIVE', 'name': 'Ontilyv', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1578', 'active_substance': 'opicapone', 'market_auth_holder': 'Bial - Portela &amp; C&#170;, SA', 'atc_code': 'N04BX04'}"
EU-1-09-568,"{'status': 'ACTIVE', 'name': 'Clopidogrel Viatris', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/568', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'Viatris Limited', 'atc_code': 'B01AC04'}"
EU-1-09-559,"{'status': 'ACTIVE', 'name': 'Clopidogrel Taw Pharma', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/09/559', 'active_substance': 'Clopidogrel', 'market_auth_holder': 'Taw Pharma (Ireland) Limited', 'atc_code': 'B01AC04'}"
EU-1-22-1646,"{'status': 'ACTIVE', 'name': 'Amifampridine SERB', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1646', 'active_substance': 'amifampridine', 'market_auth_holder': 'SERB S.A.', 'atc_code': 'N07XX05'}"
EU-1-20-1525,"{'status': 'ACTIVE', 'name': 'JCOVDEN', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1525', 'active_substance': 'COVID-19 vaccine (Ad26.COV2-S [recombinant])', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'J07BX03'}"
EU-1-21-1565,"{'status': 'ACTIVE', 'name': 'Ryeqo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1565', 'active_substance': 'relugolix / estradiol / norethisterone acetate', 'market_auth_holder': 'Gedeon Richter Plc.', 'atc_code': 'H01CC54'}"
EU-1-21-1529,"{'status': 'ACTIVE', 'name': 'Vaxzevria', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1529', 'active_substance': 'COVID-19 Vaccine (ChAdOx1-S [recombinant])', 'market_auth_holder': 'AstraZeneca AB', 'atc_code': 'J07BX03'}"
EU-1-22-1625,"{'status': 'ACTIVE', 'name': 'Paxlovid', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1625', 'active_substance': '(1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide / ritonavir', 'market_auth_holder': 'Pfizer Europe MA EEIG'}"
EU-1-22-1657,"{'status': 'ACTIVE', 'name': 'Kinpeygo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1657', 'active_substance': 'budesonide', 'market_auth_holder': 'STADA Arzneimittel AG'}"
EU-1-21-1559,"{'status': 'ACTIVE', 'name': 'Enspryng', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1559', 'active_substance': 'satralizumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L04AC19'}"
EU-1-21-1560,"{'status': 'ACTIVE', 'name': 'Celsunax', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1560', 'active_substance': 'ioflupane (123I)', 'market_auth_holder': 'Pinax Pharma GmbH', 'atc_code': 'V09AB03'}"
EU-1-21-1579,"{'status': 'ACTIVE', 'name': 'Nexviadyme', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1579', 'active_substance': 'avalglucosidase alfa', 'market_auth_holder': 'Genzyme Europe B.V.'}"
EU-1-22-1628,"{'status': 'ACTIVE', 'name': 'Sondelbay', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1628', 'active_substance': 'teriparatide', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'H05AA02'}"
EU-1-22-1659,"{'status': 'ACTIVE', 'name': 'Xenpozyme', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1659', 'active_substance': 'olipudase alfa', 'market_auth_holder': 'Genzyme Europe B.V.'}"
EU-1-22-1660,"{'status': 'ACTIVE', 'name': 'Zokinvy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1660', 'active_substance': 'lonafarnib', 'market_auth_holder': 'EigerBio Europe Limited'}"
EU-1-22-1661,"{'status': 'ACTIVE', 'name': 'Sitagliptin/Metformin hydrochloride Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1661', 'active_substance': 'sitagliptin/metformin hydrochloride', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'A10BD07'}"
EU-1-18-1350,"{'status': 'ACTIVE', 'name': 'Vantobra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/18/1350', 'active_substance': 'tobramycin', 'market_auth_holder': 'PARI Pharma GmbH', 'atc_code': 'J01GB01'}"
EU-1-21-1562,"{'status': 'ACTIVE', 'name': 'Xevudy', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1562', 'active_substance': 'sotrovimab', 'market_auth_holder': 'GlaxoSmithKline Trading Services Limited'}"
EU-1-15-1035,"{'status': 'ACTIVE', 'name': 'OBIZUR', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1035', 'active_substance': 'susoctocog alfa', 'market_auth_holder': 'Baxalta Innovations GmbH', 'atc_code': 'B02BD14'}"
EU-1-21-1585,"{'status': 'ACTIVE', 'name': 'Vumerity', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1585', 'active_substance': 'diroximel fumarate', 'market_auth_holder': 'Biogen Netherlands B.V.', 'atc_code': 'L04AX09'}"
EU-1-21-1586,"{'status': 'ACTIVE', 'name': 'Voraxaze', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1586', 'active_substance': 'glucarpidase', 'market_auth_holder': 'SERB SAS', 'atc_code': 'V03AF09'}"
EU-1-22-1648,"{'status': 'ACTIVE', 'name': 'CARVYKTI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1648', 'active_substance': 'ciltacabtagene autoleucel', 'market_auth_holder': 'Janssen-Cilag International NV'}"
EU-1-22-1650,"{'status': 'ACTIVE', 'name': 'Tabrecta', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1650', 'active_substance': 'capmatinib', 'market_auth_holder': 'Novartis Europharm Limited'}"
EU-1-21-1566,"{'status': 'ACTIVE', 'name': 'Bylvay', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1566', 'active_substance': 'odevixibat', 'market_auth_holder': 'Albireo AB', 'atc_code': 'A05AX05'}"
EU-1-22-1649,"{'status': 'ACTIVE', 'name': 'Lunsumio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1649', 'active_substance': 'mosunetuzumab', 'market_auth_holder': 'Roche Registration GmbH', 'atc_code': 'L01XC'}"
EU-1-21-1567,"{'status': 'ACTIVE', 'name': 'Icatibant Accord', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/21/1567', 'active_substance': 'icatibant', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'B06AC02'}"
EU-1-22-1647,"{'status': 'ACTIVE', 'name': 'Camcevi', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1647', 'active_substance': 'leuprorelin', 'market_auth_holder': 'Accord Healthcare S.L.U.', 'atc_code': 'L02AE02'}"
EU-1-20-1506,"{'status': 'ACTIVE', 'name': 'Kirsty', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/20/1506', 'active_substance': 'Insulin aspart', 'market_auth_holder': 'Mylan IRE Healthcare Limited', 'atc_code': 'A10AB05'}"
EU-1-22-1684,"{'status': 'ACTIVE', 'name': 'NULIBRY', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1684', 'active_substance': 'fosdenopterin', 'market_auth_holder': 'Comharsa Life Sciences Limited', 'atc_code': 'A16AX'}"
EU-1-22-1677,"{'status': 'ACTIVE', 'name': 'Tezspire', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1677', 'active_substance': 'tezepelumab', 'market_auth_holder': 'AstraZeneca AB'}"
EU-1-22-1678,"{'status': 'ACTIVE', 'name': 'Lupkynis', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1678', 'active_substance': 'voclosporin', 'market_auth_holder': 'Otsuka Pharmaceutical Netherlands B.V.', 'atc_code': 'L04AD03'}"
EU-1-22-1679,"{'status': 'ACTIVE', 'name': 'Opdualag', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1679', 'active_substance': 'nivolumab/relatlimab', 'market_auth_holder': 'Bristol Myers Squibb Pharma EEIG'}"
EU-1-22-1681,"{'status': 'ACTIVE', 'name': 'Amvuttra', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1681', 'active_substance': 'vutrisiran', 'market_auth_holder': 'Alnylam Netherlands B.V.'}"
EU-1-22-1683,"{'status': 'ACTIVE', 'name': 'Vabysmo', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1683', 'active_substance': 'Faricimab', 'market_auth_holder': 'Roche Registration GmbH'}"
EU-1-22-1676,"{'status': 'ACTIVE', 'name': 'Thalidomide Lipomed', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1676', 'active_substance': 'Thalidomide', 'market_auth_holder': 'Lipomed GmbH', 'atc_code': 'L04AX02'}"
EU-1-15-1057,"{'status': 'ACTIVE', 'name': 'Pemetrexed Pfizer', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/15/1057', 'active_substance': 'pemetrexed', 'market_auth_holder': 'Pfizer Europe MA EEIG', 'atc_code': 'L01BA04'}"
EU-1-22-1685,"{'status': 'ACTIVE', 'name': 'Mounjaro', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1685', 'active_substance': 'tirzepatide', 'market_auth_holder': 'Eli Lilly Nederland B.V.'}"
EU-1-22-1655,"{'status': 'ACTIVE', 'name': 'Pirfenidone axunio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1655', 'active_substance': 'pirfenidone', 'market_auth_holder': 'axunio Pharma GmbH'}"
EU-1-22-1671,"{'status': 'ACTIVE', 'name': 'Sunlenca', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1671', 'active_substance': 'lenacapavir', 'market_auth_holder': 'Gilead Sciences Ireland UC'}"
EU-1-22-1675,"{'status': 'ACTIVE', 'name': 'TECVAYLI', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1675', 'active_substance': 'teclistamab', 'market_auth_holder': 'Janssen-Cilag International NV', 'atc_code': 'L01F'}"
EU-1-22-1680,"{'status': 'ACTIVE', 'name': 'ilLuzyce', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1680', 'active_substance': 'lutetium (<sup>177</sup>Lu) chloride', 'market_auth_holder': 'Billev Pharma ApS', 'atc_code': 'V10X'}"
EU-1-07-435,"{'status': 'ACTIVE', 'name': 'Tesavel', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/07/435', 'active_substance': 'sitagliptin', 'market_auth_holder': 'Merck Sharp &amp; Dohme B.V.', 'atc_code': 'A10BH01'}"
EU-1-22-1674,"{'status': 'ACTIVE', 'name': 'Vyvgart', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1674', 'active_substance': 'efgartigimod alfa', 'market_auth_holder': 'argenx BV'}"
EU-1-22-1673,"{'status': 'ACTIVE', 'name': 'Ranivisio', 'orphan_status': 'h', 'status_type': 'a', 'eu_num': 'EU/1/22/1673', 'active_substance': 'ranibizumab', 'market_auth_holder': 'Midas Pharma GmbH', 'atc_code': 'S01LA04'}"
